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ABSTRACT 
 
 
Single nucleotide polymorphisms (SNPs) are one of the forensic markers used to 
resolve the problem of DNA typing from degraded samples. It has been found in 
previous studies that when profiling heavily degraded forensic samples the small 
amplicon required for SNP analysis has an advantage over the larger STR loci, which 
are routinely used in forensic case work. 
A total of 66 SNPs from the non-coding region of the 22 pairs of autosomal 
chromosomes were identified and SNP assays developed. Instead of selecting the SNPs 
from the available GenBank® sites, SNPs were typed from Arab individuals from 
Kuwait and United Arab Emirates (UAE) to identify polymorphic SNPs.  
In order to obtain SNP data from Arab populations, a total of 10 unrelated Arab 
individuals from Kuwait and UAE were typed. The Affymetrix GeneChip® Mapping 
250 K Array Sty І was employed to generate profiles for approximately 238,000 SNPs. 
Only autosomal SNPs were selected from the data.  
Following selection, allele frequencies were estimated using the SNaPshot™ technique 
(Applied Biosystems) with 25 UAE individuals. For this technique, PCR forward and 
reverse primers were designed to generate PCR products less than 150 bp. The single 
base extension primers were designed to hybridise 1 bp upstream from the target SNP. 
SNP characterization, including HardyWeinberg equilibrium and pair wise linkage 
disequilibrium, was carried out using the software package Arlequin v 3.1. Allele 
frequencies were calculated using Excel spreadsheets. PowerStats v.12 software used 
for discrimination power and match probability estimation. 
iii 
 
All the 66 SNPs were polymorphic with average heterozygosity levels of 47%. A high 
heterozygosity level is very valuable for forensic application improving the 
individualization of forensic samples (Vallone et al. 2005). The probability that two 
individuals having identical genotype profile was found to be very low, 3.058 x 10
-25
. 
The combined power of discrimination was found to be 0.999999999. This indicated 
that the selected SNPs met the parameters needed for forensic application. 
The SNPs genotype sensitivity gave profiles from minute amounts of DNA template as 
little as 100 pico grams (pg) and optimal and reproducible results at 300 pg of DNA 
template. 
The profiling of DNA from forensic samples is not always possible. This can be due to 
insufficient amount of samples being recovered and in many cases, DNA degradation. 
Biological materials that are recovered from the scene of the crime have often been 
exposed to sub-optimal environmental conditions such as high temperature and 
humidity.  
SNPs performance on degraded samples was tested on artificially degraded saliva and 
semen samples. Controlled temperature and humidity experiments were performed to 
study the effect of these environmental factors on the samples. Also uncontrolled 
experiments on samples being subjected to different weather conditions (UK summer 
and UAE winter and summer) was performed in order to study and compare both 
weather effects on saliva samples. The triplex sets of SNPs that were developed for such 
study showed full allele profiles when compared to STRs, the current method used in 
forensic labs. In addition, SNPs produced a higher success rate than STRs when tested 
with samples obtained from human teeth remains and on samples subjected to DNase 1 
digestion. The small size of SNPs, between 90 and 147 base pair (bp), showed more 
resistance to degradation than the STRs size ranging between 100 and 360 bp. 
iv 
 
This study demonstrated that the 66 SNPs selected are useful markers when the typing 
of degraded samples by STRs fails to produce complete or partial profiles. 
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1.1. Overview 
The majority of forensic analyses are concerned with the identification, characterisation 
and matching of forensic evidence. Frequently, the forensic scientist is asked to 
characterise biological samples from the scene of a crime for comparison with a 
potential suspect. Biological samples may include blood, semen, and saliva stains 
(Patzelt, 2004). Another category of forensic genetics is based around the testing of 
biological relationships and the identification of human remains, which may have been 
subjected to environmental insult. 
1.2. Classic Genetic Markers 
The suggestion that genetic markers may be applied to identify forensic samples is not a 
new concept (Altukhov and Salmenkova, 2002). The discovery of immunological and 
biochemical markers such as haemoglobin, blood grouping (ABO) and acid 
phosphatase, have been developed and applied to forensic analysis since 1915 (Patzelt, 
2004; Jobling and Gill, 2004). These classic markers provide valuable evidence. 
However, these genetic markers show only small levels of individual variation and it is 
therefore difficult in many cases to produce a profile with a very high match probability. 
For example, the ABO blood group system can be used to classify people into only four 
different types: blood groups A, B, AB and O. The matching of an ABO type between a 
forensic blood stain and suspect therefore provides only weak statistical evidence for 
true association. Furthermore, these markers are unstable and frequently deteriorate in 
forensic specimens due to environmental effects such as heat, humidity and time 
(Budimlija et al., 2003). 
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1.3. Human Genome  
1.3.1. Genomic Deoxyribonucleic Acid  
Deoxyribonucleic acid (DNA) is the genetic material found in the cell nucleus. The 
human body is composed of trillions of cells, each cell, with the exception of red blood 
cells contains 46 chromosomes. The human genome is composed of 3.2 giga base pairs 
(Gb) of DNA (in a haploid cell). Individuals share approximately 99.9% homology 
through their genetic code; their genetic differences are determined by the remaining 
0.1% of DNA (Baltimore, 2001; Li et al., 2006).  
DNA contains length and sequence polymorphisms (Figure 1.1). The polymorphisms 
that have received most attention are related to disease, which lead directly to an 
individual developing an illness. Analysing regions of the genome that are not subject to 
selection pressure has also allowed DNA to be used to study human evolution. In 
addition, DNA analysis offers valuable information in forensic science with 
polymorphisms allowing the typing and identification of biological materials (Budowele 
et al., 2005). 
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Figure 1.1. Shown above is a schematic diagram, which was adapted from Kashayab et 
al. (2004) and shows DNA polymorphisms in the human genome.  
 
1.3.1.1. Coding Region 
The portion of gene sequence in the human genome that is translated to protein is 
located in the coding regions, which are called exons, and represent only 1.1% of the 
genome (Baltimore, 2001). This region is responsible for an individual's phenotype such 
as skin colour and hair type, as well as all the underlying biochemical processes.  
1.3.1.2. Noncoding Region 
As reported by Venter et al. (2001) and Collins et al. (2004) in the analysis of the 
human genome sequence, noncoding DNA accounts for 99% of the genome. Most of 
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the genetic variation between humans is found within these noncoding regions 
(Sachidanandam et al., 2001). 
1.3.2. DNA Polymorphisms 
The a lleles are alternative forms of a gene that represent variation at specific position 
on chromosome and when the allele of a particular marker is present at 1% or greater in 
a given population, then that particular marker is considered to be polymorphic 
(Brookes, 1999). 
Forensic DNA analysis began in 1985 after the discovery by Jeffreys et al. (1985) of 
variable number tandem repeats (VNTRs) or minisatellites. Minisatellites consist of a 
core region of DNA, which is typically 10 bp to 100 bp and is repeated tandemly. The 
variation of VNTRs between individuals exists due to different numbers of the core unit 
(Jeffreys et al., 1985). 
VNTR technology was limited because it required a relatively large amount of high 
molecular weight DNA, which was not available from many forensic samples (Patzelt, 
2004). 
1.3.3. Polymerase Chain Reaction Mediated Analysis 
Advances in molecular biology have made it possible to explore DNA variation 
directly. This, in turn, has led to the development of powerful DNA typing systems and 
the majority of these systems are based on the polymerase chain reaction (PCR), which 
is an enzymatic process by which a specific region of DNA is replicated many times to 
yield several million copies of a particular sequence (Saiki et al., 1985; Mullis et al., 
1986). DNA amplification technology based on PCR is ideally suited for the analysis of 
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forensic samples, due to its sensitivity, its speed and its ability to provide sufficient 
copies of target sequences of DNA required for forensic comparison (Schneider et al., 
2004; Kline et al., 2005).  
1.3.3.1. Short Tandem Repeats 
Short tandem repeats (STRs), also known as microsatellites, consist of tandem repeat 
sequences (Figure 1.2), with repeats consisting of 1-6 bp (Krawczak and Schmidtke, 
1994). STRs are abundant throughout the human genome and occur on average every 
6,000-10,000 bp (Beckmann and Weber, 1992).  
Commercially available kits generate products that range between 100 bp and 450 bp. 
PCR-based systems, unlike VNTRs, require only one nanogram (ng) of DNA (Butler, 
2007), and by typing several loci (typically at least 9 loci) simultaneously, high levels of 
discrimination can be achieved. The probability of two unrelated individuals having the 
same AmpFℓSTR® SGM plus® (which profiles 10 STR loci) profile is approximately 1 
in 10
-13
 (Butler et al., 2003; Gill, 2002; Tsukada et al., 2002). 
Using STRs to analyse highly degraded DNA in samples collected from crime scenes, 
including burnt and highly decomposed remains, is not always possible (Gill, 2002). In 
such samples, the DNA length is subjected to a reduction and ultimately larger STRs 
such as FGA (in the SGM plus
®
) loci are affected and allelic drop-out may be observed 
(Butler, 2006). 
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Figure 1.2. Shown above are two STR alleles containing 5 and 7 repeats of the core 
repeat. Also shown are the PCR primer binding sites that flank the repeat region. 
 
1.3.3.2. Mini Short Tandem Repeats 
Since PCR product sizes are governed by the primer binding site (Butler et al., 2004). In 
many cases it is possible to reduce the size of most PCR products by moving the primer 
binding site closer to the core repeat of the STRs (Figure 1.3) (Tsukada et al., 2002; 
Butler et al., 2003). 
However, some STRs loci are not suitable for forensic analysis due to unsuitable primer 
sites or larger allele sizes, such as D13S317 and FGA (Butler et al., 2003). Moreover, 
the discriminatory power of commercial mini STR kits is lower than standard STR kits 
markers; only 8 loci are currently available in a commercial multiplex kit.  
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Figure 1.3. Shown above is a schematic diagram illustrating the difference of PCR 
primer binding sites between a STR and mini STRs. In the case of the mini STR, the 
primers bind nearer to the repeats.  
 
The mini STR kits are designed for use along with one of the standards STR kit, for 
example the AmpFℓSTR® MiniFiler™ is designed to be used with the AmpFℓSTR® 
Identifiler
®
 kit. 
1.3.3.3. Y- Chromosome STRs 
STRs markers on the Y chromosome can be considered as a fundamental tool in a 
number of forensic identification applications (Jobling, 2001; Gill et al., 2001; Sanchez 
et al., 2003). These STRs contain male genetic information  (Butler, 2006) and thus may 
be applied to sexual assault cases where a mixture of male and female DNA is likely to 
be found (Jobling, 2001; Kayser, 2007). These STRs can also be useful in cases where 
the male genetic information is crucial, such as paternity cases, especially in the absence 
of the father, necessitating the testing of more distant relatives (Gill et al., 2001; 
Sanchez et al., 2003). 
Despite their utility in forensic application, STRs on the Y chromosome encounter 
limitations as markers due to their haplotype nature, and lack of meiotic recombination. 
Consequently, their impact in forensic cases is reduced in terms of discrimination: the 
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genetic features of these STRs are inherited and passed from one generation to another 
among related males without change. However Y STRs can be applied for exclusion 
purposes (Palo et al. 2007).  
1.3.3.4. Mitochondrial DNA 
Human mitochondrial DNA (mtDNA) consists of approximately 16.5 kb (16,569 bp) of 
closed, double stranded, circular DNA (Holland and Parsons, 1999). Most of the 
sequence variation in this DNA is found in 2 hypervariable segments: hypervariable 
segment І (HVS-І) and hypervariable segment ІІ (HVSІІ (Holland and Parsons, 1999).  
In the context of forensic DNA typing, mtDNA is a powerful tool for typing damaged 
forensic samples. This is due to the fact that cells contain a high mitochondrial copy 
number, which is greater than 1000 per cell (Salas et al., 2007). The relative abundance 
of mtDNA makes it suitable to recover genetic information for forensic identification 
where the amount of nuclear DNA present is insufficient for analysis or the DNA is in a 
highly degraded state (Vallone et al., 2004; Niederstätter et al., 2006). 
Due to the maternal mode of inheritance of mtDNA, the match probability of two 
individuals sharing the same profile is relatively high. 
1.3.3.5. Low Copy Number 
Full STR profiles can be routinely obtained from 250 picograms (pg) of DNA (Gill, 
2001). The amount of template DNA recovered from many forensic samples is adequate 
(Clayton et al., 1995). However, in many cases, such as with touch DNA, insufficient 
DNA for standard profiling is recovered (Wolff and Gemmell, 2008). 
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To generate DNA profiles from samples with low copy number (LCN) different 
strategies have been employed to overcome the loss of genetic information (Mulero et 
al., 2008).  These include: increasing the number of cycles from standard PCR protocol 
from 28-30 to 34 cycles, which was found to favour of number of detected alleles (Gill, 
2001; Kloosterman and Kersbergen, 2003); reducing the PCR volume; filtration of the 
amplicon to remove ions that compete with DNA when being injected into the capillary; 
and adding more amplified product to the denature formamide; increasing injection time 
(Budowle et al, 2001; Forster et al, 2008). However, although these modifications to 
PCR and detection methodology led to improvements in some cases, ambiguous results 
that often interfere with the analysis of profiles led many forensic laboratories to stop 
using the method. Because of the sensitivity of the new method to contamination, 
exogenous DNA can be amplified along side the evidential DNA, introducing unrelated 
alleles. In addition, unbalanced alleles in heterozygote samples are often observed 
(Budowle et al., 2001; Gill et al., 2001). 
1.4. Single Nucleotide Polymorphisms  
Single nucleotide polymorphism (SNPs) in the human genome are the change of single 
nucleotides at a particular loci (Figure 1.4). On the basis of the number of alleles in each 
locus, SNPs are counted as biallelic polymorphisms, however, triallelic SNPs are also 
known to occur at a very low frequency within the human genome (Brookes, 1999). 
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Figure 1.4. Shown above is a schematic diagram illustrating two DNA strands carrying 
a SNP: T and C. 
SNPs occur, on average, every 1000 bp in the human genome, which leads to a high 
quantity of SNPs, most of which lie outside the coding region of the genome (Collins et 
al., 2001; Cooper et al., 1985; Metzker, 2005; Venter et al., 2001). These SNPs 
constitute more than 80% of genome variation with the remaining 20% of variation due 
to length polymorphisms, insertions, deletions and duplications (Haff and Smirnov, 
1997).  
The announcement of sequence mapping of the human genome in 2001 by the 
international human genome sequencing consortium, a worldwide collaboration of 
different groups, has increased the scientific communities’s knowledge of SNPs greatly. 
The collaborating groups included: the haplotype map consortium (HapMap) (Sobrino 
et al., 2005), the SNP consortium (TSC) (Thorisson and Stein, 2003), and a number of 
other private groups and foundations such as academic centres and pharmaceutical 
companies (Halim and Altsbuler, 2001). Sequencing the human genome has provided 
researchers with tools and strategies to understand genetic variations, and the relation of 
phenotypes and the genes associated with particular diseases in humans (Gray et al., 
2000). 
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1.4.1. Methods for the detection of SNPs  
Large numbers of SNP sequences have been discovered over the past few years, which 
has led to a large amount of data becoming available for forensic applications 
(Thorisson and Stein, 2003). However, with the completion of the Human Genome 
Project, the discovery of SNPs has put great pressure on DNA technologists to design 
techniques and methods to meet the demand of researchers and scientists (Jenkins and 
Gibson, 2002).  
In choosing a particular technique for SNP detection, it is important to consider the 
three main principles that govern the process: 
- allelic discrimination reactions; 
- detection techniques; and 
- assay formats (Landegren et al., 1998; Sobrino et al., 2005). 
1.4.1.1. Allelic Discrimination Reactions 
Allelic discrimination reactions are methods to determine the type of variants of 
sequence on target DNA. On the basic alleles, variants can be classified as either 
homozygous; that is where two of the same kinds of variants are present, or 
heterozygous, where two different variants are present (Vallone et al., 2004).  
Based on the mechanisms of the allelic discrimination reactions, different basic 
principles can be applied, including: allele specific hybridization (Wallace et al., 1979), 
primer extension (Syvanen, 1999), oligonucleotide ligation (Chen et al., 1998) and 
invasive cleavage (Olivier et al., 2002).  
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In the following outline, each discrimination reaction method is illustrated with 
examples for both its detection and assay format methods. 
1.4.1.2. Allele Specific Hybridisation (ASH) 
This method, also known as allele specific oligonucleotide (ASO), is based on the 
difference of thermal stability between two probes that hybridise with the target DNA 
(Wallace et al., 1979). The probe that is complementary to the variant SNP has a 
relatively high melting temperature. Conversely, the probe that has a mismatched 
sequence has a relatively low melting temperature. The product of allelic discrimination 
can be detected by many techniques, for example, fluorescence resonance energy 
transfer (FRET), which is the basis of the TaqMan assay, as shown in Figure 1.5 (Oliver 
et al., 2000; McGuigan and Ralston, 2002).  
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Figure 1.5. Shown above is a schematic representation of ASH using a TaqMan
®
 probe. 
Illustrated is primer binding and allelic discrimination, which is achieved by the 
selective annealing of match probe and template sequence. The assay is based in the 5′ 
exonuclease activity of Taq polymerase. When the probe is intact the quencher interacts 
with the fluorophore (reporter) by fluorescence resonance energy transfer (FRET), 
quenching its fluorescence. In the extension step, the 5′ nucleotide, that has the 
fluorescent dye attached, is cleaved by the 5′ exonuclease activity of the Taq 
polymerase, leading to an increase in fluorescence of the reporter dye. A mismatched 
probe is displaced without fragmentation and no fluorescence is detected. Adapted from 
Livak (1999). 
 
1.4.1.3. Primer Extension (PE) 
This is one of the most frequently used detection methods currently used for SNP 
genotyping and is also known as minisequencing (Syvanen, 1999; Sanchez et al., 2003) 
and single base primer extension (SBE) (Inagaki et al., 2002). The mechanism of this 
method is based on the activity of DNA polymerase. However, PE methods can be 
divided into two types based on the principle of the extension mechanisms of the 
primer.  In the first type, the primer binds upstream to the variant sequence on the target 
DNA. The dideoxynucleotide (ddNTP) that is complementary to polymorphic position 
is incorporated at the 3′ end of the primer by DNA polymerase (Syvanen, 1999). The 
product can then be detected by microarrays as used by the Affymetrix method (Divne 
and Allen, 2005) or electrophoresis as in the SNaPshot
™
 technique (Figure 1.6) 
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(Budowel, 2004). The second type involves the primer annealing to the polymorphic 
sequence and being extended by DNA polymerase only if it is a perfect match, with the 
product being determined using a technique such as pyrosequencing (Figure 1.7) 
(Ronaghi, 2001). 
 
 
 
Figure 1.6. Shown above is a schematic diagram of PE using a single nucleotide primer 
extension assay. Under optimised conditions, a primer anneals to its target DNA 
immediately upstream to the SNP and is extended with single ddNTP complementary to 
the polymorphic base. The SNP patterns can be determined by the electrophoretic peaks 
as in SNaPshot
™
. This figure was adapted from Sobrino et al. (2005). 
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Figure 1.7. Shown above is a schematic representation of PE using an allelic specific 
extension. When there is a perfect match, the primer is extended by DNA polymerase 
Sobrino et al. (2005). 
 
1.4.1.4. Allele Specific Oligonucleotide Ligation (ASOL) 
The ASOL method requires three probes one of which is a generic probe that is 
designed to anneal to just one sequence on the polymorphic site (downstream) and two 
others which are allele specific probes. The generic probe and allele specific probes 
hybridise to the target DNA in tandem; the 5′ end of the generic probe joins to the 3′ end 
of the allele specific probe. However, the heterozygous sample will have both allele 
specific probes matched to the polymorphic sites on both strands (Figure 1.8) 
(Landegren et al., 1988).  
The principle of this method depends on two factors: the first of these factors is 
hybridisation of the generic probe to the sequence adjacent to the SNP and the match 
between the sequences on allele specific probe to the SNP on the target DNA. The 
second of these factors is the ability of the ligase enzyme to join the two probes together 
by covalent bonding (Landegren et al., 1988).  
Target DNA 
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Figure 1.8. Shown above is a schematic diagram of ASOL. The common probe is 
hybridised adjacent to the allelic-specific probe. When there is a perfect match of the 
allelic-specific probe, DNA ligase joins both allelic-specific and common probes 
Adapted from Sobrino et al. (2005). 
 
1.4.1.5. Invasive Cleavage 
The reaction of this method is performed directly on genomic DNA, without prior 
amplification and is carried out in two stages (Figure 1.9) (Rao et al., 2003; Olivier et 
al., 2002; Lu et al., 2004). 
The concept of the TaqMan assay (FRET) can be utilised in this method to monitor the 
alleles. The quencher is placed at the 3′ end of the allele specific probe and the labelled 
dye at the 5′ arm. The signal is only released when the invasive structure is formed on 
the target DNA (perfect match) (Olivier et al., 2002; Lu et al., 2004).   
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Figure 1.9. Shown above is a schematic illustration of the invasive cleavage allelic 
discrimination reaction. The invader probe and allele- specific probe anneal to the target 
DNA with an overlap of one nucleotide forming a structure that is recognised by 5′ 
exonuclease, releasing the 5′ arm of the allele specific probe. If the allele specific probe 
is not match the nucleotide at the SNP position, cleavage will not occur. Adapted from 
Sobrino et al. (2005). 
1.4.2. Detection Methods 
As was described above, the detection of SNPs at specific loci is dependent up on the 
mechanism of the allelic discriminatory reactions. Some discrimination reactions can be 
measured using different platforms. 
1.4.3. Assay Format of SNP 
There are two different categories which are related to SNP assay format. The first 
category of assay involves homogenous reaction in which the assay is performed in 
solution in a closed tube, as in the SNaPshot technique. The second category of assay, 
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which is normally referred to as heterogenous reaction, involves a solid support like 
microarray chip such as used in the Affymetrix technique (Gibson, 2006). 
1.5. Forensic Biological Evidence 
The purpose of forensic science is to identify and match biological samples. The 
recovery and analysis of DNA from such samples is the challenge for forensic 
scientists. Most of the biological samples such as blood, semen, saliva and tissue, which 
are found at the scene of crime, are exposed to environmental insult before collection. 
This can lead to degradation, especially in hot climates such as those found in the 
Arabian Gulf region. A large amount of forensic evidence can be lost using 
conventional STR technology (Bender et al., 2004).  
1.6. DNA Degradation 
It is well established that DNA can easily fragment in biological samples. Within cells, 
segments of double helix DNA are protected to some degree through association with 
the histones (Lewin, 2004). However, the linker DNA that connects the nucleosomes is 
more vulnerable and is often the point at which DNA degradation starts to occur (Coble 
and Butler, 2005). 
Microorganisms can accelerate the breakdown of DNA. Deposited cellular material is a 
good source of nutrients for microorganisms, such as bacteria and fungi. Such 
microorganisms will secrete nucleases and, if the environmental conditions allow their 
growth, they can rapidly destroy the entire DNA (Bender et al., 2004; Vacca et al., 
2005). Even without microorganisms, the breakdown of the cellular structure of 
deposited material will leave the DNA exposed to the cells’ own nucleases (Pääbo et al., 
2004; Neaves et al., 2009). 
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In addition to enzymatic effects, some chemical substances can also affect the DNA 
strands. For example, the hydrogen bonds that are present at the carbon atoms number 
1, 2, 3, 4 and 5 of deoxyribose sugar of the DNA strand can react with compounds, such 
as hydrogen peroxide through oxidation (Pogozelski and Tullius, 1998). Also, chemical 
compound like nitric oxide (N2O2), can cause damage to DNA through deamination 
(removal of amino group) from both pyrimidines and purines bases (Nguyen et al., 
1992). These oxidation and deamination processes lead to modification of primary 
structure of the DNA strand.  
If the cellular material is exposed to direct sunlight the nitrogenous bases of DNA have 
the ability to absorb energy emitted by UV radiation (Hall and Ballatyne, 2004). This 
can lead to a photochemical reaction which alters the primary structure of the DNA 
strand leading to the formation of pyrimidine dimers (Mitchell et al., 1992).  This does 
not destroy the DNA, but the cross-linking renders the DNA inert in a PCR. 
1.7. Aims of the Project 
Within the forensic field, there is a need for new markers that can overcome the 
problems encountered in typing degraded DNA (Budowele et al., 2005). SNPs represent 
the smallest available polymorphic markers. 
In the present study, the focus will be on the identification of SNPs that may be 
informative in a forensic context within the Arab Population. To achieve this aim, 
individuals from the United Arab Emirates (UAE) and Kuwait have been employed for 
the first time as candidates to develop the use of SNP identification in forensic 
applications.  
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It was decided to generate the data from unrelated Arab individuals from Kuwait and 
UAE, instead of selecting available SNPs from the GenBank
®
. To obtain such data, the 
Affymetrix
®
 technique was used.  
The resulting SNP candidates from the autosomal chromosomes were then evaluated 
using the SNaPshot
™
 technique. Rigorous strategies and criteria were used to select 
SNPs. A series of statistical calculations were also used to determine the informative 
value of the SNP markers for the use in forensic analysis.  
Finally based on the statistical calculations such as heterozygosity and discrimination 
power, at the completion of this research 66 of the best SNPs were selected as potential 
forensic markers.  Their utility for the analysis of degraded DNA was assessed using 
both simulated and real forensic cases. 
1.8. Population Overview 
1.8.1. United Arab Emirates  
The United Arab Emirates (UAE) comprises seven Emirates that were united in 
December 2, 1971 to form the State of UAE. Abu Dhabi is its capital and the political 
Emirate, whilst Dubai is the second Emirate and is famous for business and as a tourist 
attraction. Other Emirates of the UAE include: Sharjah, Ajman, Umm Al Qaiwain, Ras 
Al Khaimah and Fujairah.  
UAE is a part of the Gulf Cooperation Council (GCC), which consists of six Gulf 
Countries; Bahrain, Kuwait, Oman, Saudi Arabia, Qatar, and UAE.  
According to the 2006 census, the population of the UAE stood at 4.43 million. The 
indigenous inhabitants are called Emirati and constitute 20% of the total population. 
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The rest of the population are migrants and include South Asian (Indians, Pakistanis and 
Bangladeshis), Afghanis, Iranians, along with people from other Arab countries such as 
Palestine, the Yemen and Oman (www.vesitabudhabi.ae). Geographically, the UAE is 
situated along the coast of southern Arabian Gulf Sea, sharing borders with Oman, and 
Saudi Arabia (Figure 1.12). 
 
 
Figure 1.10. Shown above is a map of the UAE indicating its borders with neighbouring 
GCC Countries. Saudi Arabia is located to the west, south and southeast whilst Oman 
lies to the southeast and northeast. Figure 1.12 was obtained from the UAE Ministry of 
Information and Culture, (1992). 
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1.8.2. Kuwait 
The State of Kuwait is a part of the GCC, with a population of 963,571 Kuwaiti 
nationals according to the 2005 census (Al-Ghunaim, 2007). In addition to Kuwaitis, 
other people living and working in Kuwait include Iranians, Asians, and members of 
other Arab nations such as Palestine and Egypt.  The state of Kuwait is situated on the 
northern tip of the Arabian Gulf Sea, sharing borders with Saudi Arabia and Iraq 
(Figure1.13). 
Figure 1.11. Shown above is a map of Kuwait indicating its borders with Saudi Arabia, 
which is located to the south west, and Iraq, which lies to the west and north.  
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2.1. Sample Collection 
In the following work, all samples were given with informed consent and were 
anonymised upon receipt. Samples of dried blood from 5 unrelated Kuwaiti individuals 
were collected and stored on FTA
®
 paper by the Kuwait General Department of 
Criminal Evidence. Samples of dried blood from 5 unrelated UAE Arab individuals 
were collected by the Abu Dhabi Forensic Science Laboratory and placed on cotton 
swatches. To carry out the population study samples of dried blood from 100 unrelated 
United Arab Emirates (UAE) individuals were collected by the Dubai Police Crime 
Laboratory. The UAE samples were collected and stored on FTA
® 
cards (Whatman
®
 
Bioscience, UK).  
2.2. Affymetrix SNP Screening 
2.2.1. Extraction and Purification of DNA  
2.2.1.1. DNA Extraction 
An area (1 cm
2
) of cotton or FTA
® 
card (from 5 Kuwaiti) was cut using sterile scissors 
and placed into a 1.5 ml tube (ELKay, UK). Using the modified method of Foran 
(2006), 500 µl of extraction buffer (0.01 M Tris, 0.01 M EDTA, 0.1 M NaCl and 2% 
SDS), 10 µl of 1 M DTT (Promega, US), and 20 µl of Proteinase K (20 mg/ml) (Qiagen 
Ltd, UK) was added to the tube. Samples were pulse vortexed and incubated on a 
Techne DB-2A heating block (Techne, USA) at 37 °C overnight (more than 10 h). 
Samples were removed from the heating block, briefly centrifuged at 13,000 rpm 
(Eppendorf 5415D, radius 6.4 cm) to remove condensation from the sides of the tube 
and purified as described in Section 2.2.1.2 
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2.2.1.2. Organic Solvent Purification 
The following protocol was carried out in a flow hood. After the overnight incubation 
the samples, which were observed to be reddish coloured solutions, were individually 
transferred to a 1.5 ml tube, leaving behind the cotton/FTA
®
 Card residue. As a first 
step, to each tube, 500 µl of phenol/chloroform/isoamyl alcohol in the ratio 25:24:1 
(v/v) and at pH 8.0 (Fisher Bio Reagents, UK) was added. Each tube was then inverted 
several times until the solution appeared milky, vortexed and centrifuged at 13,000 rpm 
for 5 min. The pale yellow supernatant was removed so as not to disturb the lower 
organic phase, and retained. The retained supernatant was transferred into a new 1.5 ml 
tube. To each tube, a further 400 µl of phenol/chloroform/isoamyl alcohol was added 
and the previous step repeated. The resulting semi-clear supernatant was transferred into 
a Centricon
®
 filter MY-100 membrane (Millipore, UK) and 1X TE buffer (1.0 M Tris 
HCl, 0.1 M EDTA, pH 8.0; Sigma, UK) was added to make the volume up to 2 ml. 
Each tube was then centrifuged (Falcon 6/300 Sanyo, radius 11.7 cm) at 3,500 rpm for 
15  minutes (mins). The DNA sample in the filter was washed with TE buffer and 
centrifuged at 3,500 rpm for 15 mins. The filter was then inverted into a storage tube 
and centrifuged at 3,500 rpm for 5 mins. The resulting DNA samples were collected 
(approximately 35 µl) and stored at 4 °C for future use. 
2.2.2. DNA Quantification 
DNA samples that were extracted as described in Section. 2.2.1.1, were quantified using 
real-time PCR. 
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2.2.2.1. Application of the Quantifiler™ Human DNA Quantification 
Kit 
DNA concentrations in samples were determined using the Quantifiler
™
 Human DNA 
Quantification Kit (Applied Biosystems, USA) with the ABI 7500 real-time PCR 
machine (Applied Biosystems). The procedure was carried out according to the 
manufacturer’s protocol with the exception that the final volume of the reaction was 
reduced by half. Using 0.2 ml tubes, serial dilutions of the DNA standard, which was 
provided by the manufacturer, were prepared with TE buffer (Section 2.2.1.2) to give 
final DNA concentrations of 50, 16.5, 5.56, 1.85, 0.62, 0.21, 0.07 and 0.02 ng/µl. These 
DNA dilutions were stored in -20 °C for further use.  
The total volume for the reaction was 12.5 µl, which comprised 5.25 µl of Quantifiler 
PCR Reaction Mix, 6.25 µl of Quantifiler Human Primer Mix and 1 µl of the DNA 
sample, including the non-template control (NTC) and the DNA standard. The reaction 
was prepared in a master mix. A MicroAmp
™
 optical 96-well reaction plate (Applied 
Biosystems) was placed on its base (MicroAmp
™
 splash free 96-well base) and 11.5 µl 
from the master mix was loaded into each well. Then, 1 µl of diluted DNA standard was 
loaded into the corresponding wells: each standard was set up in duplicate. Next to the 
standards, two wells were set for NTC into which 1 µl of TE buffer was loaded, then 1 
µl of each sample was added into its corresponding well. When samples and standards 
were loaded, care was taken to avoid the formation of air bubbles.  
The plate was sealed with an optical adhesive cover (Applied Biosystems) and placed 
into the ABI 7500, which was switched on prior to the reaction preparation.  The 
thermal cycler protocol was performed in two stages: stage 1, hold at 95.0 °C for 
 10 minute (min); stage 2 consisted of 40 cycles at 95 °C for 15 seconds (s) followed by 
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60.0 °C for 1 min. After completion of the amplification the DNA concentration for 
each sample was estimated in ng /µl. 
2.2.3. Whole Genome Amplification 
2.2.4. Overview 
Whole genome amplification is a well established technique to help overcome situations 
where there is insufficient DNA for analysis (Schneider et al., 2004). In the present 
study, whole genome amplification was used to increase the amount of DNA in samples 
from UAE and Kuwaiti individuals that were < 50 ng /µl to the levels that were required 
to conduct analysis using the Affymetrix Genechip
®
. 
2.2.5. REPLI-g
®
 Midi Kit 
Whole genome amplification was performed with the QIAGEN REPLI-g
®
 Midi kit.  
The method was based on the use of enzyme phi 29 (Ф 29) DNA polymerase.  
The procedure for whole genome amplification was carried out according to the 
manufacturer’s instructions. To a series of 1.5 ml microcentrifuge tubes was added 5 µl 
of reaction buffer, D1, and 5 µl of DNA sample containing < 50 ng of genomic DNA. A 
positive control sample was also prepared, containing 10 ng of DNA. All the tubes were 
briefly centrifuged at 13,000 rpm and then incubated at room temperature (23 °C) for 3 
mins. After incubation, 10 µl of buffer N1 was added to each tube, the solution was 
mixed and briefly centrifuged at 13,000 rpm.  To each tube was then added, 29 µl of 
REPLI-g Midi reaction buffer and 1 µl of REPLI-g Midi DNA polymerase, which was 
prepared as a master mix. Each tube was then incubated on a heating block overnight 
(30 °C) for 16 h and the reactions terminated by heating the block to 65 °C for 3 mins. 
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After cooling, the samples were removed and retained for further use. To assess the 
results of whole genome amplification, incubated samples were analysed using agarose 
gel electrophoresis (AGE) as described in Section 2.2.5.1.  
2.2.5.1. Agarose Gel Electrophoresis (AGE) 
AGE was conducted using a 0.5% (w/v) SeaKem
®
 LE agarose gel in a tray tank (6 cm × 
6 cm), which was submerged under TAE buffer (per 1000 ml: 4.84 g Tris Base, 1.14 ml 
glacial acetic acid, 2 ml 0.5 EDTA (pH 8.0)). Samples for AGE were prepared as 
follows: 2 µl of DNA were separately placed in test tubes and to each was added 2 µl of 
distilled water (dH2O), 1 µl of gel loading buffer, and 6 × bromophenol blue (ABgene). 
As a size marker, a similar sample was also prepared except that amplified DNA was 
replaced with 2 µl of a Lamda Hind III 23 kilo base pair (kb) ladder (ABgene
™
, UK). 
Immediately prior to use, the Lamda Hind III ladder solution was heated at 56 °C for 15 
mins. The gel was run at 100 V for 30 mins, stained in 0.5 µg/ml ethidium bromide 
(EtBr) and visualised using a UV transilluminator (Bio Doc- It
™ 
Imaging System, US). 
2.3. SNPs Screening 
2.3.1. Affymetrix
®
 GeneChip
®
 Human Mapping 250K 
Array Sty 1 
SNP analysis was conducted on samples (Section 2.1) obtained from 10 unrelated 
individuals from Kuwait and the UAE. The samples were analysed using GeneChip
®
 
Human Mapping 250K Array Sty 1. Due to specialist instrumentation requirements and 
the unavailability of essential equipment at the University of Central Lancashire, the 
samples were sent for analysis to Geneservice Ltd, UK. 
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2.3.2. Selection of Candidate SNPs  
2.3.2.1. Software 
Microsoft Office Access 
Microsoft
®
 Office Access 2003 was used to accommodate the high volume of SNP data 
obtained in this study. For further data analysis, Microsoft
® 
Office Excel 2003 was 
employed  
2.3.3. Identification of SNPs  
For the initial identification of SNP markers, two different strategies were followed. 
First, a total of 238,304 SNPs from each Kuwaiti and UAE individual were linked 
together by Microsoft
®
 Office Access 2003. The link was set to allow the combination 
of data from each individual into one group. This link was made by accessing the 
national centre for biotechnology information (NCBI) reference identifiers (dbSNP rs). 
Second, the data were rearranged according to autosomal chromosomes to reflect the 
number of SNPs in each chromosome that would be selected. For initial screening, 
SNPs with confidence values less than 0.09 were selected. This value was part of the 
Affymetrix
®
 250K chip analysis properties that were determined during SNP 
genotyping. This confidence value (< 0.09) permitted pooling of the data whose 
probability value indicated that more than 91% of SNPs were correctly genotyped. This, 
in turn, allowed a further reduction of the data size to a few thousand candidate SNPs. 
Ultimately, the reduction in size of the SNPs became appropriate for transference to an 
Excel sheet for further assessments.  
The data was sorted according to the frequencies in ascending order using Excel. The 
SNPs with frequencies of 0.45 – 0.55 for each allele were selected. 
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2.3.4. Strategies and Criteria  
In order to confirm the status of SNPs, and to determine conclusive screening results, 
several databases were interrogated. These included: Ensembl 
(http://www.ensembl.org), the Haplotype Map (HapMap) database (http://hapmap.org), 
the National Center for Biotechnology Information (NCBI) database 
(http://www.ncbi.nlm.nih.gov). As the above sites became publicly available during the 
course of the present research, they were incorporated into the data analysis strategy. 
Also, a review of the existing literature identified a number of other properties to 
consider when selecting SNPs. 
On the basis of position of the SNPs on the chromosomes, the following selection 
criteria were used: 
1- The position of currently used STR markers in forensic analysis were identified and 
SNP candidates were selected at least 1 Mb from these regions.  
2- SNPs that occurred at a distance of at least 100 kb from each other were targeted, as 
this distance was found to reduce the association between SNPs (Sanchez et al., 2006, 
Phillips et al., 2004). 
3- To ensure the availability of specific regions for primer design and to prevent any 
complication during this process SNPs were selected so as to be 100 bp from any other 
characterised polymorphism (Sanchez et al., 2006).  
5- Only SNPs that were located in the intergenic region were selected.  
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2.3.5. Design of PCR Primers  
The PCR primer pairs (forward and reverse) used in this study was designed using the 
publicly available software: Primer3 (http://www.fro.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi) and Oligonucleotide Properties Calculator software 
(http://www.basic.nothwestern.edu/biotools/oligocalc.html). The design properties were 
based on singleplex primer conditions.  
Template sequences 150 bp from both sides of the SNP marker were selected as primer 
binding sites and 20-30 bases upstream and downstream from the SNP sites were 
excluded as candidate PCR primer binding sites. The amplicon size was kept at less 
than 150 bp, to maximise amplification efficiency when typing degraded samples.  The  
G-C contents of each primer was in the range of 35-60%, and in order to avoid hairpin 
formation, the 3′ end of each primer was checked for any complementary sequence to 
other parts of the primer as well as primer – primer interaction for each primer pair 
(Sanchez and Endicott, 2006).  
To ensure the specificity of each primer for the target sequence, the test for non- 
specific target sites within the genome was determined using NCBI basic local 
alignment search tool (BLAST) program (www.ncbi.nlm.nih.gov/BLAST). 
2.3.6. Primer Synthesis and Purity 
The primers were synthesized by Invitrogen
™
 and were delivered desalted and 
lyophilised. Stock solutions of 100 µM primers were prepared by appropriate dilution 
with TE buffer. For example, primers supplied as 24.0 nanomoles were diluted with 240 
µl of 1  TE buffer. Stocks were kept at -20 °C, while an aliquot of 10 µM working 
solution for each primer was kept at 4 °C. 
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2.3.7. PCR Primer Optimisations 
Each primer pair was optimised using single locus amplification. The PCR optimisation 
were carried out using thermal cyclers GeneAmp
®
 2700 , GeneAmp 
® 
9700 and Veriti 
™
 
(Applied Biosystem) with the following PCR conditions: samples contained 0.5 ng of 
DNA template and primer 0.32 µM in a total reaction volume of 12.5 µl containing 
 1.1 X ReadyMix
™ 
PCR master mix (ABgene™ UK). The MgCl2 concentration in the 
reaction was adjusted to 2.5 mM by adding 1.0 mM from 25 mM stock (Applied 
Biosystems).  
Each primer pair was tested using the following singleplex PCR conditions and cycle 
programme (Table 2.1). 
 
Table 2.1. Indicated below are the cycling conditions and PCR Programmes for 
PCR primer optimization. 
 
  
Steps 
 
Program A 
 
Program B 
 
Program C 
 
Program D 
 
Program E 
 
Stage 1 Denature 
95 °C  
3 min 
95 °C  
3 min 
95  °C  
3 min 
95 °C  
3 min 
95 °C  
3 min 
Stage 2 Denature 
94 °C  
1 min 
94 °C  
1 min 
94 °C 
 1 min 
94 °C 
 1 min 
94 °C 
 1 min 
 Annealing 
56 °C 
1 min 
58 °C  
1 min 
60 °C  
1 min 
62 °C  
1 min 
64 °C  
1 min 
 Extended1 
72 °C  
1 min 
72 °C  
1 min 
72 °C 
 1 min 
72 °C  
1 min 
72 °C  
 1 min 
 Extended 2 
65 °C 
     7 min 
65 °C  
7 min 
65 °C  
7 min 
65 °C  
7 min 
65 °C   
 7 min 
Stage       
3 Hold
 a 
12 °C 12 °C 12 °C 12 °C 12 °C 
a 
Hold is the final step for PCR till samples are removed from the PCR cycler. 
All programmes were run for 30 cycles. 
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2.3.7.1. Gel Analysis of PCR Products  
The PCR products of singleplex amplification were checked using AGE. 
Electrophoresis was conducted as described in Section 2.2.5.1 except that: a 2.5% (w/v) 
SeaKem
®
 LE agarose gel and a tray tank (12 cm x 6 cm), which was loaded with 1  
TBE buffer (per 1000 ml: 10.8 gm Tris base, 5.5 gm Boric Acid, 4 ml 0.5 M EDTA at 
pH 8.0 at room temperature) were used. In addition, a 20 bp ladder (ABgene™) was 
used as a size marker. Samples for AGE were prepared as follows: 2 µl of amplified 
PCR products and the size marker were separately placed in test tubes and to each was 
added 2 µl of distilled water, and 1 µl of gel loading buffer (ABgene™). 
2.3.8. Singleplex PCR Reaction 
 One PCR programme to amplify all primers individually was set up according to the 
conditions for PCR optimisation as described in Section 2.3.7 except that the following 
conditions were employed, based on the modified methodology of Sanchez and 
Endicott (2006): stage 1 was conducted at 95 °C for 3 mins; stage 2 at 94 °C for 1 min, 
60 °C for 1 min, 72 °C for 1 min; this was repeated for 30 cycles, and then the reaction 
was incubated at 65 °C for 7 mins followed by 12 °C until samples were removed from 
the thermocycler. Three independent replicates were performed for each primer pair. 
2.3.9. Gel analysis of Singleplex PCR Product 
The amplified products of the PCR reaction were assayed as described in 2.2.5.1 except 
that a 2.5 % agarose gel was used.  
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2.3.10. PCR Reaction Clean Up 
The remaining PCR products were purified to remove any excess of primers and dNTPs 
that were not incorporated during the amplification. The purification was carried out 
with the MinElute
™
 PCR purification spin column (Qiagen) following the 
manufacturer’s protocol. The PCR product was eluted in 10 µl of elution buffer (EB). 
Alternatively, 0.5 µl ExoSAP-IT kit
®
 (USB
®
, Germany) was added to 1 µl of PCR 
product and incubated at 37 °C for 15 mins, and inactivated at 80 °C for 15 mins, as 
indicated by the manufacturer’s protocol. 
2.3.11. Design of Single Base Extension Primers 
Single base extension (SBE) primers were designed to hybridise to the target DNA one 
base from the 3′ end of polymorphic SNPs. Unless stated otherwise, the programmes, 
conditions and properties described in Section 2.3.5 were used to design SBE primers. 
Essentially, sequences, which were approximately 30 bp upstream and downstream of 
the SNP site, were selected as primer binding sites. The annealing temperature was kept 
between 60 °C ± 2 °C (Lindblad-Toh et al., 2000). During the initial stages of primer 
design, a number of the primers were made of different sizes (extended) by adding 
multiples of four poly-thymidine tail (poly T) to the 5′ end of the primers, as suggested 
by the Applied Biosystems SNaPshot
®
 User’s Manual (Biosystems, 2000).  
2.3.12. Synthesis and Purities of SBE Primers 
The SBE primers were synthesised by Invitrogen
™
 and delivered in a lyophilised form. 
Primers that were less than 30 bases were delivered as desalted and primers more than 
30 bases in length purified using reverse phase chromatography. A stock solution of 
primers (100 µM) was prepared by adding the appropriate volume of 1X TE buffer 
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(Section 2.2.1.2), which was then kept at -20 °C. However, for more immediate use, 10 
µM aliquots were prepared for each primer and kept at 4 °C. 
2.3.13. Screening of SBE Primers 
SBE primers were screened against non-template PCR amplicon to check as to whether 
any possible self extension or any unrelated peaks would be produced. The screening 
was carried out according to the manufacturer’s protocol with the exception that the 
final volume of the reaction was reduced by half. The reaction components were 2 µl of 
SNaPshot
™
 mix, 0.5 µM (0.5 µl) of SBE primer and 2.5 µl dH2O. Thermal cycling 
conditions were applied as described in the SNaPshot
™
 protocol: 96 °C for 10 s, 50 °C 
for 5 s, and 60 °C for 30 s, for 25 cycles. The product of the SNaPshot was purified and 
analysed as described below Sections 2.3.15 and 2.3.16.   
2.3.14. Primer Extension Reaction 
The primer extension reactions were carried out in a total volume of 5 µl, which 
comprised: 2 µl of SNaPshot
™
 mix, 0.5 µl of SBE primer (0.5 µM), 1.5 µl of dH2O and 
1 µl of PCR singleplex amplicons. Each reaction was performed with positive and 
negative controls as described in the manufacturer’s protocol. Thermal cycling 
conditions for the reaction were as described in Section 2.3.13.   
2.3.15. Removal of Unincorporated ddNTPs 
The excess of fluorescently labelled ddNTPs in the primer extension reaction were 
removed by the addition of shrimp alkaline phosphatase (SAP). 1 µl of SAP (1 unit/µl; 
USB
®
, Germany) was added to the reaction tube, the reaction contents mixed briefly 
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and incubated at 37 °C for 40 mins, then at 90 °C for 5 mins to inactivate the enzyme 
(Vallone et al., 2005). The purified samples were kept at 4 °C. 
2.3.16. ABI 310 PRISM
®
 Genetic Analyzer  
In a 200 µl PCR tube, 1 µl of SAP- treated primer extension products was diluted in 
10 µl of Hi-Di
™
 formamide and 0.3 µl GeneScan
™
 120-LIZ
  
internal size standard 
(Applied Biosystems). The samples were mixed, briefly centrifuged at 13,000 rpm and 
then incubated at 95 °C for 5 mins. The samples were placed on ice prior to capillary 
electrophoresis (CE) ABI 310 PRISM
®
 Genetic Analyzer as in Section 2.3.17.  
2.3.17. ABI 310 PRISM
® 
Genetic Analyzer Set Up 
The separation of the SBE products was performed in a 47 cm long capillary (36 cm 
well-to-read) (Web Scientific Ltd, UK) using POP™4 polymer (Applied Biosystems). 
Electrophoresis running buffer (Applied Biosystems) was used in 1X concentration. The 
GS POP 4 (1 ml) E5 run module with dye set DS- 02 (filter set E5): dR110 (blue), 
dR6G (green), dTAMRA
™
 (yellow), dROX
™
 (red) and LIZ
®
 (orange) was used with the 
following parameters: run temperature 60 °C, syringe pump time 150 s, pre-run voltage 
15 kV, pre run time 120 s, injection time 5 s, and injection voltage 15 kV, run voltage 
15 kV, run time 24 mins. Data analyses were performed using the software: GeneScan
™
 
version 3.7 and GeneMapper 
™
 ID version 3.1. Three independent replicates were 
performed for each SNP reaction. 
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2.4. Sampling of UAE Individuals 
2.4.1. Extraction Procedure 
Blood from 100 UAE individuals were collected as described in Section 2.1 and DNA 
extracted as indicated in Section 2.2.2.1. These samples were then purified as described 
in Section 2.4.2. 
2.4.2. Purifications 
DNA extracted from the blood of 100 UAE individuals (Section 2.4.1) was purified 
using phenol/chloroform/isoayml alcohol as described in Section 2.2.1.2, except that a 
Microcon
®
 YM-30 membrane (Millpore, UK) was used to concentrate the sample, 
which retained 15-20 µl. The supernatant from the second step of this protocol, which 
was a phenol/chloroform wash, was transferred to the microcon filter and the volume 
was brought up to the edge of the tube by adding 1X TE buffer. The microcon was 
centrifuged at 13,000 rpm for 12 mins (MSE-micro Centaur, SANYO) at room 
temperature (23 °C) and the filtrate was discarded. Approximately 400 µl of 1X TE was 
then added as a washing step to the microcon filter and the whole centrifuged at 13,000 
rpm for 10 mins. The microcon filter was inverted into a new microcon collection tube 
and centrifuged at 1000 rpm for 3 mins. Approximately 20 µl of sample was collected 
and the stock tubes were stored at -20 °C. DNA in these samples was then quantified as 
described in Section 2.4.3. 
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2.4.3. Quantification  
An estimation of DNA concentration from the 100 UAE samples was determined using 
the Quantifiler
™
 Human DNA Quantification Kit (Applied Biosystems) with ABI 7500 
real time PCR (Applied Biosystems), as described Section 2.2.2.1  
2.4.4. SNP Genotyping 
In order to obtain quantitative information of allele frequencies of the candidate SNPs, 
each SNP was tested with 25 UAE samples. The reactions were carried out in 
singleplex. The analysis was performed as described in Sections 2.3.8 to 2.3.10 and 
2.3.14, and 2.3.15 to 2.3.17. 
2.4.5. Sensitivity Study 
In order to determine the threshold amount of DNA to be correctly genotyped using 
SNPs, two DNA samples from two volunteer individuals were studied. Buccal samples 
on sterile cotton swabs were collected and allowed to air dry at room temperature (22 
°C) for approximately 1 h. 
DNA was extracted using Qiagen
®
 QIAamp
®
 DNA Mini Kit. The extraction was 
performed according to the manufacturer's protocol instruction for spin extraction as 
described in Section 2.4.6. 
2.4.6. Qiagen
®
 QIAamp
®
 DNA Mini Kit Spin Extraction 
The swab head containing the buccal sample was cut and placed in 1.5 ml tube. To this 
tube, 400 µl of 1X phosphate buffered saline (PBS: 137 mM NaCl2, 2.7 mM KCl, 4.3 
mM Na2HPO4, 1.47 mM KH2PO4 at pH 7.4), 20 µl of proteinase K (Qiagen
®
) and 400 
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µl of buffer AL (provided by the manufacturer) were added. The tube was briefly 
vortexed and incubated at 56 °C for 2 h. The tube was then centrifuged at  13,000 rpm 
to remove any condensation left on the cap, 400 µl of 100% ethanol was added and the 
tube vortexed. Approximately 700 µl of the extracted sample was transferred into a spin 
column, which had previously been placed in a 2 ml tube (both provided by the 
manufacturer), and centrifuged at 8000 rpm for 1 min. The solution in the bottom tube 
was discarded and the last step was repeated until all remaining extracted sample was 
transferred into the column. 500 µl of AW1 solution (provided by the manufacturer) 
was added to the spin column, which was placed into a new 1.5 ml tube and the column 
was then centrifuged at 8000 rpm for 1 min. The solution from the lower tube was 
discarded and 500 µl of AW2 (provided by the manufacturer) was added to the column, 
centrifuged at 13,000 rpm for 1 min and solution from the bottom tube was discarded. 
The spin column was centrifuged once more at 13,000 rpm for 1 min to remove any 
residual ethanol. The 1.5 ml tube was removed and discarded, and the spin column 
placed in a fresh 1.5 ml tube with its cap cut and 150 µl of elution buffer (AE) was 
added. The spin column was let to stand for 1 min at room temp (23 °C) to allow the 
DNA sample to be eluted from the spin column filter into the solution. The column was 
then centrifuged at 8000 rpm for 1 min and DNA that had collected in the bottom tube 
was transferred into a fresh capped tube, and store at 4 °C for further analysis. 
The extracted DNA was quantified using Quantifiler
™
 Human DNA Quantification Kit 
(Applied Biosystems) as described in Section 2.2.2.1. 
2.4.7. Sequential Dilution of DNA 
DNA from the two different buccal swabs extracted in Section 2.4.6 was diluted with 
1 X TE buffer to give solutions with final DNA concentrations of: 100 pg/µl, 200 pg/µl, 
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300 pg/µl, 400 pg/µl, 500 pg/µl, 1000 pg/µl, 2000 pg/µl, 4000 pg/µl, and 8000 pg/µl. 
These dilution factors were based on the DNA concentration values obtained in Section 
2.4.6. 
2.4.8. SNP Amplification and Genotyping 
The loci of four SNPs from four different chromosomes (Table 2.2) were included in 
this study. PCR was performed thrice at all the dilutions described in Section 2.3.8 and 
2.3.10. The triplicate singleplex genotyping method was performed using a ABI 310 
Prism
®
 Genetic Analyser following the SBE reaction as described in Sections 2.3.14 to 
2.3.15 using the conditions described in Sections 2.3.16 and 2.3.17. 
SNP genotypes and relative fluorescence units (RFU) values for each homozygote and 
heterozygote peaks in each dilution were observed and assessed. 
 
 
2.4.9. Multiplexing of SNP 
To study the effect of degradation on the SNPs assay (Chapter 6), two sets of triplex 
PCR mixtures were used. The length of PCR products were categorised by size: small 
(<100 bp), medium (100-120 bp) and large (130-147 bp) as shown in Table 2.3. In order 
Table 2.2. Indicated below are the position on chromosome, the SNP type and PCR 
length for each of the 4 SNP loci used in the sensitivity study in Chapter 5. 
 
SNP 
code 
SNP ref Position SNP genotype PCR Length (bp) 
 
4-2 
 
rs7684079 
 
4 
 
A/C 
 
130 
12-1 rs6487665 12 C/T 119 
17-3 rs1872236 17 A/C 147 
19-2 rs17304618 19 A/G 110 
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to distinguish each SNP locus from others carrying the same fluorescent ddNTP dyes 
SBE primers were selected to be of different lengths (Schoske et al., 2003). Also, SNPs 
in the triplex sets were selected to contain the 4 possible labelled nucleotides (C, G, A 
and T).  
 
Table 2.3. Indicated below are the PCR and SBE primers in the triplex sets with 
their SNP reference and position. 
 
 
SNP code 
 
SNP ref 
 
SNP genotype 
 
Position 
 
PCR size (bp) 
 
SBE size (bp) 
 
 
 
Triplex 1 
 
4-4 
 
 
rs9995245 
 
A/G 
 
4 
 
90 
 
28 
19-2 
 
rs17304618 A/G 19 110 58 
13-4 
 
rs2892545 C/T 13 142 37 
 
Triplex 2 
 
21 
 
 
rs8130475 
 
A/G
* 
 
21 
 
92 
 
28 
18-3 
 
rs9950394 C/T
* 
18 119 54 
17-3 
 
rs1872236 A/C 17 147 42 
      * Genotypes are for reverse sequence. 
2.4.10. Triplex Optimisation 
PCR Conditions  
Each set of the triplex (Section 2.4.9) was screened for primer dimer formation using 
the AutoDimer program (Vallone and Butler, 2004). The optimisation was carried out in 
a 12.5 µl reaction volume containing: 1.1 X ReadyMix
™ 
PCR master mix (ABgene™) 
and 0.5 ng/µl DNA. The procedure was performed in 4 PCR reactions, each containing 
different concentration of primers, which were: 0.2 µM, 0.32 µM, and 0.4 µM, while 
the concentration of MgCl2 was kept constant in each tube at 2.5 mM as in the 
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singleplex reaction (Table 2.4). PCR products for each reaction were checked using 
AGE as described in Section 2.2.5.1, except that a 2.5% (w/v) agarose gel was used. 
Based on the number and intensity of bands present, the relevant concentration of 
primers was determined. Then the MgCl2 concentration was optimised while PCR 
primer concentration was kept constant: assays of each triplex set was performed in two 
PCR tubes each with 2.5 and 3.0 mM of MgCl2 present (Table 2.5). The result was 
accepted when all three bands in the triplex were sharply defined. Based on this 
analysis, the final optimal primer concentrations were found to range between 0.2 and 
0.4 µM whilst that of MgCl2 was found to be 3 mM. All other conditions for triplex 
optimisation were as described for the singleplex reaction in Section 2.3.7. The thermal 
cycling programme was carried out as described in Section 2.3.8. After the cycling 
program, the reactions were then left at 12 °C until samples were removed from the 
thermocycler. 
 
 
 
 
 
 
 
 
Table 2.4. Indicated below are the PCR primer optimizations for triplex 1 and 2. PCR 
tubes 1 to 3 contained equal concentration of primers, while for tube 4, the primers were 
mixed in different concentrations. For all the reactions, the MgCl2 concentration was kept 
constant at 2.5 mM. 
 
                        
              Set 1( 4-4, 13-4 and 19-2)                                                  Set 2 (21-17-3 and 18-3) 
 
PCR 
Tube 
 
Primers 
Code 
 
Primer 
Conc. µM 
 
MgCl2 
Conc. mM 
 
PCR 
Tube 
 
Primers 
Code 
 
Primer 
Conc. µM 
 
MgCl2 
Conc. mM 
1 all primers 0.2 2.5 1 all primers 0.2 2.5 
2 all primers 0.32 2.5 2 all primers 0.32 2.5 
3 all primers 0.4 2.5 3 all primers 0.4 2.5 
4 
4-4 & 13-4 
19-2 
0.2 
0.4 
2.5 4 
21 &17-3 
18-3 
0.2 
0.4 
2.5 
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SBE Reaction Conditions 
As PCR primers, the SBE primers were also checked for primer dimmer formation 
using the AutoDimer program. The triplex reaction was then carried out as described in 
Section 2.3.14, except that the SBE primers concentration used in all cases was 0.2 µM.  
Purifications 
The end products of PCR and SBE reactions were purified to remove excess primers 
and unused ddNTPs by using 0.5 µl of ExoSAP-IT kit
®
 (USB
®
) and 1 µl of SAP 
(USB
®
) as described in Sections 2.3.10 and 2.3.15. 
2.4.11. Triplex Genotyping 
Analysis of the optimised triplex set was carried out using the ABI 310 Prism
®
 Genetic 
Analyser as described in Sections 2.3.16 and 2.3.17. 
2.5. Degradation Assessments 
2.5.1. Controlled Environmental Conditions 
In this method, in order to generate degraded DNA samples were exposedto 
environmental insult with the humidity and temperature controlled in the laboratory. 
Table 2.5. Indicated below are the optimal MgCl2 concentrations for analysis of 
triplex set 1 and 2 when the concentration of primers are kept constant. 
 
             
             Set 1( 4-4, 13-4 and 19-2)                                           Set 2 (21-17-3 and 18-3) 
 
PCR 
Tube 
 
Primers 
Code 
 
Primer 
Conc. µM 
 
MgCl2 
Conc. mM 
 
PCR 
Tube 
 
Primers 
Code 
 
Primer 
Conc. µM 
 
MgCl2 
Conc. 
mM 
1 
4-4 & 13-
4 
19-2 
0.4 
0.2 
2.5 1 
21 &17-3 
18-3 
0.2 
0.4 
2.5 
2 
4-4 & 13-
4 
19-2 
0.4 
0.2 
3.0 2 
21 &17-3 
18-3 
0.2 
0.4 
3.0 
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A. Humidity and Temperature 
A 50 µl of sample (saliva/semen) was pipetted onto a sterile cotton swab (COPAN) and 
kept in an incubator at 37 °C with a humidity of 98% ± 2% for a period of 18 days. 
The humid environment was prepared as follows: layers of tissue paper were saturated 
with distilled water (dH2O) and folded to fit a solid plastic container. The swabs were 
placed into a rack inside the container so that they were not touching. An EL-USB2-
RH/ temperature Data logger (LASCAR electronics, UK) inside the container was used 
to monitor the humidity and temperature during the experiment (Figure 2.1). The USB 
data logger was set up in accordance with the manufacturer's instructions. In order to 
prevent the loss of water vapours, the container was tightly sealed and incubated at 37 
°C in a hybridisation oven (HYBAID™, UK). Samples were removed at 3 days 
intervals and stored at -20 °C until processed further.  
 
 
Figure 2.1. Shown above is the data over a 3 day incubation period were recorded on 
the USB data logger. The relative humidity percentage (% rh) was 98% and the 
temperature was 37 °C. 
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B. Room Temperature 
 The samples were prepared as described above in humidity and temperature and kept at 
room temperature in a laminar flow hood cabinet. Temperature was recorded using a 
thermometer; every 3 days sample was removed and stored at -20 °C. Temperature 
ranged from 21-24 °C. 
2.5.2. Environmental Conditions 
UAE Weather in December/ January and September 
Two uncontrolled experiments were conducted in two different UAE climates: 
December 2007 to January 2008 (Table 2.6), with temperatures ranging between 21 °C 
and 24 °C; and September 2008, with temperatures ranging between 35°C and 39 °C 
(Table 2.7). 
50 µl of saliva from a female donor was added onto a microscopic glass slide. The 
samples were placed outside exposed to environmental conditions. The samples were 
removed after a set of period of 3, 6, 12 days and the temperature was taken from the 
recorded using UAE weather forecasting service (Table 2.8) and (Table 2.9).  
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Table 2.6. Indicated below are the UAE weather conditions in 
December/January for degraded saliva samples.  
 
 
Duration (days) 
 
3 
 
6 
 
12 
 
 
Start date at 1 pm 
 
Start temp (°C) 
 
 
 
20/12/07 
 
24 
 
 
 
20/12/07 
 
24 
 
 
 
20/12/07 
 
24 
 
 
 
End date 
 
 
 
23/12/07 
1pm 
 
 
26/12/07 
1. 05 pm 
 
 
01/01/08 
1 pm 
 
 
Weather condition 
 
 
 
partially cloudy 
 
 
 
sunny - partially 
cloudy 
 
 
sunny-partially 
cloudy 
 
 
End temp (°C) 
 
 
 
21 
 
 
 
22 
 
 
 
24 
 
Table 2.7. Indicated below are UAE weather conditions in September/October for 
degraded saliva samples.  
 
 
Duration (days) 
 
 
3 
 
 
6 
 
 
12 
 
 
18 
 
 
Start date at 10 am 
 
Start temp (°C) 
 
18/09/08 
 
35 
 
18/09/08 
 
35 
 
18/09/08 
 
 35 
 
18/09/08 
 
35 
 
 
End date  
 
 
 
21/09/08 
10.30 
 
 
24/09/08 
10 am 
 
 
30/09/08 
10 am 
 
 
06/10/08  
10 am 
 
 
Weather condition 
 
 
sunny 
 
sunny  
 
sunny 
 
sunny 
 
End temp (°C) 
 
39 37 35 34 
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Table 2.8. Shown below are the December 2007 hourly data obtained from Met 
Office UAE. 
 
Date 
 
 
 
 
Time  
(24 hr clock) 
 
 
 
Relative 
 Humidity % 
 
 
Temperature (°C) 
 
 
 
20/12/2007 00:00 75 20.8 
20/12/2007 01:00 78 20.2 
20/12/2007 02:00 78 19.4 
20/12/2007 03:00 79 18.7 
20/12/2007 04:00 63 20.4 
20/12/2007 05:00 57 21.5 
20/12/2007 06:00 47 24.2 
20/12/2007 07:00 46 24.7 
20/12/2007 08:00 46 24.8 
20/12/2007 09:00 45 24.9 
20/12/2007 10:00 48 24.7 
20/12/2007 11:00 52 24.3 
20/12/2007 12:00 53 24.0 
20/12/2007 13:00 55 23.5 
20/12/2007 14:00 59 23.2 
20/12/2007 15:00 62 22.9 
20/12/2007 16:00 65 22.5 
20/12/2007 17:00 65 22.1 
20/12/2007 18:00 68 21.8 
20/12/2007 19:00 70 21.5 
20/12/2007 20:00 72 20.6 
20/12/2007 21:00 73 20.1 
20/12/2007 22:00 72 19.8 
20/12/2007 23:00 69 19.5 
 
Average 
  
62.4 
 
 
22.2 
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UK Weather Conditions 
The experiment was conducted in August 2008 (Table 2.10). A 50 µl of saliva from a 
female volunteer was added onto each microscopic glass slide. Samples were placed 
outside and exposed to weather conditions such as light, UV and humidity. However, 
the experiment was conducted in a covered, outside environment, to prevent the sample 
from being washed away by the rain. The temperature was taken from the recorded 
using UK weather forecasting service (Table 2.11) Samples were removed at 3 day 
intervals and stored at - 20 °C until the experiment was completed. 
Table 2.9 Shown below are the September hourly data obtained from Met Office 
UAE. 
 
Date 
 
 
 
Time  
(24 hr clock) 
 
 
 
Relative 
Humidity % 
 
 
Temperature 
(°C) 
 
 
18/09/2008 00:00 61 29.0 
18/09/2008 01:00 61 28.4 
18/09/2008 02:00 61 28.2 
18/09/2008 03:00 55 30.3 
18/09/2008 04:00 53 30.8 
18/09/2008 05:00 49 33.1 
18/09/2008 06:00 43 35.5 
18/09/2008 07:00 44 35.6 
18/09/2008 08:00 43 36.0 
18/09/2008 09:00 41 35.8 
18/09/2008 10:00 43 35.1 
18/09/2008 11:00 48 34.5 
18/09/2008 12:00 47 34.5 
18/09/2008 13:00 52 34.0 
18/09/2008 14:00 54 33.6 
18/09/2008 15:00 52 33.2 
18/09/2008 16:00 56 32.8 
18/09/2008 17:00 59 32.0 
18/09/2008 18:00 62 31.3 
18/09/2008 19:00 62 30.7 
18/09/2008 20:00 62 30.3 
18/09/2008 21:00 64 29.6 
18/09/2008 22:00 86 28.9 
18/09/2008 23:00 70 28.4 
 
Average 
 
 
 
55.3 
 
32.2 
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Table 2.10. UK weather conditions in August for degraded saliva samples. 
 
 
 
Duration  (days) 
 
3 6 9 12 15 18 
 
Start date at 12 pm 
 
Start temp (°C) 
 
01/08/08 
 
19 
01/08/08 
 
19 
01/08/08 
 
19 
01/08/08 
 
19 
01/08/08 
 
19 
01/08/08 
 
19 
 
End date 
 
04/08/08 
12.45 pm 
07/08/08 
13.05 pm 
10/08/08 
12 pm 
13/08/08 
12 pm 
16/08/08 
12.05pm 
19/08/08 
12 pm 
 
Weather conditions 
 
 
Cloudy-
raining 
Raining Cloudy Raining Raining Raining 
 
End temp (°C) 
 
18 18 19 19 19 17 
Table 2.11. An example of the hourly data obtained from Met Office UK. 
 
Date 
 
 
 
 
Time  
(24 hr clock) 
 
 
 
Relative 
Humidity % 
 
 
Temperature 
(°C) 
 
 
04/08/2008 00:00 92.4 10.9 
04/08/2008 01:00 96.1 10.5 
04/08/2008 02:00 96.2 11.2 
04/08/2008 03:00 95.1 11.7 
04/08/2008 04:00 95.1 12.0 
04/08/2008 05:00 92.7 12.3 
04/08/2008 06:00 89.5 13.0 
04/08/2008 07:00 88.6 13.9 
04/08/2008 08:00 91.1 14.6 
04/08/2008 09:00 95.5 14.4 
04/08/2008 10:00 90.3 15.5 
04/08/2008 11:00 85.6 16.9 
04/08/2008 12:00 78.0 17.3 
04/08/2008 13:00 72.1 18.4 
04/08/2008 14:00 62.9 19.0 
04/08/2008 15:00 64.6 19.0 
04/08/2008 16:00 57.0 19.7 
04/08/2008 17:00 64.6 18.9 
04/08/2008 18:00 64.1 18.5 
04/08/2008 19:00 67.7 17.5 
04/08/2008 20:00 74.7 15.6 
04/08/2008 21:00 83.6 13.0 
04/08/2008 22:00 87.5 13.8 
04/08/2008 23:00 87.7 14.3 
Average  82.1 15.1 
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2.5.3. Reference Samples  
Reference samples were taken at the start of each experiment to represent time zero. 
The samples were prepared as follows: 50 µl of the sample was placed onto a sterile 
cotton swab and kept for approximately 1 h at room temperature (22 °C) to air dry. 
Samples were then stored at -20 °C until all experiments were completed and ready for 
extraction. 
2.5.4. Extraction and Quantification 
2.5.5. DNA Extraction from Semen Stains 
The extraction procedure was carried out following the protocol in the QIAamp
®
 DNA 
Investigator Handbook (Qiagen 2007) as described below in Section 2.5.6. The 
concentration of extracted DNA was estimated using the Quantifiler
®
 Human DNA Kit 
as described in Section 2.2.2. 
2.5.6. QIAamp
®
 DNA Investigator 
DNA was extracted according to the QIAamp
®
 DNA Investigator Handbook protocol 
for isolation of DNA from sexual assaults. The swab heads, containing the semen, were 
cut off and the samples were placed into a 1.5 ml microcentrifuge tube, with 400 µl of 
ATL (Qiagen), 20 µl (2 mg/ml) of Proteinase K (Qiagen) and 10 µl of 1 M DTT (0.13 
g/ml) added. The sample was pulse vortexed, incubated in a dry block at 56 °C for 2 h 
with vortexing approximately every 10 mins to ensure maximal lysis. After incubation, 
the tube was centrifuged at 13,000 rpm, 400 µl of AL (Qiagen) added, after which the 
sample was vortexed again and incubated in a dry block at 70 °C for 10 mins. Following 
incubation, the sample was briefly centrifuged at 13,000 rpm and 300 µl of 96% ethanol 
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was added. The sample was again briefly centrifuged at 13,000 rpm. A spin column 
(Qiagen) was placed into a 2 ml collection tube (Qiagen) and approximately 700 µl of 
the extracted sample was transferred into the column. The column was centrifuged at 
8,000 rpm for 1 min, and the solution in the collection tube was discarded. The above 
step was repeated until all the extracted solution was transferred into the column. 500 µl 
of AW1 (Qiagen) was added and centrifuged at 8,000 rpm for 1 min. The solution from 
the collection tube was discarded, 500 µl of AW2 (Qiagen) was then added and the 
column centrifuged at 13,000 rpm for 1 min. To remove any trace of AW2, the the 
sample was centrifuged for a further 3 mins. The spin column was placed into clean 
microcentrifuge with its cap removed, the column was uncapped and kept at room 
temperature for 1 min. 150 µl of AE buffer was added into the spin column incubated at 
room temperature for 1 min and was centrifuged at 13,000 rpm for 1 min. DNA was 
recovered and transferred into new capped 1.5 ml microcentrifuge tube and stored at 4 
°C until quantification.  
The concentration of extracted DNA was estimated using the Quantifiler
®
 Human DNA 
Kit (Applied Biosystems) as described earlier in Section 2.2.2.1. 
2.5.7. DNA Extraction from Saliva Stains 
The saliva sample on the microscopic glass slide was transferred onto sterile cotton 
swab as follows: a dry swab was moistened with 1X TE buffer, and used to lift up the 
sample from the glass slide. The extraction procedures for all saliva samples were 
carried out using Qiagene
™
 QIAamp
®
 DNA Mini Kit as described in Section 2.4.6. 
(Chapter 2). The DNA was quantified using Quantifiler
®
 Human DNA Kit as described 
above. 
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2.5.8. Amplification and Genotyping 
To evaluate the efficiency of the degradation study, both sets of samples (saliva and 
semen) generated under all above conditions were examined using two different 
methods; SNP and STR analysis.  
2.5.9. SNP Typing 
Amplification was carried out based on the results obtained from Quantifiler
®
 Human 
DNA Kit. SNP amplification was carried out in 2 separate triplexes (Section 2.4.9) 
using 0.5 ng of template, except for samples with low concentrations (<0.1 ng/µl), 
where the DNA template ranged from 0.06-0.24 ng. The thermal cycling was carried out 
in a GeneAmp
®
 9700 (Applied Biosystems) as described in Section 2.4.10. PCR 
products were purified using 0.5 µl of ExoSAP-IT Kit
® 
(USB
®
, Germany) with 1.0 µl of 
PCR product as described in Section 2.3.10.  
ABI SNaPshot
™
 Multiplex Kit was used to genotype SNP with SBE primer triplex 
method in two reactions. The reactions were performed according to the manufacturer's 
protocol as described earlier (2.3.14) with 0.2 µM of SBE primer triplex, these six loci 
for each DNA sample were profiled. Unincorporated ddNTPs were removed by using 1 
µl of SAP (USB
®
). 
Genotypes for the SNPs were detected on ABI 310 PRISM
®
 Genetic Analyzer using the 
E5 run module. 
2.5.10. STR Typing 
STR typing was performed using the commercial AmpFℓSTR® SGM Plus® Kit 
(Applied Biosystems, Foster City, USA) according to the manufacturer's instructions, 
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except that  the reaction volume was reduced by 1/4. For SNP analysis, DNA templates 
ranging from 0.06 ng to 0.5 ng were amplified in an STR reaction buffer consisting of 
4.83 µl of GeneAmpFISTR
®
 PCR Reaction Mix, 2.53 µl of AmpliFISTR
® 
SGM plus
®
 
Primer set, 0.23 µl of AmpliTaq Gold
®
 DNA polymerase at 1.25 unit/µl and 4.91 µl 
dH2O. A thermal cycling GeneAmp
®
 9700 (Applied Biosystems) was used for the 
amplification with the following conditions: stage 1, 95 °C for 11 mins; stage 2, 94 °C 
for 1 min, 59 °C for 1 min, 72 °C for 1 min, for 28 cycles, and incubation at 60 °C for 
45 mins followed by 12 °C until the samples were analysed.  
1 µl of PCR product obtained above and 1 µl of AmpFℓSTR® SGM Plus® Allelic 
Ladder were separately diluted with 10 µl of Hi-Di
™
 formamide and 0.5 µl GeneScan
™
 
500 ROX
™
 size standards, in a 200 µl PCR tube. The allelic ladder and the PCR 
samples were then immediately placed into the genetic analyzer without a denaturation 
step (Butler et al., 2003). STR alleles were separated electrophoretically using ABI 
Prism
®
 310 Genetic Analyzer (Applied Biosystems) and run module filter GS STR POP 
4 (1 ml) F for dye set DS- 32 (filter set F): 5-FAM (blue), JOE (green), NED (yellow) 
and ROX (red). The capillary electrophoresis was performed using a 47 cm capillary 
(Web Scientific Ltd, UK) using POP
™
4 polymer, and 1X electrophoresis running buffer 
(Applied Biosystems). Data analyses were performed using software GeneScan
™
 
version 3.7 and GeneMapper
™
 ID version 3.1. 
2.5.11. Extraction and Purification of Teeth samples 
2.5.11.1. Cleaning 
The surfaces of the teeth were cleaned from dirt and any debris. Each tooth was placed 
in a sterile 50 ml plastic tube, approximately 15 ml of dH2O was added, and the tube 
was manually agitated approximately 10 times. The dH2O was removed from the tube 
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and 15 ml of 10% bleach was added and the tube was agitated 10 times. The bleach was 
then removed and the teeth were rinsed in 15 ml of dH2O to remove any trace of bleach 
that could interfere with the later analysis. Following the removal of dH2O, the teeth 
were submerged in 95% ethanol and the tube was agitated again before the ethanol was 
removed. 
Following cleaning, the teeth were air dried under a flow hood cabinet overnight. 
2.5.11.2. Grinding 
Each cleaned tooth was ground separately in a Freezer Mill (SPEX CertiPrep
INC
 6750) 
following the manufacturer’s instructions. The bone powder was then placed in a sterile 
15 ml tube and stored at -20 °C. 
2.5.11.3. Extraction 
Decalcification 
The removal of calcium from tooth powder before extraction can help during the 
extraction of DNA (Loreille et al., 2007). Approximately 100 mg of powdered tooth 
was placed in a 5 ml tube (SARSTEDT AG & Co. Nümbrecht, Germany). Following 
the protocol in Loreille et al 2007, 1 ml of 0.5 M EDTA at pH 8.0 (Sigma, UK) was 
added and the tube was gently shaken a few times to mix the powder and EDTA. The 
mixture was then placed in the fridge at 4 °C overnight (for more than 16 h). After 
incubation the tube was centrifuged at 2000g (spectrafuge 24 D- Labnet) for 2 mins and 
the supernatant solution removed leaving behind the powder. 
Qiagen DNeasy® Blood and Tissue Kit 
DNA was extracted from the decalcificated bone powder using the DNeasy
®
 Blood and 
Tissue kit (Qiagen) with a modification. 1 ml of ATL buffer (Qiagen), 100 µl 
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(20mg/ml) of Protinase K (Qiagen) and 10 µl of 1 M DTT (0.13gm/ml) was added into 
the tube containing the bone powder. The tube was placed in a rotator (HYBAID-
Micro-4) at 55 °C for approximately 72 h (until most of bone powder had dissolved). 
Following incubation, the sample was centrifuged at 8000 rpm for 1 min to remove any 
residue on the inner side of tube as a result of overnight incubation and the supernatant 
solution was transferred into a new 5 ml tube. 1ml of AL buffer (Qiagen) was added 
into the tube, the sample was mixed and incubated at 70 °C in the rotator for 30 mins. 
The sample was the briefly centrifuged at 8000 rpm and 1 ml of absolute ethanol 
(Qiagen) was added before the tube was mixed. A spin column (Qiagen) was placed 
into a 2 ml collection tube (Qiagen) and the extracted sample was transferred onto the 
column. The column was centrifuged at 8000 rpm for 1 min and the solution in the 
collection tube was discarded. The above step was repeated until all the extracted 
solution was transferred into the column. The spin column was placed onto new 
collection tube and 500 µl of AW1 buffer (Qiagen) was added and centrifuged at 
8000 rpm for 1 min, the solution from the collection tube was discarded, 500 µl of AW2 
buffer (Qiagen) was then added and the column centrifuged at 13,000 rpm for 1 min. To 
remove any trace of AW2, the sample was centrifuged for a further 1 min at 
13,000 rpm, the collection tube was removed and the column was placed into 1.5 ml 
microcentrifuge tube. The DNA was then eluted using two steps. 25 µl of AE buffer 
(Qiagen) was added onto the spin column, incubated at room temperature for 5 mins 
and centrifuged at 8000 rpm for 1 min. The eluted DNA was then removed into a new 
1.5 ml tube. The elution step was repeated using 25 µl of AE buffer onto the same 
column and the above steps repeated. The samples were stored at 4 °C until 
quantification. 
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2.5.11.4. Quantification 
The concentration of extracted DNA was estimated using the Quantifiler
®
 Human DNA 
Kit (Applied Biosystems) with the ABI 7500 real time PCR (Applied Biosystems). The 
procedure was carried out as described earlier in Section 2.2.2.1. Each bone sample was 
quantified in duplicate.  
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CHAPTER 3  
              
IDENTIFICATION of 
  
POLYMORPHIC SNPs 
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3.1. Overview 
The potential of SNPs as a forensic tool has been widely acknowledged over the last 
few years. The most attractive feature of SNPs is their short amplicon size and therefore 
their suitability for analysis of degraded DNA (Butler, 2007; Inagaki et al., 2004). Also, 
because of their low mutation rates from one generation to the next, SNPs can be used 
to test kinship (Sachidanandam et al., 2001). SNP mutation rates are found to be 10
-8
 
compared to 10
-3 
for STRs, which are the current forensic method used for DNA 
profiling (Butler et al., 2007). 
3.1.1. SNP Classification 
The biallelic nature of SNPs provide three different genotype variations (Butler et al., 
2007). If the alleles at an SNP locus are G and A, then the possible genotypes for both 
alleles can be GG, AA, and GA. However, classification of any SNP is based on six 
categories dependent on the variation of the four nitrogenous bases (A, C, G, and T) at 
each locus on the DNA strand.  These classifications are A↔G, C↔T, A↔C, A↔T, 
C↔G, and T↔G, but since DNA occurs in double complementary strands (Figure 3.1), 
then typical basic classification of SNPs can be explained as A↔G (T↔C), C↔T 
(G↔A), A↔C (T↔G), A↔T (T↔A), C↔G (G↔C) and T↔G (A↔C), where the 
bases in the brackets represent the complementary strand (Brookes, 1999). 
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3.2. Aims of this Chapter 
The main objectives of this chapter are: 
 To analyse the SNPs (approximately 250,000) in 10 of Arab individuals from 
the United Arab Emirates and Kuwait (5 individuals from each country). 
 To select 100 SNPs from all autosomal chromosomes with balanced minor and 
major allele frequencies. These SNPs should be distributed proportionally on the 
22 autosomal chromosomes. 
 
 
 
Figure 3.1. Shown above is a schematic diagram representing variation at 
a locus with SNP G/A on the two complementary strands. The 
complementary strands contain the bases C/T.  
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3.3. Methods 
3.3.1. Samples 
The samples used in this study were blood stains on FTA
®
 cards, obtained from five 
Arab individuals from Kuwait, and blood stains on five cotton swatches, obtained from 
five Arab individuals from the UAE.  
The purpose of including these two Arab populations was to generate in-house SNP 
data that could be used to identify informative SNPs for forensic purposes. Also, when 
this study was conducted, it was the first time that samples from UAE and Kuwaiti 
individuals had been used in this type of investigation. 
3.3.1.1. DNA Extraction and Quantification  
Extraction of DNA from the 10 samples was performed using a standard 
phenol/chloroform procedure following digestion with Proteinase K as described in 
Section 2.2.1.1. This method was selected in order to achieve a high yield of DNA 
template (Dixon et al., 2005a). Following extraction, the concentration of DNA was 
estimated using the Quantifiler
®
 Human DNA Quantification kit (Applied Biosystems) 
with the ABI 7500 real-time PCR. Samples with insufficient concentrations (< 50 ng/µl) 
were amplified using phi 29 DNA polymerase, as described in Section 2.2.5. The 
extraction and quantification of samples was carried out as described in Sections 2.2.1.1 
to 2.2.2. 
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3.3.2. Genotyping Methods and Techniques  
3.3.2.1. Affymetrix® GeneChip® Technique 
Allele Specific Hybridisation Method 
Allele specific hybridisation is the basis of the Affymetrix GeneChip
®
 system (Figure 
3.2). This method is based on the annealing of a labelled amplicon containing the 
polymorphic site to a probe that is attached to an array (Goto et al., 2002). Annealing 
occurs as the amplicon contains the complementary sequence to the probe (Wallace et 
al., 1979). The hybridisation reaction is washed to remove any mismatch strands, 
enabling the complementary strands to be detected. 
 
Probe
 
Figure 3.2. Shown above is an illustration of the allele specific 
hybridisation method. [A] represents a biotinylated single strand 
amplicon which hybridises perfectly with the complementary probe 
sequence to form a stable double strand; [B] represents a mismatch 
double strand which is removed during the post-hybridisation wash. 
 
GeneChip
®
 Method 
The main feature of GeneChip
®
 is the capability to detect thousands of SNPs in a single 
reaction. Each microarray contains sets of DNA probes with the SNP sequences that 
were selected from GenBank
®
. These probes are designed to be sensitive and 
specifically to hybridise only to the target sequence (Liu et al., 2003). In this project 
GeneChip
®
 Mapping 250K Arrays Sty kit was used (Figure 3.3).  
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In this method there were three main steps: (1) PCR amplification of the DNA sequence 
containing the target SNP; (2) fragmentation of PCR products using endonuclease 
DNase І; (3) labelling of PCR products and hybridisation to the probes in the arrays 
(Figure 3.4).  
Genomic DNA (250 ng) was digested using the restriction enzyme Sty which cut the 
target DNA into segments that were, on average, between 250 bp and 1,000 bp. The 
digested fragments become the substrate for the adapter ligation enzyme which attached 
an adapter. A single common primer, complementary to the adapter, was used to 
amplify the fragments (Matsuzaki et al., 2004). The PCR products were then 
fragmented by the enzyme DNase І. Finally, the fragments were biotinylated before 
hybridisation to the array probes by allele specific hybridisation. Subsequently, only the 
complementary sequences attached to array probes would be detected after purification 
and staining with Streptavidin Phycoerythrin. Genotyping Analysis Software (GTYPE) 
and GeneChip
® 
Operating software (GCOS) were used for SNP detection. 
Front Back
Plastic cartridge
Probe array on
glass substrate 
 
Figure 3.3. Shown above is the Affymetrix
®
 GeneChip
®
 Probe 
Array consisting of a square glass substrate mounted in a plastic 
cartridge. The glass contains an array of oligonucleotides mounted 
on its inner surface. 
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Sty Sty Sty
DNA strand
Sty Digestion
Ligation
One primer 
Amplification
Fragmentation & Biotin 
Labelling
Hybridization and   
Detection
 
 
Figure 3.4. Shown above is the digestion of human genomic DNA with Sty and then the 
ligation of an adapter which contains a PCR primer site. The DNA is amplified, using 
the common primer, and the fragments are then digested by DNAse І to an average size 
of less than 180 bp, labelled with biotin, and then hybridised to the GeneChip
®
 Mapping 
250K Array. Figure 3.4 was adapted from Matsuzaki et al. (2004). 
 
 
 
3.3.2.2. Strategies and Criteria for SNPs Selection 
In order to obtain informative SNP markers, strategies and criteria were formulated. 
Based on the previous strategies that were described in Section 2.3.4, the selection of 
100 SNPs as an initial target was carried out. The number of SNPs selected on each 
chromosome was in proportion to the length of the individual chromosomes (Table 3.1). 
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SNPs from Y and X chromosomes where eliminated from the selection, profiles of 
autosomal SNP exhibit high variability due to chromosomal assortment recombination 
and mutation leading to low match probability (Jobling and Gill, 2004). Y-chromosome 
is male specific and less diverse than autosomal SNPs as mutation is the only function 
to diversity for the Y haplotypes, therefore Y profiles show relatively high match 
probability (Jobling and Gill, 2004). Profiles from X chromosome showed less variation 
from the autosomal profiles, this due to low heterozygosity level on X chromosome;  
possibly due to strong selection on the X chromosome which is owing to the 
hemizgosity in male (Sachidanandam, et al., 2001). 
Table 3.1 Shown below are the different number of SNPs that were selected on 
each autosomal chromosome in the genome. The target number of SNPs selected 
was based on the size of each chromosome. Chromosome length was obtained from 
Ensembl Genome Browser (www.ensembl.org). 
 
 
Chromosome 
 
Chromosome size 
(Mb) 
 
Percentage 
(Mb%) 
 
 
Target number 
of SNPs 
1 247 8.6 9 
2 243 8.5 9 
3 200 7.0 7 
4 191 6.7 7 
5 181 6.3 6 
6 171 6.0 6 
7 159 5.5 5 
8 146 5.1 5 
9 140 4.9 5 
10 135 4.7 5 
11 134 4.7 5 
12 132 4.6 5 
13 114 4.0 4 
14 106 3.7 4 
15 100 3.5 3 
16 89 3.1 3 
17 79 2.8 3 
18 76 2.7 3 
19 64 2.2 2 
20 62 2.2 2 
21 46.9 1.6 1 
22 50 1.7 1 
           
 Total 
 
 
2866 
 
100 
 
100 
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3.4. Results 
3.4.1. DNA Extraction 
During the quantification of DNA, which was extracted from Kuwait and UAE 
specimens, some of the samples were found to be less than 50 ng/µl (Table 3.2). 
3.4.2. Whole Genome Amplification 
3.4.2.1. Phi 29(Φ29) DNA Polymerase 
The DNA concentration required for the Affymetrix
®
 genotyping method is 50 ng/µl. 
Therefore the samples with a concentration less than this were amplified using Φ29 
DNA polymerase using the Qiagen REPLI-g
®
 Midi kit (Figure 3.5). 
Table 3.2 Quantification results for DNA in UAE and Kuwait samples used for 
Affymetrix
®
 Genotyping. 
 
 
Quantification values (ng/µl) 
 
 
No 
 
UAE Samples 
 
Kuwait Samples 
 
 
1 
 
47.8 
 
5.8 
2 90.2 5.2 
3 100 4.3 
4 65.4 7.2 
5 126.3 
 
5.0 
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The strand displacement amplification mechanisms of Ф29 DNA polymerase overcame 
the need for the re-extraction of the samples with, the DNA amplified directly from the 
original extracts.  
 
 
 
Figure 3.5. Shown above are the results of 1% agarose gel eletrophoresis of DNA samples 
following whole genome amplification using REPLI-g Midi Kit. Lane І is a 23 Kb Hind 
III ladder; lane 2 is the positive control, lanes 3-8 are Kuwait and UAE samples 
(samples with quantification results < 50 ng/µl) respectively. 
 
3.4.2.2. SNP Genotyping 
As specialised instruments and software were required for SNP screening using the 
Affymetrix technique, the DNA from the 10 samples (Section 3.4.1) were sent to an 
external supplier (Geneservice Ltd, UK). The SNP data were returned in the form of 
notepad file: for each sample a separate notepad file was supplied. 
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3.1.1. Analysis of SNP Data 
For the initial selection of SNPs and in order to process the large amount of data 
generated by Affymetrix (approximately 238,000 SNPs for each of the samples from 
Kuwait and UAE) in the form of a notepad document (Figure 3.6) the data were 
analysed using Microsoft
®
 Office Access and Microsoft
®
 Office Excel.  
3.1.1.1. Microsoft® Office Access 
The process consisted of two steps. 
1. Copying the SNP data from the notepad documents into Microsoft
®
 Office Access 
software. 
The first stage was to create separate tables. Since there were 10 separate notepad 
documents obtained from the Affymetrix
®
 genotyping 10 tables were designed. (Figure 
3.7) and then the appropriate data from the notepad were imported into each of the 
tables (Figure 3.8).  
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1           2                   3                  4            5                  6              7                 8   9
 
Figure 3.6. Shown above is an example of how data for approximately 238,000 SNPs 
was stored after Affymetrix
®
 genotyping. The information in this example was for 
sample identification during analysis as S1047. Numbers: [1] represents serial number, 
[2] represents Affymetrix SNP ID, [3] represents the chromosome number, [4] 
represents the position of SNPs on the chromosome, [5] represents NCBI Database 
reference SNP ID (dbSNP rs ID), [6] represents the allele call type (S104-
STY_220906), for example rs7572851 is BB (nucleotide TT),  [7] represents confidence 
values, [8-9] represent allele types (A/B), for example the SNP rs7572851 is CT.  
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Figure 3.7. Shown above are 10 tables representing 10 
different samples copied from the Affymetrix® to 
Microsoft® Office Access for further processing.  
 
Figure 33.8. Shown above is a table illustrating how the data was presented in the 
Microsoft
®
 Office Access software. The table represents one sample with the arrow 
at the bottom of the table indicating the amount of SNP data generated by the 
Affymetrix
®
 genotyping method. The columns represent: serial number, Affymetrix 
SNP ID, chromosome number, database reference SNP ID, alleles call, confidence 
values, alleles type (A and B) and SNP flanking sequence, respectively. 
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Figure 33.9. Shown above is a table illustrating how the data was presented in 
the Microsoft
®
 Office Access software. The table represents one sample with 
the arrow at the bottom of the table indicating the amount of SNP data 
generated by the Affymetrix
®
 genotyping method. The columns represent: 
serial number, Affymetrix SNP ID, chromosome number, database reference 
SNP ID, alleles call, confidence values, alleles type (A and B) and SNP 
flanking sequence, respectively. 
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2. Processing the data 
The first stage was to collate the information from each chromosome, so that data from 
all 10 individuals would be linked (Figure 3.9). 
 
Figure 3.10. Shown above is how the 10 tables were linked together through 
their db SNP ID which is a part of Affymetrix
®
 data. This allowed the 10 
tables to behave as one group. The figure shows 8 tables out of the 10 due to 
space limitations. The arrows was showing the criteria of the confidence value 
(< 0.09) for chromosome number 1. 
 
 
Following the linking of the data, 22 queries were carried out, representing one for each 
chromosome. The queries selected all data from each chromosome that displayed a 
confidence level of < 0.09 (greater than 91% confidence that the data is correct) which 
was then analysed (Figure 3.10).  
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Figure 3.11. Shown above is the final output of Microsoft
®
 Office Access. The table 
illustrated is for chromosome 1 and shows the data for all the 10 samples in the group. 
All samples share the same SNP identification through dbSNP RS ID which was set 
during the query design to link the samples. Arrows represent < 0.09 confidence values. 
The circles represent two samples.  
 
 
This reduced the amount of data from the total of 229,944 SNPs which were analysed to 
a total of 56,826 SNPs (Table 3.3). Therefore, the final outcome of the Microsoft
®
 
Office Access process was 22 tables representing 22 autosomal chromosomes, each  
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with all 10 samples, ranging from 4,938 to 666 SNPs, all with confidence levels of > 
91% for the data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.2.3. Microsoft® Office Excel 
The data obtained from the Microsoft
®
 Office Access queries were found suitable for 
importation into the Excel sheets. Each of the chromosome tables were imported into an 
 
Table 3.3. Shown below are the different numbers of SNPs selected on different 
chromosomes as a result of < 0.09 confidence value was selected. Also shown is the 
initial number of SNPs obtained from Affymetrix
®
.  
 
 
Chromosome 
Number 
 
 
Initial SNPs 
 
Selected SNPs 
 
1 
 
19958 
 
4938 
2 18850 4879 
3 15118 3776 
4 12872 3219 
5 14701 3630 
6 14174 3465 
7 11713 2804 
8 12388 3266 
9 10807 2741 
10 14104 3558 
11 12822 3141 
12 11791 3023 
13 7950 2053 
14 7404 1921 
15 7253 1711 
16 8159 2012 
17 6345 1352 
18 6616 1720 
19 3638 696 
20 6500 1561 
21 3142 686 
22 
 
3647 666 
 
Total 
 
 
229944 
 
56826 
 
 
  
 
 
 
 
 
 
             
Showin
g 
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excel sheet separately. These Excel sheets were then used as the working file for the 
SNP data and their analysis during the entire project, unless otherwise stated. 
In order to obtain the allele frequency for the SNPs data, minor modifications to the 
data were required.  
1. Arrangement of the data  
The data sheet described in Figure 3.10 was modified for the following SNPs analysis. 
The confidence values were removed whilst a column designated for allele frequencies 
was added (Figure 3.11). 
 
 
Figure 3.12. Shown above is an example of the data arrangement in the Excel sheet for 
chromosome 21. Columns [B] and [C] represent the allele call type for the particular 
SNP, lane [D] represents the reference identifier for the SNPs and columns [E-N] 
represent the type of alleles type, which were designated as A and B for each of the 10 
samples under study. 
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2. Sorting the allele genotypes  
 The allele genotypes generated by Affymetrix were in the form of A and B which 
represent the biallelic nature of the SNPs. The allele forms were changed for simplicity 
to the numbers 1 and 2 and only the frequency of the A allele was calculated, since the 
frequency of the other allele (B) can be inferred. For this, the allele B was kept blank, 
AA was given the number 2 and allele A (part of AB) was given the number 1 (Figure 
3.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AB AA
BB
 
 
Figure 3.13. Shown above is data for chromosome 21 after the allelic 
designation (columns E to N represented sample 1 to 10) were changed from 
A and B to 1 and 2. Column V shows the ascending frequency of the alleles. 
The equation for calculating the frequency appears at the top of the table in a 
green circle. 
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The frequencies of the allele A were calculated using Excel and the equation 
(Frequency = SUM(En:Nn)/20) where E and N represented the cells in which the alleles 
were present, n represented the location of the cell in the sheet and 20 was the number 
of alleles under study (10 samples). The frequencies were then sorted in ascending order 
and the SNPs with frequencies ranging from 0.45-55 were selected and entered in a new 
Excel sheet (Table 3.4). A total of 4,123 SNPs were selected from 22 chromosomes. 
The rationale behind the selection of SNPs with allele frequencies ranging between 0.45 
and 0.55 was to enhance the level heterozygosity of the selected SNPs. This in turn, will 
maximise the information for each SNP locus, thereby producing low match probability 
which is essential for forensic application (Kidd et al., 2006).  
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3.4.3. Interpretation Criteria of SNP Selection 
The first step was to target SNPs that were located in the intergenic region and (Figure 
3.13) shows an example of an SNP that meets the criterion of being located in such a 
region.  
A second criterion was that SNPs should occur at a distance of at least 100 bp from any 
other characterised polymorphisms (Figure 3.14).  
 
Table 3.4. Shown below are the different number of SNPs selected with frequencies 
ranging from 0.45- 0.55, from 22 autosomal chromosomes. 
 
 
Chromosome Number 
 
 
Number of SNPs 
 
1 
 
317 
2 418 
3 279 
4 238 
5 253 
6 262 
7 227 
8 251 
9 209 
10 241 
11 191 
12 197 
13 140 
14 157 
15 127 
16 160 
17 97 
18 112 
19 40 
20 117 
21 53 
22 
 
37 
 
Total 
 
4123 
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Figure 3.14. Shown above is an example of the different locations of SNPs on a 
chromosome. The grey colour indicates that SNPs are located in an intergenic 
region. Other colours indicate SNPs that are located in genic regions. The arrow 
represents the target SNP selected for code rs4820621 on chromosome 22. 
 
 
Target SNP
 
 
Figure 3.15. Shown above is an example of a target SNP with no SNP within 
100 bp. The arrow represents the target SNP 1-1 (rs12041851) on chromosome 1. 
 
100 bp 
100 bp 
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In other cases, such as for SNPs rs11892626, rs7573184, rs1445561, rs7858174, 
rs180921, rs8057434, rs17304618 and rs4820621, which occur on chromosome 2, 8, 9, 
10, 16, 19 and 22 respectively, although these SNPs failed to meet the criterion of 
having no other SNPs within 100 bp, they were not rejected at this point (Figure 3.15). 
This did not have any negative impact on the results, as care was taken during primer 
design to avoid the overlapping SNP (Chapter 4). 
No SNPs were found that were in close proximity to the commonly used forensic STRs.  
Some examples are shown in Table 3.5. 
 
Target SNP
67 bp
 
 
Figure 3.16. Shown above is an example of a target SNP which is located within 
100 bp of other neighbouring SNPs. The figure represents target SNP 22 
(rs4820621) with an SNP located 67 bp downstream of the target SNP. 
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3.4.4. Selection of Candidate SNP loci 
The number of SNPs selected on each chromosome was proportional to the size of the 
chromosome. Chromosomes 1 and 2 had the greatest number of selected SNPs with 9 
and 6 respectively. Most SNPs selected were from both distal regions of the p-arm and 
q-arm of the chromosome. Except for loci on chromosomes 13, 14, 15, 18 and 19, 
where SNPs were selected from the q-arm only, due to a lack of suitable loci on the p-
arm. Subsequently, for initial screening, a total of 75 SNPs were selected from the 22 
autosmal chromosomes (Table 3.6). 
 
 
 
Table 3.5. Shown below is an example of the positioning of SNPs and STRs that 
are found on the same chromosome. 
 
Chromosome SNP  STR  
 db SNP RS ID  
 
position (Mb)  
 
reference 
 
position (Mb) 
1 rs4951124 203.049170 F13B 195.3 
2 rs75580941 150.753046 TPOX 1.541580 
3 rs978979 56.508056 D3S1358 45.520600 
4 rs4975214 130.470433 FGA 155.723730 
19 rs10414856 33.595469 D19S433 35.1 
21 rs8130475 33.114415 Penta D 43.9 
   D21S11 19.5 
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Table 3.6. Shown below are the 75 autosomal SNPs selected for analysis  and their 
corresponding chromosomes.          
 
 
No 
 
 
chromosome 
 
In-house 
SNP code 
 
 
db SNP RS ID 
1 01 1-1 rs12041851 
2 01 1-2 rs10864499 
3 01 1-3 rs4951124 
4 01 1-4 rs4652245 
5 01 1-5 rs12759915 
6 01 1-6 rs1202593 
7 01 1-7 rs2982742 
8 01 1-8 rs576736 
9 01 1-9 rs10864713 
10 02 2-1 rs4832461 
11 02 2-2 rs1250915 
12 02 2-3 rs11892626 
13 02 2-4 rs7573184 
14 02 2-5 rs6542461 
15 02 2-6 rs7580941 
16 03 3-1 rs2649734 
17 03 3-2 rs6807414 
18 03 3-3 rs6793629 
19 03 3-4 rs12629514 
20 03 3-5 rs978979 
21 04 4-1 rs1822841 
22 04 4-2 rs7684079 
23 04 4-3 rs2546275 
24 04 4-4 rs9995245 
25 04 4-5 rs4975214 
26 05 5-1 rs6594747 
27 05 5-2 rs7723568 
28 05 5-3 rs7444492 
29 05 5-4 rs4703439 
30 06 6-1 rs6915280 
31 06 6-2 rs17559298 
32 06 6-3 rs1570281 
33 06 6-4 rs3846764 
34 07 7-1 rs217013 
35 07 7-2 rs1525830 
36 7 7-3 rs7786414 
37 8 8-1 rs4105594 
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Table 3.6 (continued). 
 
 
No 
 
 
chromosome 
 
In-house 
SNP code 
 
 
db SNP RS ID 
38 8 8-2 rs1445561 
39 8 8-3 rs9297236 
40 9 9-1 rs7858174 
41 9 9-2 rs10491520 
42 9 9-3 rs10965215 
43 10 10-1 rs180921 
44 10 10-2 rs555325 
45 10 10-3 rs12764177 
46 11 11-1 rs517679 
47 11 11-2 rs2941043 
48 12 12-1 rs6487665 
49 12 12-2 rs10777845 
50 13 13-1 rs4435117 
51 13 13-2 rs4941487 
52 13 13-3 rs7338627 
53 13 13-4 rs2892545 
54 14 14-1 rs17095615 
55 14 14-2 rs11628091 
56 14 14-3 rs1489870 
57 14 14-4 rs10133956 
58 15 15-1 rs4778706 
59 15 15-2 rs3848179 
60 15 15-3 rs1529883 
61 16 16-1 rs8057434 
62 16 16-2 rs7204754 
63 16 16-3 rs1477389 
64 17 17-1 rs4925075 
65 17 17-2 rs2045660 
66 17 17-3 rs1872236 
67 18 18-1 rs4891524 
68 18 18-2 rs17064977 
69 18 18-3 rs9950394 
70 19 19-1 rs10414856 
71 19 19-2 rs17304618 
72 20 20-1 rs6098780 
73 20 20-2 rs745661 
74 21 21 rs8130475 
75 22 22 rs4820621 
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3.5. Discussion 
The allele specific hybridisation method incorporated in the Affymetrix
®
 microarray 
technique provides a reliable genotype of tens of thousands of SNPs with information 
such as the allele’s types, the position of each SNP on the chromosome and the flanking 
sequence (Thompson et al., 2005).  
Evaluation of Affymetrix
®
 Results 
The use of the Affymetrix
®
 GeneChip 250K Array Sty genotyping method allowed the 
generation of more than 238,000 SNPs from the whole genome. 
High quantity DNA (more than 250 ng/5µl) was required for the Affymetrix
®
 
genotyping method. In order to obtain such concentrations, whole genome amplification 
was used. For this, the double properties of the Ф29 enzyme, as a DNA polymerase and 
exonuclease, were employed. The DNA polymerase activity of the enzyme incorporated 
nucleotide bases at the 3′ end of the primer whilst its exonuclease activity cleaved 
nucleotides at the 5′ end of the double stranded DNA (Perez-Arnaiz et al., 2006). This 
double action resulting high DNA concentrations, ranging within DNA fragments from 
2kb to 100 kb (Qiagen, 2005). Due to Ф29 polymerase activity, the concentration of 
amplified DNA can increase to more than 10 times the expected level using Taq DNA 
polymerase amplification (Schneider et al., 2004).    
As the Affymetrix
®
 technique generated large data sets powerful software such as 
Microsoft
®
 Office Access was needed. This allowed the data to be analysed and stored 
in tables which were then exported into Microsoft
®
 Office Excel. The use of publicly 
available GenBank sites such as HapMap, NCBI, and Ensemble, and the criteria 
formulated in this study (Section 2.3.4) allowed the selection of 75 SNPs to be further 
characterised for forensic applications. 
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Comparison with other SNP Methods 
In order to evaluate the identification of SNP results obtained in this study by using the 
Affymetrix
®
 GeneChip
®
 method, some autosomal SNPs generated with different SNP 
typing methods were assessed.  
Inagaki et al. (2004) developed a 39-plex autosomal SNP including the amelogenin 
locus. The multiplex was based on SBE reactions in 5 tubes using the SNaPshot
™
 
method. The 39 SNPs were selected from different SNP databases including, Japanese 
SNP (JSNP) database. 
Vallone et al (2005) developed 70 autosomal SNPs markers typed in 11 tubes of 6-plex 
and a single 4-plex reaction. The allele discrimination was performed using SNaPshot
™
. 
All SNPs were obtained using the Orchid Cellmark (Dallas, USA) Autosomal SNP 
Information. These 70 loci were selected from 20 autosomal chromosomes. The 
polymorphism loci used involved one SNP type only (C/T).  
Another collection of SNPs was selected by Kidd et al (2005) from Applied Biosystems 
off the shelf. 19 SNPs TaqMan markers were developed in their study. 
More recently, Sanchez et al (2006) developed a 52 autosomal SNP multiplex in two 
separate reactions, a 29-plex and 23-plex PCR and SBE for SNaPshot
™
 reaction.  The 
selection was based on ‘The SNP Consortium’, the SNPs were selected from all 
autosomal chromosomes.  
The 75 SNPs identefied in this study were obtained from screening Arab individuals 
using the Affymetrix
®
 GeneChip
®
 rather than selecting SNP from available GenBank 
databases. The objective in using this screening method was to generate SNPs markers 
that were obtained from individuals (UAE and Kuwait) with SNP profiles not included 
in the GenBank
®
 database (at the time the research was conducted). In comparison, all 
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of the above described methods used SNP loci initial screened from genotyped 
populations available at the GenBank
®
 databases. Also, the pre-selection of SNPs from 
Affymetrix
®
 data was based on 0.45-0.55 frequencies. In addition, during the selection 
all the autosomal chromosomes were targeted, as were 52 SNPs developed by Sanchez 
et al. (2006). In this study and others, selection from entire autosomal chromosomes 
helped to select unlinked SNPs. Studies have reported that Linkage Disequilibrium 
(LD) (the association between SNPs) is reduced when SNPs are selected to be 100 kb 
from each other (Phillips et al., 2004; Sanchez and Endicott, 2006).  
With the large amount of SNP data (238,000 SNPs per sample) obtained using the 
Affymetrix
®
 screening, a significant period of time was needed in order to process the 
data. This was a disadvantage of screening such a high number of SNPs. Affymetrix 
GeneChip
®
 of less than 250 kb could therefore be a more appropriate method for 
screening forensic SNP markers. 
3.6. Conclusion 
In conclusion, regardless of the time taken for SNP identification, a 75 autosomal SNP 
panel was selected. The SNPs have been selected for high heterozyosity in the target 
individuals. Further characterisation is to be carried out in the following Chapters to 
select the best SNPs for forensic applications. 
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CHAPTER 4  
 
ANALYSIS of SNPs 
 
using SNaPshot 
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4.1. Overview 
Completion of the Human Genome Project provided billions of base pairs of DNA 
sequence to the scientific community (Reich et al., 2001). This work identified the 
positions of more than 5 million SNPs, providing more understanding and information 
for the study of human genetics (Sachidanandam et al., 2001; Venter et al., 2001; 
Collins et al., 2004) and another tool for forensic applications (Budowle, 2004).  
4.2. Aims of this Chapter 
 To design a series of assays to evaluate the utility of SNPs identified in Chapter 
3, as markers for forensic applications.  Essentially, this involves amplifying 
these SNPs on a PCR amplicon followed by genotyping using a single base 
extension method (SNaPshot); 
 To perform a concordance study between SNapShot™ and Affymetrix® 
genotypes.  
4.3. Results 
4.3.1. Assessment and Evaluation of SNPs 
The SNaPshot
™
 kit was used to characterise individual SNPs which were selected after 
analysis using the Affymetrix
® 
GeneChip
®
 250K Array Sty, as described in Chapter 3. 
Accurate primer design and rigorous purifications were necessary steps for 
characterisation in order to achieve unambiguous results when using the SNaPshot 
method (Sanchez and Endicott, 2006). The procedure was conducted according to the 
manufacturer’s protocol (Figure 4.1). 
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Figure 4.1. Shown above is a flow diagram describing the steps in the SNaPshot
™
 
protocol. Template DNA was amplified producing PCR products less than 150 bp long. 
Excess primers and dNTPs were removed by the addition of ExoSAP-IT enzyme. 
Purified PCR products were then analysed by a SNaPshot
™
 reaction in the presence of 
SBE primers, followed by a final purification step in which Shrimp Alkaline 
Phosphatase (SAP) was added to remove unused ddNTPs. Finally, the ABI Prism 310 
Genetic Analyser was used to detect SNPs. 
 
4.3.1.1. PCR Primer Design 
In total, 150 PCR primers were designed, fulfilling the criteria described in Section 
2.3.5. Primer 3 (http://www.fro.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) was used 
to aid primer design, (Figure 4.2) the sequence data flanking the SNP was imported 
Amplification of 
Target DNA 
PCR Products 
<150 bp 
PCR Purification 
(ExoSAP-IT) 
SNaPshot
™
 Reaction 
(SBE methods) 
SBE Reaction 
Purification (SAP) 
Detection of 
SNPs (ABI 310) 
Design PCR  
Primers 
Design SBE  
Primers 
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from the National Center for Biotechnology Information (NCBI) database 
(http://www.ncbi.nlm.nih.gov).  
The primer sequences were checked using Oligonucleotide Properties 
(http://www.basic.nothwestern.edu/biotools/oligocalc.html), which analysed these 
sequences for putative secondary structure. Finally, the primer sequences were checked 
using the Basic Local Alignment Search Tool (BLAST), to check for both specific and 
non-specific binding sites. Ultimately, 75 primer pairs were designed (Table 4.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Shown above is PCR primer design for SNP code 22. The arrow 
shows the position of the target SNP and the circle shows the position of 
another unrelated SNP.  
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Table 4.1. Shown below are 75 PCR primers sorted by chromosome position. Each 
primer set consists of a forward and reverse primer. The predicted annealing temperature 
and amplicon length is shown.  
 
Chromosome 
 
 
In-house 
SNP 
code 
 
NCBI ref 
 
 
PCR Primer
a 
 
 
PCR 
annealing 
temp (°C) 
 
Amplicon 
length 
(bp) 
 
01 1-1 rs12041851 CCTGATTTATGAGAGGAGCTGA     60 137 
   GCCTGCACTGCACATTCTA        57  
01 1-2 rs10864499 GATCAAAGGGGAGAGCACAC 60 127 
   CAAGGAGTAGGCCAGGTTCC  63  
01 1-3 rs4951124 GACGACAAGTTACCTGCCTGA 61 144 
   TCAGGGGTCGAACTAGACCTT 61  
01 1-4 rs4652245 GGAAGAAATGGAGTAAGGATGA 60 124 
   CACCCCCTTCAACTCAGTCT 58  
01 1-5 rs12759915 AGTGCAAATGGGAAGAAAGG 56 113 
   CAGAAAGTGTCAGGAGGGCTA 61  
01 1-6 rs1202593 GCAATGGGCAGTAGATCAAG 58 122 
   AGGGCAGCATCTGGAATAAC 58  
01 1-7 rs2982742 GGACACACTCTAATTTCTCCATGT 62 115 
   CAAAGGAGTTAATAGTCCCATTGT 60  
01 1-8 rs576736 CTCACTTAGCCTCACAACAACC 62 140 
   TGGGTGAGTCTCCTTGTTCA 58  
01 1-9 rs10864713 CAATATCCAATCCACCAGCA 56 96 
   GGACTAAGGTTCCTGCCAGA 60  
02 2-1 rs4832461 CACCGATCTCAGCCTGGTAA 58 108 
   CATATCTTTGGAGCCCTGGA 60  
02 2-2 rs1250915 GCAAATAATCTGGTGGCTGAG  60 115 
   TCCAGGTTCAAACCGAATGT 56  
02 2-3 rs11892626 AGATGCACCCTCCTAGAGCA  60 112 
   TCAGAGTGAGGGGAATAGCTG  61  
02 2-4 rs7573184 TCCCAGATGACCAGAAACCT  58 120 
   GAGCCTTGTCTTCTTTCCACA  60  
02 2-5 rs6542461 TTTAAGCCCTTGGTTCATGTG 57 130 
   CCAGTGTTCTGATTCCAGCA 58  
02 2-6 rs7580941 CTTTCCTTCTGGCTTCTTGG 58 121 
   ATGAGAAGTCTGCCAAAGCAA 57  
03 3-1 rs2649734 GAATGGCACTCTGGTGGAGT 60 139 
   AGGACTGAGAGAGGGACACCT 63  
03 3-2 rs6807414 TGAAAGAGAAAGATGGTGTGAAA 58 107 
   TGGAACACCAACAGTGTATGC 60  
03 3-3 rs6793629 AGACTGATTCTCTAGGCAGAGC 62 116 
   CACAGTGTCCTCTTGAACACG 61  
03 3-4 rs12629514 TTGGCAGATAGCATTATCAGGA 58 136 
   AGGCCACTGTTCATTTCCAG 58  
03 3-5 rs978979 TTGCCACTTCCTAATTGTCTGA 58 128 
   TTTATCATTTCTCTTCCCTTCCA 58  
04 4-1 rs1822841 CCAAACTTCCGCTTAATGTTACC 61 129 
   GCAAAGCTCATGTATGTAGAA 58  
04 4-2 rs7684079 CATTCTACCCTGGCCTGAGC 63 130 
   ACCAGAAAGAGGAGGGAGGA 60  
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Table 4.1 (continued) 
 
Chromosome 
 
 
In-house 
SNP 
code 
 
NCBI ref 
 
 
PCR Primer
a 
 
 
PCR 
annealing 
temp (°C) 
 
Amplicon 
length 
(bp) 
 
04 4-3 rs2546275 AGGACAGTTGGCCAAATACAAT 58 120 
   CACAGGTTCATCCAAGAGCA 58  
04 4-4 rs9995245 CAGGTGAAACAAATAGCCAGAA 58 90 
   GAGAAGCTTCCACCTGAATTTG 60  
04 4-5 rs4975214 GATGGGTAGGTTTATCCAAGG 60 124 
   TTGACAGAGCATTACTGGTTCTT 59  
05 5-1 rs6594747 GGAAAAGCAAGTGCCATTATTTA 58 140 
   GCCTCAGGGCTCTATTCTTTG 61  
05 5-2 rs7723568 GTGGAGTGAAGCCCTGAATG 60 129 
   ACAGATGGCAGAAGGCAGAG 60  
05 5-3 rs7444492 GGGTTAAACAAAGGAGAAATGC 58 130 
   AATCACTTGCCCAAGGTCAC 58  
05 5-4 rs4703439 CTGTGGGAAGTGGATGCTG 60 123 
   ACTCCGAGCTCTTCCTCTGA 60  
06 6-1 rs6915280 TGGACACTTACTGAGTTCCTCTTT 62 111 
   TTCACCGTTATTCCGAGAGC 58  
06 6-2 rs17559298 ACCCCGTGTCCACATAGTCT 60 98 
   ACAGTTTCCAAAGCCAGAGC 58  
06 6-3 rs1570281 GGGATTTGATCTGCTTTATTCTC 59 116 
   ATCTGCCAGCCATTGTCTTC 58  
06 6-4 rs3846764 TCTAGGTAATAAACTGGGTTTCCA 60 106 
   GAGGTAAAAGCTGCCCTTGA 58  
07 7-1 rs217013 GCAGCGAATACCAGGCTC 60 120 
   GCAGCAAGGTAAGAAAAAGCA 57  
07 7-2 rs1525830 CCTTCTTATCATGTCACGTTGG 60 118 
   AAAGGTCACATGACGGTGGA 58  
07 7-3 rs7786414 GGGGTCTTGAGATGTTGCAG   60 119 
   GCTGTGGTTCTTGGTGACCT   60  
08 8-1 rs4105594 GGGTCGGCTTATTTCTCACA 58 102 
   CATTTCCCCAGCTATGGTGT 58  
08 8-2 rs1445561 TGCCAGAGGAAGGTGTATCA 58 112 
   GCTGTAGACATTAGGGCACCA 61  
08 8-3 rs9297236 AGACTGGGAAACTGAAGTGTGA 60 105 
   CAGGGGAAGTAGGGCTAGAAA 61  
09 9-1 rs7858174 GGTCAAATGCCAAGTGAAGC 58 106 
   CCCTTCTCAAGACCACCTGA 60  
09 9-2 rs10491520 CCTTCCCCCTTAATCTGTCC 60 119 
   GGCTATGCCCCTTTTGCTAT 58  
09 9-3 rs10965215 TCCTGATGGAATGTTTAGTCTGA 59 135 
   CAGCATGGACACCAATATTCTC 60  
10 10-1 rs180921 GTATCCTGGGGGCAATTTCT 58 131 
   TGATCTGCTTTTACGTCTTATCTCC 63  
10 10-2 rs555325 ACTGCAGGTGCTCGTTGTCT 60 104 
   CTGATCCCCTTCCCTCTCTT 60  
10 10-3 rs12764177 TTGTAGCCAGGAATCTGGTTG 60 118 
   CTTCAGGTTCTCTAGGGTGGA 61  
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Table 4.1 (continued) 
 
 
Chromosome 
 
In-house 
SNP 
code 
 
 
NCBI ref 
 
 
 
PCR Primer
a
 
 
PCR 
annealing 
temp (°C) 
 
 
Amplicon 
length 
(bp) 
 
11 11-1 rs517679 GCCAGATGAGGACTGTGTTG 60 120 
   TGAGCTGCTACAGATTTATGCTACA 63  
11 11-2 rs2941043 CCTCTAGGATGCCAAGCAGT 60 117 
   CTTTGGTTCTTCGACCTGTAAA 58  
12 12-1 rs6487665 GGGCCTGAGTCAATTTTCAG 58 119 
   TGAAGAAGGACTAAGGGAATCA 58  
12 12-2 rs10777845 CCCTTGAATCCTCATGGAGTT 60 108 
   CACAACATTATTGGGCGGCTA 60  
13 13-1 rs4435117 AGTTCCTGCCTAACATTCCTG 60 119 
   AGATCAGTTCCACCTCCCACT 61  
13 13-2 rs4941487 ATGGCCACCTAGGGAAACTT 58 126 
   TCCTCTTTTGTTGACACCTTG  57  
13 13-3 rs7338627 ACACAGCTGCCCAGGAAAAG 60 112 
   TGCTGCTAACTCTGGACTGG  60  
13 13-4 rs2892545 ATCTGCATGAGTTCCTTTCAA 57 142 
   GTACGGTGGGTCCTCGAAAA 60  
14 14-1 rs17095615 GCTCCCTCGACCGATTTTAT 58 117 
   AACCTAACCCCCAAGGCAAT 58  
14 14-2 rs11628091 TCCCTCACTCCTGGAAACAC 60 118 
   ATGAGGAGGGACCAACCAAG    60  
14 14-3 rs1489870 TCATGTTCTCAGGGTACTTGGTT 61 113 
   TGCAGCAATCCAGACTGAAC 58  
14 14-4 rs10133956 AGCAGAGTTGCGTAAAGCAG 58 95 
    GAACTCGAATCCAGGTCTCC    60  
15 15-1 rs4778706 AGCCCCACGCAAATGTATGT 58 120 
   TTGAAGGAGGCAGTTGATCTC 60  
15 15-2 rs3848179 GTCAGGCTGGAAATGGTAAGA 60 139 
   TGACTCATCCGACTTTACTTTTCT 60  
15 15-3 rs1529883 GGTCATCCTCCAAAGAACACA 60 126 
   TGGCACTTCATTGCTGACTC 58  
16 16-1 rs8057434 GCCATCACTGTGTGAGCAAG 60 127 
   CCATGCTTTCCATTTCTACTCC 60  
16 16-2 rs7204754 CAAGCTAAATAAATGGCCAAGG 58 133 
   AGAGAGATCTTGGGGGAC GT 61  
16 16-3 rs1477389 CATGGCAGTTTCTTATTTCTGG 58 120 
   GAGCTCCAATTTAACGCCATC 60  
17 17-1 rs4925075 TTGATTTTTGGCTAGCATTTAGG 58 119 
   GGATGACTCCAGACCAATGC 60  
17 17-2 rs2045660 CCATCCCCAGCCTACCTA 58 144 
   GCAGCATTTAAACAGGCTTTCT 58  
17 17-3 rs1872236 GCTCCGAGTCAGGTCTTGAA 60 147 
   GGAAGAAGAGCCGACATCCT 60  
18 18-1 rs4891524 TGAGGCCAATCTTATCTTCTTGA 58 108 
   GAGTAACCTGCGTGGAAGGA 60  
18 18-2 rs17064977 GAACACCTGGGGAAAGAACA 58 109 
   AATGCCCAGGACCTCACTTT 58  
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The predicted annealing temperature for the 150 primers was 60 °C ± 3 °C except for 
primers 1-5, 1-9, 2-2 and 22 where it was 56 °C. During optimisation, these primers 
produced acceptable amplification products at an annealing temperature of 60 °C 
(Figure 4.3). The G+C contents for each primer were kept between 35-60%. Moreover, 
at least 1 but not more than 4 G/Cs were present within the first 7 nucleotides from the 
3′ end of the primer pair. Exceptions occurred with the forward primers for SNPs 
rs6594747 and rs17095615 (SNP codes 5-1 and 14-1 respectively). G/C bases were 
included in the 3′ portion of the primers to increase hydrogen bonding, which in turn 
enhances the specificity of the primer (Dixon et al., 2005a; Dieffenbach and Dveksler, 
2003). The primer size was kept less or equal to 25 bp in length. For successful 
amplification of targeted regions it was found that all the 75 primer pairs could be 
amplified at an annealing temperature of 60 °C. Also, for the optimal performance of 
primers, the magnesium chloride (MgCl2) concentration was adjusted to 2.5 mM. 
Table 4.1 (continued) 
 
Chromosome 
 
In-house 
SNP 
code 
 
 
NCBI ref 
 
 
PCR Primer
a
 
 
PCR 
annealing 
temp (°C) 
 
Amplicon 
length (bp) 
 
18 18-3 rs9950394 TGCTGTTCCCATGGTAGTGA 58 119 
   GGGGAAGGAAAACAAGTACC 61  
19 19-1 rs10414856 TAGCAAGGTGCACATGAAGC 58 129 
   TGCAGTTATTGGGGTCTATGC 60  
19 19-2 rs17304618 TTCAGTGTTCTTGGGCACAG 58 110 
   ATTAGGCATCCAAGACCGCATA 60  
20 20-1 rs6098780 TGAGCATCCCTTACTTCTCCA 60 123 
   GGCCATTCGGAAAGAACTGT 58  
20 20-2 rs745661 TGGGTGCAGTGAGGTAGCTT 60 110 
   CTTGTTGCTCCACCTTCCTT 58  
21 21 rs8130475 TCCTCTCACAACTTGCTTGG 58 92 
   TGCATGACAGTGGAAGACCA 58  
22 22 rs4820621 TCTCTTGGGAGGACCTTCTG 60 113 
     AAGCACAGCCAGCATCTTTT 56  
 
a
 primer sequences are shown from 5′ to 3′ orientation 
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1     2      3     4      5     6      7     8      9   10   
11  12  13   14  15   16   17 17117  
                           5      6      7       8      9     10
 
 
Figure 4.3. Shown above is an example of annealing temperature optimisation for 
chromosome 1. Lane 1 represents a 20 bp allelic ladder, lanes 2 to 10 represent an 
annealing temperature of 60 °C for SNP codes 1-1 to 1-9. The optimisation products 
were run on a 2.5% (w/v) agarose gel. 
 
 
4.3.1.2. SBE Primers 
The 75 single base extension primers (SBE) (Table 4.2) were designed to anneal 1 bp 
upstream (3′ end) to the SNP. The steps for primer characterisations were similar to the 
PCR primers described in Section 4.3.1.1.  
The orientation of each primer was given in respect to the SNP position on the target 
strand (forward or reverse). Also, the orientation was dependent on the most suitable 
primer that met the criteria for SBE as described in Section 2.3.11. Poly-thymidine 
(poly-T) tails were included in some primers at the 5′ end to increase their length. The 
addition of poly-T tail does not have any significant effect on the annealing temperature 
(Dixon et al., 2005a). This was important because the properties of the fluorescent dye  
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used to label the ddNTPs was observed to have a more pronounced effect on the 
electrophoretic mobility of shorter primers in comparison to larger primers which were 
more than 25 bp. Therefore, all SBE primers were designed to be more than 25 bp 
except primers 1-1 and 15-1 which were 20 bp and 22 bp respectively. The effect of the 
dye on the sequence electrophoretic mobility was within the range that was expected. 
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Table 4.2. Shown below are 75 SBE primer sequences and their direction of orientation. F 
represents forward orientation and R represents reverse orientation. 
 
 
Chromosome 
 
In-house 
SNP 
Code 
 
NCBI ref 
 
SBE primer
a 
 
Direction 
SNP 
allele 
01 1-1 rs12041851 CCCTGGAGTTGGCCAAAAGA F A/G 
01 1-2 rs10864499 TGCCCCCTCTTTCATCCACC    F C/T 
01 1-3 rs4951124 AGGGACTGGGCCTCAAGTA R C/T 
01 1-4 rs4652245 CCAAGGTTATATTTTACAGAAACAGCTAG R G/T 
01 1-5 rs12759915 TAACAGCATTCCAGATTTCAG  R A/G 
01 1-6 rs1202593 ACAGATGCAGGCCTGAGTCAT    R A/G 
01 1-7 rs2982742 GTCAGTCCACATCTAGAGTATC  R A/C 
01 1-8 rs576736 CCTCTTCAAATCTTAAGTTGCTAG  R A/G 
01 1-9 rs10864713 AGAGAAGAGGCGCATTTGAG R C/T 
02 2-1 rs4832461 TCCAAATGGCTCTGGGTCAC F A/C 
02 2-2 rs1250915 ACAGAGAAGTGGTTTTAGAAGG F A/T 
02 2-3 rs11892626 CTCCTCGATTCTCTTCTAACAAG F G/T 
02 2-4 rs7573184 TGGGACTGTTGCATTTGTTTCTT F C/G 
02 2-5 rs6542461 CATGAAGCATTTTAAGACACTGGA F A/G 
02 2-6 rs7580941 CATCAATAGGTGTAGCCCAC F A/G 
03 3-1 rs2649734 CATGCTCCTTGATGTTCTCTCAA F C/T 
03 3-2 rs6807414 ACAGTAAGGGTTAACACATGCT F A/G 
03 3-3 rs6793629 TGTTCCTAGGCTTGAAACTAGAA R A/G 
03 3-4 rs12629514 TCATCAGAAAGCATGCAGAGTTG F C/T 
03 3-5 rs978979 ACCACTCTAAGACGCATACTTTT R A/G 
04 4-1 rs1822841 ATCAACCAAATTGTTCTACCACGA F C/T 
04 4-2 rs7684079 CCACCTGCAAGGGAAGATGT F A/C 
04 4-3 rs2546275 TCATTAGCTGTTAACAATTCCAG F C/T 
04 4-4 rs9995245 AGTACATCAAAGCAGGTAGCATA F A/G 
04 4-5 rs4975214 TGTGGCATCTCTCTCTGGCA R C/T 
05 5-1 rs6594747 AGGCTTATTTTCTTGCTGCTGA  R C/T 
05 5-2 rs7723568 CGGCAAATGAGACTCGTTCC F A/C 
05 5-3 rs7444492 CCTCATAACAATAAGGTGACACA F C/T 
05 5-4 rs4703439 AAGGACCGAGAGGTGATTGA F C/T 
06 6-1 rs6915280 TCGTGCTGGGTATGTTGCTAAG F A/T 
06 6-2 rs17559298 TCTCTAATGAGGGTGGCTTG F C/T 
06 6-3 rs1570281 GCTTCCAGAACAGTACCAGGA F A/C 
06 6-4 rs3846764 ACTTCATCTTGTAACGAGACTTTG R G/T 
07 7-1 rs217013 TGGTTGACTGCATTTCTTGGCTT F A/G 
07 7-2 rs1525830 CTGAGCCAAGCGATCCAAAC R C/T 
07 7-3 rs7786414 GATCCCAAGACTTTCACCAAAG R C/T 
08 8-1 rs4105594 TCCCACTTCAAGCCCACAAT F A/C 
08 8-2 rs1445561 AGGAAGAAGGACTCACACCC F A/G 
08 8-3 rs9297236 GATTAATAACAGTGCTACCAAAAGTC F A/G 
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4.3.1.3. Evaluation of SBE Primers 
The primers were evaluated to ensure that they produced the expected results and that 
no artefact peaks, that would interfere with the target peaks, were generated. To achieve 
this aim, a SNaPshot
™
 reaction was set up except that, instead of the DNA template, 1 
µl of dH2O was added to the reaction, as described in Section 2.3.14. Certain non-
specific peaks were observed in the green dye electropherograms, as in primer codes 13-
Table 4.2 (continued). 
 
 
Chromosome 
 
In-house 
SNP 
code 
 
NCBI ref 
 
SBE Primer
a 
 
Direction 
SNP 
allele 
09 9-1 rs7858174 TTGGGTTCAGCAACTTGGAAGTG F C/T 
09 9-2 rs10491520 GTTTGTCTGTCTACCAACCTATCT F C/G 
09 9-3 rs10965215 GTTTTGCAGGACTATTTGCCAC F A/G 
10 10-1 rs180921 GTGGCAGGCAGTACTTGACCT F C/G 
10 10-2 rs555325 CACCATTTGTCACCCACTTTCT F C/T 
10 10-3 rs12764177 ACCTCAGGCAAAGAGCTTAGCT R A/C 
11 11-1 rs517679 TTGAAATTAGGCACCTGTCCACT F C/T 
11 11-2 rs2941043 GGTATGAAAGGCCGTGTGAAAAT R A/G 
12 12-1 rs6487665 TCTCATTCATTGACGTGTTTAGG F C/T 
12 12-2 rs10777845 ACTTGCCACATACTGCTCGTC F C/T 
13 13-1 rs4435117 CTAAATCTAGACTGCAGTTT R A/G 
13 13-2 rs4941487 CTAACATGTTAGCTTCAAGGCTT R A/G 
13 13-3 rs7338627 TTCAATCACTTGTGCCAGATGT R A/C 
13 13-4 rs2892545 AGAAGTCATGCTTTCAGTTA F C/T 
14 14-1 rs17095615 TTGGAAAATCAGTGATCCTCAACTG R A/G 
14 14-2 rs11628091 GCTTTGATGTCCCGAGTCCA F A/C 
14 14-3 rs1489870 GTATGGTTTTTCTAAGGAACAGA F A/G 
14 14-4 rs10133956 CGCCTCCATTGAATTGGCTC F C/G 
15 15-1 rs4778706 CCCTGTTGCAAAGTAAAAGCCT F A/T 
15 15-2 rs3848179 CTCCTTTGCTTGGCCTGATAG R C/T 
15 15-3 rs1529883 ACTCACATTTATCTCATGGTTAGTTAT R C/G 
16 16-1 rs8057434 AAATGGAGTGTAAACTGCAAACGT F C/G 
16 16-2 rs7204754 AAGTGTTGTGTTAATTTGGCTCCAT R A/T 
16 16-3 rs1477389 TAGCTTCTGGGCATGTGACA F C/G 
17 17-1 rs4925075 CTGGCTGGATGCCCACTTAG F A/G 
17 17-2 rs2045660 AAGGCAGCAGGAAAAGGCTCA F C/T 
17 17-3 rs1872236 TTCCTTCTTCAATTTAGGGGTTGA F A/C 
18 18-1 rs4891524 ATTACAGCATGTTCTCCTGAGCA F A/C 
18 18-2 rs17064977 AAGTTGGAAGAGGAGCGACTC F C/T 
18 18-3 rs9950394 ATAAGCTGGCAGGAGAGCAAG R A/G 
19 19-1 rs10414856 GAAGAGTTCCCCCAAGCAA F C/T 
19 19-2 rs17304618 TGTGCCTGTGGAGTCACTC F A/G 
20 20-1 rs6098780 CGAACTGCATTTCACATCACTCT F C/G 
20 20-2 rs745661 CTCTGTGTTCTCTCTATTCCATC F A/T 
21 21 rs8130475 GAAAGGTTGGCTAATAGTCAGGT R C/T 
22 22 rs4820621 CTCTTTCCCTTGCCTTTCCG F C/T 
 
a
 SBE primer for SNaPshot™ analysis are listed from 5′ to 3′.  
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1 and 14-1 (Figure 4.4). These peaks could have originated from the addition of ddATP 
to the 3′ end of none target SBE primers. Since the electrophoretic mobility and their 
fluorescent dyes of these primers were constant, the non-specific peaks were identified 
(Figure 4.5). 
 
 
B
C
T
A
 
 
 
Figure 4.4. Shown above is an example of SBE evaluation. [A] represents 
an electropherogram of the internal standard Liz -120 without any artefact 
peaks. [B] represents the SNaPshot™ reaction with the same SBE primer 
with presence of template amplicon; two clear peaks are produced that 
represent the expected alleles. The figure is for SNP code 22. 
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Figure 4.5. Shown above are electropherograms representing SBE 
primer evaluation for SNP 13-1. [A] represents the SNaPshot™ 
reaction without the DNA template and the 9 peaks of GeneScan™ 
LIZ-120 size standard. [B] represents the SNaPshot™ reaction with 
DNA template and the SNP target CT. The arrows represent the extra 
peak observed due to the non-target SBE primer peak, which can be 
differentiated from the true allele peaks. 
 
 
4.3.1.4. Performance of the SBE Primer Reactions 
To evaluate the performance, reproducibility and specificity of the designed SBE 
primers, the reactions were performed in triplicate (Figure 4.6).  
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Figure 4.6. Shown above are Electropherogram A and B, which represent repeat 2 and 
3 respectively for SNP code 19-1. 
 
Each replicate was compared to the expected size of the SNP.  No allele varied by more 
than 4 bp from the true allele size when the SBE primer was 25 bp or more. Also, each 
replicate was determined to have the correct genotype: homozygote loci appeared as a 
single peak and heterozygote loci as two peaks. In relation to the actual SBE primer 
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size, it was found that the peak signal size from a ddG incorporation showed no 
significant difference. It was also found that ddA incorporation led to an allele size 1 bp 
bigger than that of ddG, whilst that of ddT was 2-3 bp higher than ddG. The biggest 
allele size difference was observed for ddC, which was up to 4 bp higher than that of 
ddG. These differences in peak signal size were pronounced in primers shorter than 30 
bp (Figure 4.7). 
 
C
T
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[A]
G
A
 
 
Figure 4.7. Shown above are electrophoretic peaks of SBE primer reaction. [A] 
represents SNP code1-1 (actual SNP size 21 bp) with heterozygote alleles AG and 
giving sizes of 26 bp and 27 bp respectively. [B] represents SNP code 17-2 (actual 38 
bp) with heterozygote alleles CT with allele sizes of 39 bp and 40 bp respectively. 
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In addition, the replicates were determined to have a minimum threshold of 100 relative 
fluorescent units (RFUs) and the peak ratio of heterozygote alleles at each locus was 
recorded and calculated according to the dye signal effect observed on each of the SNP 
types. The maximum peak ratio for heterozygote alleles was 4:1 – this is due to the 
variation in signal strength from the four ddNTPs. All SBE primers were observed to 
have the correct sizes and genotypes except for the primers 4-5, 7-3, 10-1, 10-3, 16-3 
and 20-1, which showed extra peaks that could interfere with the legitimate SNP peak 
(Figure 4.8). In addition, during the analysis SNPs 6-3, 17-1 and 17-3 were observed to 
be intronic. These intronic SNPs along with those that produced artefacts were rejected, 
and the number of candidate SNPs was reduced to 66 (Table 4.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8. Shown above is an example of incorrect genotype observed due to the 
impurity of the SBE primer. The electropherogram represents primer 20-1 with 
unrelated heterozygote G/C (blue/green) peaks. The target peak is homozygote GG. 
This SNP was rejected. 
target peak
extra peak
extra peak
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Table 4.3. Shown below are data for the 66 SNPs that produced clear results after 
SBE: The average size and standard deviation (s.d.) for each triplicate are shown. The 
highlighted figures indicate slight increases in s.d.  
 
 
In-house 
Code 
 
SNP 
Genotype
a 
 
 
Alleles 
 
 
SNP size 
  Allele A  Allele B  
 
Average 
 
s.d. 
 
Average 
 
s.d. 
1-1 AG GG 21   26.59 0.29 
1-2 CT TT 25   29.80 0.07 
1-3 CT TT 29   34.56 0.09 
1-4 GT R AA 37 40.44 0.25   
1-5 AG R CC 33 34.39 0.15   
1-6 AG R CC 41 43.57 0.18   
1-7 AC R GG 45 46.51 0.21   
1-8 AG R TT 49 52.01 0.23   
1-9 CT R AA 53 56.43 0.16   
2-1 AC CC 28   28.83 0.226 
2-2 AT AT 27 33.47 0.59 33.09 0.60 
2-3 GT GT 28 30.69 0.14 32.90 0.42 
2-4 CG GC 28 32.41 0.28 33.60 0.56 
2-5 AG AG 29 30.71 0.35 32.06 0.44 
2-6 AG GG 29   29.80 0.94 
3-1 CT CT 28 31.61 0.31   
3-2 AG GG 27   32.02 0.57 
3-3 AG R CC 28 32.02 0.58   
3-4 CT TT 28   32.35 0.40 
3-5 AG R CT 28 30.87 0.27 32.48 0.31 
4-1 GT TT 29   31.82 0.12 
4-2 AC CC 29   31.53 0.12 
4-3 CT CT 28 30.85 0.266 32.25 1.08 
4-4 AG AG 28 29.25 0.10 30.09 0.09 
5-1 CT R AG 27 31.41 0.06 33.04 0.01 
5-2 AC AC 29 31.74 0.14 31.18 0.12 
5-3 CT TT 28   30.94 0.71 
5-4 CT CT 29 31.76 0.02 33.61 0.04 
6-1 AT AA 27 34.24 0.01   
6-2 CT CC 29 30.64 0.26   
6-4 GT R AC 29 33.47 0.02 32.17 0.04 
7-1 AG AG 28 31.82 0.37 33.69 0.05 
7-2 CT R GG 29   29.73 0.26 
8-1 AC AC 29 30.87 0.07 30.10 0.08 
8-2 AG AG 29 29.14 0.14 30.77 0.02 
8-3 AG AG 31 31.72 0.03 32.76 0.02 
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4.3.2. Multiplexing 
For this study to assess the potential for combining the primer sets, 6 loci were selected 
to represent the developed 66 SNPs markers (Table 4.4). These markers were selected 
to have different lengths of PCR products, ranging from larger PCR product; 142 bp-
147 bp, medium,; 110 bp-119 bp; and small; 90 bp-92 bp. Therefore, two triplex sets 
were used. 
 
Table 4.3 (continued). 
 
In-house 
Code 
 
SNP 
Genotype
a 
 
 
Alleles 
 
 
SNP size 
Allele A  Allele B  
 
Average 
 
s.d. 
 
Average 
 
s.d. 
9-1 CT TT 28   33.77 0.01 
9-2 CG CG 29 31.15 0.02 32.17 0.04 
9-3 AG AG 27 29.04 0 30.48 0.05 
10-2 CT TT 27   31.39 0.13 
11-1 CT CC 28 29.63 0.04   
11-2 AGR CC 28 30.92 0.02   
12-1 CT TT 28   34.14 0.01 
12-2 CT CC 26 28.33 0.05   
13-1 AG R CT 25 28.63 0.47 29.79 0.55 
13-2 AG R CT 32 34.52 0.08 35.52 0.03 
13-3 AC R GT 35 37.27 0.13 39.73 0.29 
13-4 CT TT 37 41.10 0.39   
14-1 AG R CT 46 49.81 0.12 49.44 0.31 
14-2 AC CC 45 47.52 0.20   
14-3 AG GG 52 54.50 0.89   
14-4 CG CC 53 54.94 0.19   
15-1 AT AT 23 27.69 0.89 27.52 0.76 
15-2 CT R GG 26 29.85 0.56   
15-3 CG R CC 32 35.17 0.13   
16-1 CG CG 37 38.38 0.22 39.20 0.30 
16-2 AT R AA 30 34.63 0.05   
17-3 AC AA 42 46.02 0.30   
18-1 AC AC 46 48.67 0.19 48.25 0.20 
18-2 CT CC 50 51.78 0.07   
18-3 AG R CT 54 56.01 0.64 56.67 0.08 
19-1 CT CT 58 58.83 0.06 59.49 0.03 
19-2 AG AG 58 59.27 0.07 60.08 0.07 
20-2 AT TT 40 44.22 0.12   
21 CT AA 28 33.43 0.03   
22 CT CC 27 30.83 0.45   
 
a 
The SNP genotypes are arranged in forward sequence as in the NCBI database. R 
represents the reverse sequence used during SBE primer design. 
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The triplex optimisation and genotyping was performed as described in Sections 2.4.10 
and 2.4.11.  
 
Table 4.4. Shown below are the PCR and the SBE primers in the triplex sets with their 
SNP reference and position. 
 
 
SNP code 
 
SNP ref 
 
SNP genotype 
 
Position 
 
PCR size (bp) 
 
SBE size (bp) 
 
 
 
      Triplex 1 
 
4-4 
 
 
rs9995245 
 
A/G 
 
4 
 
90 
 
28 
19-2 
 
rs17304618 A/G 19 110 58 
13-4 
 
rs2892545 C/T 13 142 37 
 
      Triplex 2 
 
21 
 
 
rs8130475 
 
A/G
* 
 
21 
 
92 
 
28 
18-3 
 
rs9950394 C/T
* 
18 119 54 
17-3 
 
rs1872236 A/C 17 147 42 
* Genotypes are for the reverse sequence  
The annealing temperature that was designed for singleplex (Section 2.3.8), gave almost 
the same results for both triplex sets. At 60 °C, DNA bands were observed in agarose 
gels (2.5% w/v) (Figure 4.9). 
However, the concentration of PCR primers varied slightly from the concentration used 
in the singleplex reaction, ranging from 0.2 to 0.4 µm, with the addition of 1.5 mM 
MgCl2 used to make the final concentration to 3.0 mM in the amplification reaction 
(Table 4.5). 
SBE optimisation was found to be the same as the SNaPshot
™
 singleplex condition 
except that all of the primer concentrations were reduced to 0.2 µm for both triplex sets. 
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Figure 4.9. Shown above are the results from the optimised triplexes, run on a 2.5% 
agarose gel. The primer concentration ranged from 0.2 µm to 0.4µm, MgCl2 was 3.0 µm 
and annealing temperature at 60 °C. Lanes 1 and 4 are for 20 bp ladder; lane 2 
represents triplex set 1 and lane 3 represents triplex set 2.  The full conditions are shown 
in Table 4.5. 
 
 
 
 
The multiplexes were used to assess the effectiveness of SNPs in SNaPshot on real and 
simulated forensic casework (Chapter 6). 
Table 4.5 Shown below are the optimised primer concentrations (µm) for the PCR 
triplex sets at an annealing temperature of 60 °C and 3.0 µm of MgCl2. 
 
 
Triplex 1 
SNP Code 
 
NCB ref 
 
PCR primer 
concentrations 
(µm) 
 
Triplex 2 
SNP Code 
 
NCBI ref 
 
PCR primer 
concentrations 
(µm) 
 
4-4  
 
rs9995245 A/G 
 
0.2 
 
21 
 
rs8130475 A/G R 
 
0.2 
 
19-2  
 
rs17304618 A/G 
 
0.4 
 
18-3 
 
rs9950394 C/T R 
 
0.4 
 
13-4  
 
 
 
rs2892545 C/T 
 
0.2 
 
17-3 
 
rs1872236  A/C 
 
0.2 
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4.3.3. SNaPshot
™
 vs. Affymetrix
®
 Genotype 
A comparison between the Affymetrix
®
 and SNaPshot
™
 systems was carried out to 
evaluate the SNP genotype results from each method. One Kuwaiti sample from the ten 
samples that were used for Affymetrix
®
 screening in Section 2.3 was selected for this 
study. DNA extraction and purification was performed according to the procedures 
described in Section 2.2.1. 
25 SNP loci from the 22 autosomal chromosomes were selected randomly to represent 
the 66 SNPs. Chromosomes 1, 2, and 3 contributed two loci each, when one SNP was 
selected from each of the other chromosomes. SNaPshot
™
 singleplex reactions were 
performed. The data were collected and compared with those generated from 
Affymetrix
®
 screening.  
The results obtained from the concordance study between Affymetrix
®
 and SNaPshot
™
 
showed an agreement in all 25 primers. However, the SNP code 22 (rs4820621) showed 
a deviation with homozygote TT for SNaPshot
™
 from the Affymetrix
®
 AG (R) 
heterozygote (Table 4.6). A reassessment of the primer design and the result obtained 
during the triplicate genotyping of the primers with another different sample showed 
that the expected results were obtained – heterozygous genotypes were also detected at 
this locus. This difference could be explained by the sample possibly having a mutation 
in the forward strand at the SNP rs4820621 site; the Affymetrix
®
 data generated from 
this sample used the reverse primer. However, the most likely explanation is that this 
non-concordance is that this datum from the Affymetrix
® 
was incorrect. However, for 
more confirmation the sample could be sequenced to check my mutation present at the 
primer site. 
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Table 4.6. Shown below are SNPs genotypes obtained from concordance 
study between Affymetrix
®
 and SNaPshot™. [F] represents the forward 
primer sequence and [R] represent the reverse primer sequence. The 
highlighted SNP represents the homozygote genotype TT, which deviated 
from the Affymetrix
®
 result. 
 
 
 
SNPcode/ ID 
 
Genotype 
 
Chromosome 
 
Affymetrix
® 
 
SNaPshot™ 
 
1-2/ rs10864499 C/T 1 CC F CC F 
1-9/ rs10864713 C/T 1 CT F GA R 
2-1/  rs4832461 A/C 2 AC  AC F 
2-5/ rs6542461 A/G 2 GA GA F 
3-1/ rs2649734 C/T 3 CT CT F 
3-5/ rs978979 A/G 3 GG CC R 
4-4/ rs9995245 A/G 4 GA GA F 
5-3/ rs7444492 C/T 5 CC CC F 
6-4/ rs3846764 G/T 6 TT AA R 
7-1/ rs217013 A/G 7 CC R GG F 
8-1/ rs4105594 A/C 8 TT R AA F 
9-1/ rs7858174 C/T 9 GG R CC F 
10-2/ rs11259108 C/T 10 GA R CT F 
11-1/ rs 517679 C/T 11 GG R CC F 
12-1/ rs6487665 C/T 12 GA R CT F 
13-1/ rs4435117 A/G 13 AA F TT R 
14-/ rs11628091 A/C 14 AA F AA F 
15-1/ rs4778706 A/T 15 AT F AT F 
16-1/ rs8057434 C/G 16 CC R GG F 
17-3/ rs1872236 A/C 17 CC F CC F 
18-/ rs17064977 C/T 18 CT F CT F 
19-/ rs17304618 A/G 19 AG F AG F 
20-2/ rs745661 A/T 20 AA F AA F 
21/ rs8130475 C/T 21 CT F A/G R 
22/ rs4820621 
 
CT 
 
22 
 
AG R 
 
TT F 
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4.4. Discussion 
The potential of SNPs as a forensic tool has been widely acknowledged over the last 
few years. In this respect, the most attractive feature of SNPs is their short amplicon and 
suitability for degraded DNA detection (Inagaki et al., 2004; Budowle, 2004).  
SNP Identification 
This chapter demonstrated that a careful selection from a genome screen (autosomal) 
identified candidate SNPs that could later be validated for forensic applications.  
Careful primer design, with annealing temperatures of 60 °C ± 3 °C enabled them to all 
be efficiently amplified at 60 °C. A uniform annealing temperature minimised the 
number of thermal cycler parameters, which in turn saved time and reduced variations 
as all reactions were carried out in the same thermal cycler under the same conditions. 
Moreover, equal annealing temperatures for PCR primers is an advantage when 
producing a multiplex system, as will be described below. 
In order to achieve correct SNP genotyping, an assessment of parameters, such as the 
amount of sample to be used in both the PCR and SNaPshot
™
 reactions, the SNP type, 
the SNP length and the presence of any ambiguous peaks, was required at the start of 
the SNP development. If the amount of sample is very high, or very low and unrelated 
peaks are present, then, collectively, this can lead to drop-in/drop-out alleles and 
unrelated SNP peaks. In turn, this can lead to a misinterpretation of the results, 
especially when handling samples such as those that are degraded or those of low 
concentrations. Moreover, false results can affect the statistical parameters that will be 
applied later for SNP characterisations, such as allele heterozygosity. For this, each SNP 
locus was assessed through triplicate analysis. This allowed the selection of 66 SNP 
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candidates. Additionally, the assessment for SNP genotyping was carried out in the 
presence of negative and positive controls (Applied Biosystems). This allowed for any 
ambiguous results relating to the reaction set up to be eliminated. However, during the 
assessment, it was found that one of the PCR primers (reverse) of SNP code 19-1 was 
within the region of another non target SNP at -45 bp of the target SNP. To remedy this, 
careful design of the SBE primer for that specific position was undertaken. This was 
confirmed by a successful result obtained from the assessment of the SNaPshot
™
 
reaction. 
Multiplexing 
The objective of this research was to identify SNP candidates that could be useful for 
forensic application and that might in future be multiplexed.  Therefore, formation of 
large multiplex such as that developed by Sanchez et al. (2006) is essential for typing 
forensic casework. However, in this study only a few SNPs were multiplexed to assess 
the potential for combining the primer sets. The careful optimisation of both PCR and 
SBE primers helped in the development of the triplex sets without significant 
complications. All the PCR primers in the triplexes produced acceptable results at an 
annealing temperature of 60 °C. Six SNP loci in two triplexes were chosen for further 
SNPs assessment (Chapter 6). The SNapShot technique allows up to approximately 25 
loci to be analysed in a single reaction, however, the results generated from such a large 
set loci are often difficult to interpret. Development of such a large multiplex was not 
attempted as part of this project. 
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Concordance Study 
The results obtained from the concordance study between Affymetrix
®
 and SNaPshot
™
 
genotyping provided an additional assessment of the selected SNPs. The 25 SNPs 
genotyped using SNaPshot
™
 showed full concordant with the Affymetrix
®
 results 
except at locus 22 when a homozygote for TT allele was observed. The most likely 
cause of this non-concordance is that the result from the Affymetrix
®
 was incorrect. In 
the context of this study the non-concordance is not a problem, as long as it has not led 
to the selection of monomorphic SNP loci. It would only be problematic if the genotype 
data from forensic samples analysed in different laboratories did not produce the same 
results. 
Comparison between SNaPshot
™
 and other SNP Genotyping 
Methods 
There are various SNP genotyping application in genetic field such as TaqMan
®
 SNP 
Genotyping Assays, SNPlex™ Genotyping System (Vega et al., 2005), GenPlex SNP 
Genotyping System (Musgrave-Brown et al., 2008) and Affymetrix
®
 GeneChip
®
 
Technique (Matsuzaki et al., 2004). These applications vary in cost, number of SNPs 
can be detected and DNA sample quantity. TaqMan
®
 SNP Genotyping Assays require a 
single enzymatic step and a large number of validated off-the-shelf assays that make the 
application simple and low of cost. The assay for the TaqMan
®
 SNP Genotyping is 
however limited to the detection of 2 SNPs (Vega et al., 2005). In forensic casework 
this would require the setting up of 30 to 40 separate assays in order to analyse the 
required number of SNPs, and in many forensic cases there would be 
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 insufficient DNA in the sample. The SNPlex™ and Genplex Genotyping Systems are 
highly automated, and designed for high throughput SNP application. The GenPlex 
system is a modification of the SNPlex
™
 system (Phillips et al., 2007). The SNPlex
™
 
system begins with a multiplex oligo- ligation assay (OLA) reaction that is followed by 
PCR reaction of the ligation products. The GenPlex system begins with PCR 
amplification of the template DNA followed by an OLA reaction. The assays require 
special instruments for the SNPs detection such as 3130 or 3730 DNA Genetic Analyser 
which are not available in all forensic labs (Vega et al., 2005).  
Affymetrix
®
 GeneChip
®
 Technique is also designed for high throughput application, but 
the assay requires special instruments for the detection and also a large amount of 
sample is required. This type of technique can be useful for screening purposes such as 
in clinical tests or for association studies. The same applies to other similar platforms 
provided by Illumina. All these high throughput methods require large amounts of 
DNA, which are not commonly found when analysing forensic samples. 
4.5. Conclusion 
SNaPshot
™
 Genotyping Assay in comparison to the above assays is robust and 
convenient as it can be performed in simple instrument (310 Genetic Analyser) that can 
be available in most forensic labs. The assay is sensitive with 0.5 ng/µl of sample 
detected, and suitable for high throughput application (Sanchez et al., 2006). The 
limitation of this technique was found to be in the dyes that are associated with the 
ddNTPs. Future study is needed to overcome the influence of the dyes on the detected 
SNPs.  
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CHAPTER 5  
 
CHARACTERISATION  
 
of SNPs 
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5.1. Overview 
When introducing any new marker for forensic applications, it is a prerequisite to assess 
the marker’s utility by testing parameters associated with that marker. Accordingly, the 
SNP candidates that were identified in Chapter 4 were analysed for such parameters, 
including: allele frequency, heterozyosity, match probability and discrimination power. 
In addition, forensic samples are often limited in quantity and typing the low amounts of 
these samples can cause incomplete DNA profiling or failure altogether. Low levels of 
DNA template can increase the stochastic effects of PCR (Krenke et al., 2002), resulting 
in heterozygote allele imbalance and also allele dropout. This can greatly be influenced 
the successful profiling of DNA. Therefore the performances of the selected SNPs were 
assessed using low-levels of DNA. 
5.2. Aims of this Chapter 
The objectives of this chapter are: 
 To generate allele frequencies using UAE individuals for the 66 SNPs detected 
in Chapter 4.  
 To determine the threshold sensitivity of the SNPs to generate full DNA 
profiles.  
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5.3. Generation of Allele Frequencies 
5.3.1. Samples 
Dried blood samples on FTA card
®
 from 100 UAE individuals were used. The samples 
were collected by the Dubai Police Crime Laboratory, which were received with 
informed consent, and were anonymised upon receipt (Section 2.1). 
5.3.2. DNA Extraction and Quantification 
DNA extraction was carried out using organic extraction and was followed by phenol 
chloroform purification. These procedures were carried out as described in Chapter 2 
(Sections: 2.2.1.1, 2.2.1.2 and 2.4.2).  
The estimation of DNA concentration was determined using the Quantifiler™ Human 
DNA Quantification Kit (Applied Biosystems) and the ABI 7500 real time PCR 
(Applied Biosystems). These procedures were performed as described in Section 
2.2.2.1. 
DNA concentration were found to range between 27 ng /µl and 0.39 ng/µl. Based on the 
results obtained from DNA quantification, 25 samples with DNA concentrations greater 
than 3 ng/µl (in a total volume of 20 µl) were selected to represent UAE individuals for 
the study of allele frequency  see (Appendix A1). 
5.3.2.1. Amplification and Genotyping of SNPs  
In order to generate allele frequencies for UAE individuals, the 66 SNPs that were 
identefied in Chapter 4 were genotyped. Each of the 25 UAE samples were tested using 
the 66 SNPs in singleplex reactions, resulting in 1650 singleplex SNP amplifications  
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and singleplex SNaPshot reactions, performed using the 66 PCR primer pairs and 66 
SBE primers respectively. Each SNP amplification was carried out using 0.5 ng/µl of 
DNA sample. 
5.4. Results 
5.4.1. Statistical Analyses  
5.4.1.1. Alleles Frequencies Distribution 
Since the selected SNPs are biallelic markers, a smaller number of samples are required 
to provide an accurate allele frequency compared to other markers such as STRs 
(Vaarno et al., 2004; Sanchez et al., 2006). Therefore, 25 samples from the UAE 
population were used to determine the allele frequencies of the SNPs. A total of 3300 
alleles were observed for the 66 loci. 
The results have shown that the 66 SNP loci were polymorphic with minimum observed 
heterozygosity of 20 % and a minimum allele frequency of 0.14 (Table 5.1). 
 
 
 
 
 
 
 
118 
 
 
5.4.1.2. Hardy-Weinberg Equilibrium (HWE) 
Observed heterozygosity within the population was measured to indicate departure from 
HWE expectation; the test was applied using the Markov chain method with 10000 
permutations (Arlequin v. 3.1). Three of these SNPs showed significant departure (p = 
0.043, p = 0.014 and p = 0.011) from HWE at p values < 0.05, as shown in (Table 5.2). 
Table 5.1. Shown below are the allele frequencies observed for each of the 66 
SNP loci for 25 UAE individuals listed with their genotypes. 
 
 
In-house 
 
Code 
 
 
Alleles 
 
(1, 2) 
 
Frequency 
of 
Allele 1 
 
 
Frequency 
of 
Allele 2 
 
In-house 
 
Code 
 
Alleles 
 
(1, 2) 
 
Frequency 
of 
Allele 1 
 
Frequency 
of 
Allele 2 
1-1 A, G 0.32 0.68 8-1 A, C 0.62 0.38 
1-2 C, T 0.46 0.54 8-2 A, G 0.66 0.34 
1-3 C, T 0.14 0.86 8-3 A, G 0.38 0.62 
1-4 C, A 0.36 0.64 9-1 C, T 0.4 0.6 
1-5 T, C 0.5 0.5 9-2 C, G 0.38 0.62 
1-6 T, C 0.3 0.7 9-3 A, G 0.5 0.5 
1-7 T, G 0.28 0.72 10-2 C, T 0.4 0.6 
1-8 T, C 0.64 0.36 11-1 C, T 0.68 0.32 
1-9 G, A 0.6 0.4 11-2 T, C 0.5 0.5 
2-1 A, C 0.44 0.56 12-1 C, T 0.4 0.6 
2-2 A, T 0.3 0.7 12-2 C, T 0.7 0.3 
2-3 G, T 0.66 0.34 13-1 T, C 0.46 0.54 
2-4 C, G 0.32 0.68 13-2 T, C 0.42 0.58 
2-5 A, G 0.6 0.4 13-3 T, G 0.24 0.76 
2-6 A, G 0.64 0.36 13-4 C, T 0.52 0.48 
3-1 C, T 0.32 0.68 14-1 T, C 0.4 0.6 
3-2 A, G 0.22 0.78 14-2 A, C 0.34 0.66 
3-3 T, C 0.52 0.48 14-3 A, G 0.46 0.54 
3-4 C, T 0.36 0.64 14-4 C, G 0.52 0.48 
3-5 T, C 0.28 0.72 15-1 A, T 0.34 0.66 
4-1 G, T 0.46 0.54 15-2 G, A 0.66 0.34 
4-2 A, C 0.42 0.58 15-3 G, C 0.32 0.68 
4-3 C, T 0.42 0.58 16-1 G, C 0.56 0.44 
4-4 A, G 0.66 0.34 16-2 A, T 0.24 0.76 
5-1 G, A 0.52 0.48 17-3 A, C 0.32 0.68 
5-2 A, C 0.4 0.6 18-1 A, C 0.5 0.5 
5-3 C, T 0.48 0.52 18-2 C, T 0.28 0.72 
5-4 C, T 0.48 0.52 18-3 T, C 0.36 0.64 
6-1 A, T 0.76 0.24 19-1 C, T 0.54 0.46 
6-2 C, T 0.78 0.22 19-2 A, G 0.14 0.86 
6-4 C, A 0.36 0.64 20-2 A, T 0.24 0.76 
7-1 A, G 0.3 0.7 21 G, A 0.38 0.62 
7-2 G, A 0.6 0.4 22 C, T 
 
0.72 
 
0.28 
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This deviation was expected (5%) as a result of multiple tests (1000 dememorization 
steps), which yield significant levels of false results (Rice, 1989). The Bonferroni 
correction at p>0.0008 (0.05 divided number of loci (66)) was applied to correct the 
results. After employing the Bonferroni correction, these observations were not 
significant. This indicates that the observed heterozygosity in all 66 loci is in 
equilibrium with HW heterozygosity expectation. 
5.4.1.3. Linkage Disequilibrium 
The loci data were tested for genotypic disequilibrium using the pairwise test with 
p values < 0.05. A total of 10100 pair wise comparisons for all loci were performed to 
check any correlation between alleles at any of the pairwise comparisons of the 66 loci 
using Arlequin v. 3.1 software. Most of the loci in the data behaved as expected with no 
linkage disequilibrium. However, 4 loci on different chromosomes: (7-2, 13-4), (11-2, 
15-1) and (14-4, 15-1) were observed to be significant at p < 0.05 (0.00000), some 
departure was expected as this occurs by chance (Gill et al., 2003; Kidd et al., 2006). 
However, as the number of loci affected was small, and within the levels expected for 
such a large number of loci, the affected loci were not rejected based on these results. 
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No. 
 
In-house 
Code 
 
Obs. Het 
 
Exp. Het 
 
P-value 
 
s.d. 
 
1 1-1 0.560 0.444 0.366 0.005 
2 1-2 0.360 0.507 0.216 0.004 
3 1-3 0.200 0.246 0.378 0.005 
4 1-4 0.480 0.47 1 0 
5 1-5 0.680 0.497 0.098 0.003 
6 1-6 0.440 0.458 1 0 
7 1-7 0.560 0.411 0.13 0.003 
8 1-8 0.640 0.47 0.08 0.003 
9 1-9 0.520 0.429 0.378 0.004 
10 2-1 0.720 0.503 0.043 0.002 
11 2-2 0.600 0.429 0.063 0.002 
12 2-3 0.600 0.458 0.178 0.004 
13 2-4 0.320 0.444 0.198 0.004 
14 2-5 0.560 0.49 0.665 0.005 
15 2-6 0.480 0.47 1 0 
16 3-1 0.480 0.444 1 0 
17 3-2 0.400 0.327 0.551 0.005 
18 3-3 0.480 0.509 1 0 
19 3-4 0.640 0.47 0.091 0.003 
20 3-5 0.261 0.433 0.124 0.004 
21 4-1 0.360 0.507 0.218 0.004 
22 4-2 0.520 0.497 1 0 
23 4-3 0.440 0.497 0.689 0.005 
24 4-4 0.360 0.458 0.389 0.005 
25 5-1 0.400 0.509 0.416 0.006 
26 5-2 0.4 0.49 0.432 0.004 
27 5-3 0.56 0.509 0.702 0.005 
28 5-4 0.48 0.509 1 0 
29 6-1 0.4 0.372 1 0 
30 6-2 0.44 0.35 0.313 0.005 
31 6-4 0.56 0.47 0.401 0.005 
32 7-1 0.6 0.429 0.062 0.003 
33 7-2 0.4 0.49 0.418 0.005 
Table 5.2. Shown below are the observed (Obs.) and expected (Exp.) heterozygosities 
for the 66 SNPs typed in 25 individuals. The highlighted numbers show significant 
deviation from HWE at p <0.05. 
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5.4.2. Forensic Statistics 
The 66 SNPs were analysed in order to assess the utility of the SNPs for forensic 
application. The PowerStats V.12 program was used to test the classical forensic  
parameters: power of discrimination and match probability. The tests were carried out 
independently for each locus.  
Table 5.2 (continued) 
 
 
No. 
 
In-house 
Code 
 
Obs. Het. 
 
Exp. Het. 
 
P-value 
 
s.d. 
 
34 8-1 0.44 0.481 0.69 0.005 
35 8-2 0.52 0.458 0.659 0.005 
36 8-3 0.44 0.481 0.695 0.005 
37 9-1 0.56 0.49 0.671 0.004 
38 9-2 0.36 0.481 0.225 0.004 
39 9-3 0.44 0.51 0.69 0.005 
40 10-2 0.4 0.49 0.425 0.005 
41 11-1 0.48 0.444 1 0 
42 11-2 0.6 0.51 0.442 0.005 
43 12-1 0.5 0.496 1 0 
44 12-2 0.36 0.429 0.636 0.005 
45 13-1 0.44 0.51 0.684 0.004 
46 13-2 0.68 0.497 0.087 0.003 
47 13-3 0.48 0.372 0.267 0.004 
48 13-4 0.24 0.509 0.014 0.001 
49 14-1 0.52 0.481 1 0 
50 14-2 0.64 0.47 0.095 0.003 
51 14-3 0.44 0.507 0.684 0.004 
52 14-4 0.48 0.509 1 0 
53 15-1 0.52 0.458 0.665 0.005 
54 15-2 0.52 0.458 0.662 0.004 
55 15-3 0.32 0.372 0.585 0.005 
56 16-1 0.44 0.497 0.688 0.005 
57 16-2 0.24 0.372 0.102 0.003 
58 17-3 0.4 0.444 0.655 0.005 
59 18-1 0.68 0.51 0.122 0.003 
60 18-2 0.4 0.411 1 0 
61 18-3 0.48 0.47 1 0 
62 19-1 0.44 0.481 0.698 0.005 
63 19-2 0.28 0.301 1 0 
64 20-2 0.4 0.372 1 0 
65 21 0.52 0.481 1 0 
66 
 
22 
 
0.24 
 
0.411 
 
0.055 
 
0.002 
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The selected SNPs possessed an average observed heterozygosity of 0.47. The 
probability that two individuals would have the same genotype profile (match 
probability) was found to be 3.058 × 10
-25
. Whilst the probability that two individuals 
are different (a combined power of discrimination) was found to be 0.999999999 
(99.9999999%) with a combined power of exclusion of 99.9999999% (Table 5.3). This 
indicated that the SNPs could be useful for forensic samples identification. 
5.4.3. SNPs Performance Evaluation 
5.4.3.1. Sensitivity Study 
Four SNPs from loci on different chromosomes were selected to represent the 66 SNP 
markers. To ensure all genotypes are present in the study, the SNPs were selected to 
exhibited the 4 possible genotypes (G, A, C, and T) (Table 5.4). 
In this assessment, two template samples from different individuals were included; the 
procedure was carried out as described in Section 2.4.5. The basis for selecting more 
than one sample was to achieve better assessment and analysis of the results obtained 
from the samples. Moreover, the use of two samples would increase the number of SNP 
genotypes that lead to more variation in the generated data. The major concern during 
analysis of the genotypes was the effect on heterozygote loci peak height that were 
obtained in different dilutions. 
 
 
 
Table 5.3. Shown below are the final 66 SNP locus selected from the autosomal 
chromosomes according to their forensic parameters. The results were obtained using 
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Table 5.3 (continued) 
 
 Match Power of  Power of Frequency Hom. Het. 
PowerStats software. Hom; represent homozygosity, Het; represents heterozygosity. 
 
 
In-house 
Code 
 
Match 
Probability 
 
Power of 
Discrimination 
 
Power of 
Exclusion 
 
Frequency 
of Allele A 
 
Hom. 
 
Het. 
 
1-1 0.3376 0.662 0.091 0.32 0.64 0.56 
1-2 0.3376 0.662 0.091 0.46 0.64 0.36 
1-3 0.6192 0.381 0.030 0.14 0.8 0.2 
1-4 0.4048 0.595 0.171 0.36 0.52 0.48 
1-5 0.5264 0.474 0.398 0.5 0.32 0.68 
1-6 0.4016 0.598 0.142 0.3 0.56 0.44 
1-7 0.5072 0.493 0.246 0.28 0.44 0.56 
1-8 0.5136 0.486 0.342 0.64 0.36 0.64 
1-9 0.4656 0.534 0.206 0.6 0.48 0.52 
2-1 0.565 0.435 0.460 0.44 0.28 0.72 
2-2 0.52 0.48 0.291 0.3 0.4 0.6 
2-3 0.4912 0.509 0.291 0.66 0.4 0.6 
2-4 0.3984 0.340 0.072 0.32 0.68 0.32 
2-5 0.4304 0.57 0.246 0.6 0.44 0.56 
2-6 0.4048 0.595 0.171 0.64 0.52 0.48 
3-1 0.4304 0.57 0.171 0.32 0.52 0.48 
3-2 0.5392 0.493 0.0.91 0.22 0.64 0.36 
3-3 0.3664 0.634 0.171 0.52 0.52 0.48 
3-4 0.5136 0.486 0.342 0.36 0.36 0.64 
3-5 0.4177 0.582 0.049 0.28 0.74 0.26 
4-1 0.3376 0.662 0.092 0.46 0.64 0.36 
4-2 0.3984 0.602 0.206 0.42 0.48 0.52 
4-3 0.3632 0.637 0.140 0.42 0.56 0.44 
4-4 0.3856 0.614 0.091 0.66 0.64 0.36 
5-1 0.3408 0.659 0.114 0.52 0.6 0.4 
5-2 0.36 0.640 0.114 0.4 0.6 0.4 
5-3 0.3856 0.557 0.206 0.48 0.48 0.52 
5-4 0.3664 0.634 0.171 0.48 0.52 0.48 
6-1 0.4752 0.525 0.114 0.72 0.6 0.4 
6-2 0.5072 0.493 0.140 0.78 0.56 0.44 
6-4 0.4496 0.55 0.246 0.36 0.44 0.56 
7-1 0.52 0.48 0.291 0.3 0.4 0.6 
7-2 0.36 0.64 0.114 0.6 0.6 0.4 
8-1 0.3792 0.621 0.140 0.62 0.56 0.44 
8-2 0.4368 0.563 0.206 0.66 0.48 0.52 
8-3 0.3792 0.621 0.140 0.38 0.56 0.44 
9-1 0.4304 0.559 0.246 0.4 0.44 0.56 
9-2 0.3632 0.621 0.091 0.38 0.64 0.36 
9-3 0.3504 0.65 0.140 0.5 0.56 0.44 
10-2 0.36 0.669 0.114 0.4 0.6 0.4 
11-1 0.4304 0.57 0.171 0.68 0.52 0.48 
11-2 0.44 
 
0.56 
 
0.291 
 
0.5 
 
0.4 
 
0.6 
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In-house 
Code 
 
Probability 
 
Discrimination 
 
 Exclusion 
 
of Allele A 
 
  
12-1 0.389 0.611 0.188 0.4 0.5 0.5 
12-2 0.414 0.586 0.091 0.7 0.64 0.36 
13-1 0.350 0.650 0.140 0.46 0.56 0.44 
13-2 0.526 0.474 0.398 0.42 0.32 0.68 
13-3 0.501 0.499 0.170 0.24 0.52 0.48 
13-4 0.347 0.653 0.042 0.52 0.76 0.24 
14-1 0.414 0.586 0.206 0.4 0.48 0.52 
14-2 0.514 0.486 0.342 0.34 0.36 0.64 
14-3 0.354 0.646 0.140 0.46 0.56 0.44 
14-4 0.366 0.634 0.171 0.52 0.52 0.48 
15-1 0.437 0.563 0.206 0.34 0.48 0.52 
15-2 0.437 0.563 0.206 0.66 0.48 0.52 
15-3 0.469 0.531 0.072 0.32 0.68 0.32 
16-1 0.363 0.637 0.140 0.56 0.56 0.44 
16-2 0.482 0.518 0.042 0.24 0.76 0.24 
17-3 0.405 0.595 0.114 0.32 0.6 0.4 
18-1 0.514 0.486 0.390 0.5 0.32 0.68 
18-2 0.437 0.563 0.114 0.28 0.6 0.4 
18-3 0.405 0.595 0.171 0.36 0.52 0.48 
19-1 0.379 0.521 0.140 0.54 0.56 0.44 
19-2 0.542 0.458 0.056 0.14 0.72 0.28 
20 0.475 0.525 0.114 0.24 0.6 0.4 
21 0.414 0.586 0.206 0.38 0.48 0.52 
22 0.443 0.557 0.042 0.72 0.76 0.24 
 
Total 
3.05794E-
25 
 
>99.9999999% 
 
99.9999999% 
  
0.54 
 
0.47 
 
 
 
 
 
 
 
 
The genotypes and the RFU values for each homozygote and heterozygote peaks in 
each of the 9 dilutions were observed and assessed. Each replicate was checked for the 
correct SNP and the genotypes were noted as partial profiles (pp) when one allele 
Table 5.4. Shown below are the chromosome, SNP type and PCR length for 
each of the 4 SNP loci used in the sensitivity study. 
 
 
In-house 
Code 
 
 
SNP ref 
 
 
Chromosome 
 
 
SNP genotype 
 
PCR length 
(bp) 
 
4-2 
rs7684079 4 A/C 130 
 
12-1 
rs6487665 12 C/T 119 
 
17-3 
rs1872236 17 A/C 147 
 
19-2 
rs17304618 19 A/G 110 
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dropped below the 100 RFU threshold. Normalised RFU was calculated for all alleles; 
the homozygote signals were divided into two (Table 5.5 to Table 5.9). 
 
Table 5.5 Shown below are the RFUs generated from different DNA dilution for 
individual 1.Each SNP locus was tested in triplicate and the results are before 
normalisation of RFUs. [pp] represents partial profile. 
 
DNA 
concentrations 
(pg) 
 
100 
 
200 
 
300 
 
400 
 
500 
 
1000 
 
2000 
 
4000 
 
8000 
  
SNP locus          Genotype 
12-1 /CT 358 1150 515 496 798 1421 1362 2913 4542 TT 
(119 bp) 598 897 515 924 605 1836 1172 2500 2763 TT 
 
770 
 
1429 
 
579 
 
668 
 
1236 
 
1550 
 
1919 
 
2858 
 
4178 
 
TT 
 
 
17-3 A/C 533 1144 2022 2979 1517 6398 7435 7462 7358 AA 
(147 bp) 445 1252 2819 2997 1122 5110 7366 7280 7328 AA 
 
590 
 
1447 
 
1035 
 
2605 
 
1242 
 
6106 
 
7278 
 
7139 
 
7347 
 
AA 
 
 
19-2 A/G 214 293 1025 664 682 1929 3116 5418 7138 A 
(110 bp) 
pp 
 
pp 
 
546 
 
370 
 
333 
 
635 
 
950 
 
1729 
 
3236 
 
G 
 
 188 263 826 398 560 1655 3023 6178 7154 A 
 
pp 
 
pp 
 
279 
 
385 
 
275 
 
563 
 
906 
 
1952 
 
3982 
 
G 
 
 182 285 935 470 695 1902 3192 6597 6741 A 
 
pp 
 
100 
 
165 
 
283 
 
335 
 
638 
 
955 
 
2137 
 
2131 
 
G 
 
 
4-2 /AC 456 647 486 1000 2392 4590 7173 7159 7179 CC 
(130 bp) 516 701 1129 1007 2377 4753 7415 7352 7319 CC 
 
541 
 
731 
 
1171 
 
1460 
 
2409 
 
3992 
 
6855 
 
7283 
 
7369 
 
CC 
 
126 
 
 
 
 
 
Table 5.6 Shown below are the normalised RFUs generated from different DNA 
dilution for individual 1. [pp] represents partial profile. 
 
DNA 
concentration  
(pg) 
 
100 
 
200 
 
300 
 
400 
 
500 
 
1000 
 
2000 
 
4000 
 
8000 
 
SNP          
12-1C/T 179 575 257.5 248 384 460 681 1456.5 2271 
 
179 
 
575 
 
257.5 
 
248 
 
384 
 
460 
 
681 
 
1456.5 
 
2271 
 
 299 448.5 257.5 312 302.5 368.5 586 1250 1381.5 
 
299 
 
448.5 
 
257.5 
 
312 
 
302.5 
 
368.5 
 
586 
 
1250 
 
1381.5 
 
 385 714.5 289.5 334 618 461 959.5 1429 2089 
 
385 
 
714.5 
 
289.5 
 
334 
 
618 
 
461 
 
959.5 
 
1429 
 
2089 
 
 
17-3A/C 266.5 572 1011 989.5 758.5 3199 3717.5 3731 3679 
 
266.5 
 
572 
 
1011 
 
989.5 
 
758.5 
 
3199 
 
3717.5 
 
3731 
 
3679 
 
 222.5 626 1409.5 989.5 561 2555 3683 3640 3664 
 
222.5 
 
626 
 
1409.5 
 
989.5 
 
561 
 
2555 
 
3683 
 
3640 
 
3664 
 
 295 723.5 517.5 802.5 621 3053 3639 3569.5 3673.5 
 
295 
 
723.5 
 
517.5 
 
802.5 
 
621 
 
3053 
 
3639 
 
3569.5 
 
3673.5 
 
 
19-2A/G 214 293 1025 3262 682 1929 3116 5418 7138 
 
pp 
 
pp 
 
546 
 
1356 
 
333 
 
635 
 
950 
 
1729 
 
3236 
 
 188 263 826 2886 560 1655 3023 6178 7154 
 
pp 
 
pp 
 
279 
 
2167 
 
275 
 
563 
 
906 
 
1952 
 
3982 
 
 182 285 935 3560 695 1902 3192 6597 6741 
 
pp 
 
100 
 
165 
 
1133 
 
335 
 
638 
 
955 
 
2137 
 
2131 
 
 
4-2A/C 228 323.5 243 500 1196 2295 3586.5 3579.5 3589.5 
 
228 
 
323.5 
 
1816 
 
1846.5 
 
1196 
 
2295 
 
3586.5 
 
3579.5 
 
3589.5 
 
 258 350.5 564.5 503.5 1188.5 2376.5 3707.5 3676 3659.5 
 
258 
 
350.5 
 
1453 
 
1495.5 
 
1188.5 
 
2376.5 
 
3707.5 
 
3676 
 
3659.5 
 
 270.5 365.5 585.5 730 1204.5 1996 3427.5 3641.5 3684.5 
 
270.5 
 
365.5 
 
1659 
 
2407.5 
 
1204.5 
 
1996 
 
3427.5 
 
3641.5 
 
3684.5 
 
127 
 
 
 
 
Table 5.7 Shown below are the RFUs generated from different DNA dilution for 
individual 2. The results are before normalisation of RFUs. [pp] represents partial profile. 
 
DNA 
concentrations 
(pg) 
 
100 
 
200 
 
300 
 
400 
 
500 
 
1000 
 
2000 
 
4000 
 
8000 
  
SNP          Genotype 
12-1 /CT pp 118 351 357 507 438 421 887 3160 C 
(119 bp) 
 
242 
 
240 
 
462 
 
1176 
 
1076 
 
1187 
 
1050 
 
2071 
 
7413 
 
T 
 
 pp 112 180 430 348 277 471 1682 2697 C 
 
242 
 
351 
 
357 
 
1016 
 
771 
 
574 
 
1177 
 
4574 
 
7043 
 
T 
 
 pp 101 206 281 269 214 557 942 1416 C 
 
102 
 
240 
 
358 
 
685 
 
687 
 
742 
 
950 
 
2418 
 
3718 
 
T 
 
 
17-3 A/C 2719 4051 1007 1788 7490 7372 7380 7005 6960 A 
(147 bp) 
 
260 
 
439 
 
374 
 
467 
 
2536 
 
3994 
 
5900 
 
6456 
 
6228 
 
C 
 
 2779 4680 1197 1720 7244 7193 7155 7000 6896 A 
 
166 
 
742 
 
220 
 
784 
 
2596 
 
3997 
 
4500 
 
6524 
 
6261 
 
C 
 
 3591 4382 1427 2009 7339 7201 7334 7116 6883 A 
 
415 
 
809 
 
416 
 
870 
 
4225 
 
3708 
 
5506 
 
6540 
 
6010 
 
C 
 
 
19-2 A/G 350 411 776 1173 1441 5094 7353 7245 6880 G 
(110 bp) 
 
324 
 
127 
 
598 
 
1553 
 
974 
 
2082 
 
6701 
 
7071 
 
7105 
 
A 
 
 106 837 882 789 3156 2244 7298 7187 7189 G 
 
164 
 
499 
 
801 
 
1305 
 
2640 
 
1551 
 
7284 
 
7099 
 
6963 
 
A 
 
 701 1083 660 820 3093 4240 7281 7174 7059 G 
 
185 
 
486 
 
570 
 
1104 
 
1260 
 
2903 
 
7258 
 
7115 
 
6817 
 
A 
 
 
4-2 /AC 439 664 2454 2505 3850 3077 7633 5179 7396 A 
(130 bp) 
 
272 
 
514 
 
1516 
 
1293 
 
2267 
 
1978 
 
4400 
 
2695 
 
3735 
 
C 
 
 417 1189 1804 2390 2814 6215 7596 7593 7433 A 
 
812 
 
486 
 
915 
 
1508 
 
1695 
 
2431 
 
4870 
 
5142 
 
7202 
 
C 
 
 333 663 2334 2791 3299 5427 7635 7551 7519 A 
 
391 
 
651 
 
932 
 
1537 
 
1193 
 
3029 
 
4487 
 
6459 
 
7193 
 
C 
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Table 5.8  Shown below are the normalised RFUs generated from different DNA 
dilution for individual 2. [pp] represents partial profile. 
 
 
DNA 
concentrations 
(pg) 
 
100 
 
200 
 
300 
 
400 
 
500 
 
1000 
 
2000 
 
4000 
 
8000 
 
SNP          
12-1 /CT pp 118 351 357 507 438 421 887 3160 
 
242 
 
240 
 
462 
 
1756 
 
1076 
 
1187 
 
1050 
 
2071 
 
7413 
 
 pp 112 180 430 348 277 471 1682 2697 
 
242 
 
351 
 
357 
 
1016 
 
771 
 
574 
 
1177 
 
4574 
 
7043 
 
 pp 101 206 281 269 214 557 942 1416 
 
102 
 
240 
 
358 
 
685 
 
687 
 
742 
 
950 
 
2418 
 
3718 
 
 
17-3 A/C 2719 4051 3552 3517 7490 7372 7380 7005 6960 
 
260 
 
439 
 
1808 
 
1578 
 
2536 
 
3994 
 
5900 
 
6456 
 
6228 
 
 2779 4680 3041 3404 7244 7193 7155 7000 6896 
 
166 
 
742 
 
1290 
 
1754 
 
2596 
 
3997 
 
4500 
 
6524 
 
6261 
 
 3591 4382 2517 3324 7339 7201 7334 7116 6883 
 
415 
 
809 
 
2884 
 
2235 
 
4225 
 
3708 
 
5506 
 
6540 
 
6010 
 
 
19-2 A/G 350 411 3792 3742 1441 5094 7353 7245 6880 
 
324 
 
127 
 
2820 
 
2994 
 
974 
 
2082 
 
6701 
 
7071 
 
7105 
 
 106 837 3741 2047 3156 2244 7298 7187 7189 
 
164 
 
499 
 
3835 
 
2064 
 
2640 
 
1551 
 
7284 
 
7099 
 
6963 
 
 701 1083 1301 2430 3093 4240 7281 7174 7059 
 
185 
 
486 
 
1382 
 
3158 
 
1260 
 
2903 
 
7258 
 
7115 
 
6817 
 
 
4-2 /AC 439 664 2454 2505 3850 3077 7633 5179 7396 
 
272 
 
514 
 
1516 
 
1293 
 
2267 
 
1978 
 
4400 
 
2695 
 
3735 
 
 417 1189 1804 2390 2814 6215 7596 7593 7433 
 
812 
 
486 
 
915 
 
1508 
 
1695 
 
2431 
 
4870 
 
5142 
 
7202 
 
 333 663 2334 2791 3299 5427 7635 7551 7519 
 
391 
 
651 
 
932 
 
1537 
 
1193 
 
3029 
 
4487 
 
6459 
 
7193 
 
129 
 
In this study, all 4 SNPs produced profiles and gave reproducible results for most of the 
concentrations analysed (Figure 5.1). However, for samples containing 100 pg and 200 
pg of template, some expected heterozygote loci were observed as homozygotes 
because one allele either dropped out or was below the threshold, resulting in a partial 
profile. In those templates with higher concentrations, such as 4000 pg and 8000 pg, 
some unrelated peaks from the background were observed. The more balanced peaks 
and full genotypes were obtained with 300 pg to 2000 pg of template. In general, the 
lowest RFU in both individuals was observed to be for SNP code 12-1 genotype CT. 
This observation may be due to the influence of dyes in this locus. For individual 1, the 
locus 19-2 genotype AG exhibited a partial profile, the allele G dropped below the 
threshold (RFUs 100) in the dilutions: 100 pg and 200 pg. Whilst individual 2 exhibited 
a partial profile genotype in the 100 pg dilution at locus 12-1 CT, the allele C dropped 
below the threshold. The genotype A, in loci 17-3, 19-2 and 4-2, showed profiles for 
both individuals in all the dilutions for both the homozygote and heterozygote loci. The 
other dyes all displayed some drop out. The different relative fluorescence of the dyes is 
a limitation of this methodology. 
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Figure 5.1. Shown above are the RFUs obtained from the sensitivity study of the 4 
SNPs using two DNA samples. Normalised average RFUs are shown. The error bars 
indicate the standard error of the mean.  
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5.5. Discussion 
Population Study 
The 66 loci produced the genotyping results expected in accordance with HWE. To our 
knowledge this is the first report of allele frequencies for SNPs in the UAE population. 
The allele distribution of all loci proved to be polymorphic with a minimum allele 
frequency of 0.14, which is in good agreement with the value of 0.17 reported by 
Sanchez et al (2006). 
Forensic Statistical Analysis 
A high average heterozygosity was found with a value of 0.47 and thus, the selected 66 
loci would be expected to exhibit high variability between samples. This is very 
valuable for forensic application as increases in heterozygosity improving 
individualisation of samples under comparison (Vallone et al., 2005). The value 
obtained for heterozygosity was not surprising, considering that one of the initial criteria 
for SNP selection, based on frequencies ranging 0.45-0.55, was priority to maximise the 
heterozygosity in the developed SNPs, albeit that the initial allele frequencies were 
based on only 20 alleles.  
The forensic characterisation of the 66 SNP panel showed encouraging features. With 
66 SNPs, the combined power of discrimination of > 0.99999999 was in the range 
achieved with the 52 loci (> 99.99999) reported by Sanchez et al (2006). The match 
probability of 3.058 ×10
-25
 was found to be higher than the match probability achieved 
with the CODIS markers 10
-15
 (Kidd et al., 2006). Although SNPs are not as 
polymorphic as multiallelic STRs; the biallelic SNP showed abilities to discriminate 
between unrelated and related individuals when a reasonable number of loci are 
developed. 
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Sensitivity Study 
The SNP typing results were reproducible and sensitive. The SNP profiles obtained 
from all the triplicates tested for reproducibility in the 25 individuals were all 
concordant even when SNP profiles were obtained in samples with as little as 100 pg 
template DNA. However, completely balanced genotyping was obtained at 300 pg 
compared to 500 pg needed for STR typing (Butler et al., 2007). The 52 plex that were 
developed by Sanchez, et al (2005) showed complete SNP profiles from 500 pg. This 
demonstrated that the SNPs developed in this study are suitable to be used for forensic 
samples. 
5.6. Conclusion 
In conclusion, the studies presented in this chapter show that the developed 66 SNPs 
offer both the potential for genotyping with forensic samples. The sensitivity studies 
conducted demonstrated that the SNP loci were as sensitive, and in many cases more 
sensitive than STR systems. The sensitivity levels were similar with larger multiplexes 
(Dixon et al., 2005b; Sanchez et al., 2006). 
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CHAPTER 6  
ANALYSIS of 
ARTFICIALLY 
DEGRADED DNA and 
CASEWORK SAMPLES 
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6.1. Overview 
In many cases, forensic scientists involved in the analysis of biological materials can 
only generate incomplete DNA profiles (Fondevila et al., 2008) as DNA will often 
undergo gradual fragmentation, causing the loss of one of the PCR primer binding sites 
(Pang and Cheung, 2007). Amplification failure leads to the loss of vital genetic 
information, which can be important for identification and comparison purposes: DNA 
samples of this nature are classed as degraded (Bender et al., 2004). 
In desert countries, such as the Gulf Region, a hot and humid environment is commonly 
found throughout the year; and this can be problematic when generating DNA profiles 
from forensic evidence. In this study the effect of two environmental factors on the 
degradation of DNA, the temperature and humidity, were assessed. Also, DNA samples 
subjected to endonuclease enzymatic degradation were included in this study.  
In real casework, most of the saliva and semen samples brought to the laboratory for 
analysis are collected using a swab. Therefore, in order to assess the effect of different 
environments on biological samples, saliva and semen were applied to swabs and 
incubated in both controlled and different natural environments. STRs and SNPs were 
used to assess the effectiveness of different markers when analysing degraded DNA. 
6.2. Aims of this Chapter 
To test the hypotheses that: 
 high temperature and humidity will increase the degradation of DNA; 
 SNPs of less than 150 bp can be used efficiently to improve allele profiling of 
degraded DNA; and 
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 to assess and evaluate, the performance of SNPs on degraded samples compared 
to STRs that are used routinely in forensic laboratories and in particular, the 
AmpFℓSTR® SGM Plus® (Applied Biosystems). 
6.3. Samples 
Saliva and semen samples were used in this study because these types of stains are 
commonly encountered at crimes scenes. Also, these samples were obtained without 
difficulty from volunteers at the time the experiment was conducted. Saliva and seminal 
fluid samples were collected from two individuals. DNA extractions that were degraded 
using DNase 1 from different incubation periods of 10, 60 and 180 minutes were also 
used. Analysis of these samples were carried out in the laboratory as described by Zahra 
(2009). Teeth samples were obtained from 8 different human remains, all of which were 
greater than 4 years old. 
6.4. Results 
6.4.1. DNA Extraction and Quantification 
Experiments to determine the effects of different environmental conditions (Table 6.1) 
on saliva and semen samples were performed. Extraction procedures for all saliva 
samples were carried out using Qiagen
®
 QIAamp
®
 DNA Mini Kit as described in 
Section 2.4.6 and DNA from semen was extracted using Qiagen
®
 QIAamp
®
 DNA 
according to the manufacturer’s protocol as described in Section 2.5.6 
DNA was estimated using the Quantifiler
®
 Human DNA kit with the ABI 7500 real 
time PCR machine as described in Section 2.2.2.1. 
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The results that were obtained from the Quantifiler
®
 DNA showed that the amount of 
DNA degradation was dependent on the type of sample analysed. These results are 
shown in Tables 6.2, 6.3 and 6.4.  
 
 
 
 
 
 
 
 
 
 
 
Table 6.1. Shown below are quantification results from semen and saliva samples studied 
at room temperature (22 °C). 50 µl of sample was added to a swab and the final extracted 
volume was 150 µl.  
 
  
                                                       Quantification values (ng/µl)                                    
          Saliva                                                                              Semen 
 
Days 
 
 
0 
 
 
3 
 
 
6 
 
 
9 
 
 
12 
 
 
15 
 
 
18 
 
 
0 
 
 
3 
 
 
6 
 
 
9 
 
 
12 
 
 
15 
 
 
18 
 
In
d
iv
id
u
a
l 
1
  
 
 
1.0 
 
 
 
1.33 
 
 
 
2.29 
 
 
 
1.46 
 
 
 
1.13 
 
 
 
3.02 
 
 
 
1.19 
 
 
 
4.22 
 
 
 
12.73 
 
 
 
9.13 
 
 
 
7.88 
 
 
 
16.57 
 
 
 
14.57 
 
 
 
17.29 
In
d
iv
id
u
a
l 
2
  
 
1.75 
 
 
4.09 
 
 
6.29 
 
 
5.04 
 
 
4.38 
 
 
1.38 
 
 
1.63 
 
 
5.67 
 
 
4.59 
 
 
4.30 
 
 
4.85 
 
 
3.40 
 
 
3.02 
 
 
5.22 
Table 6.2. Indicated below are the different environmental conditions that were induced 
to generate degraded DNA.    
   
 
Indoor environment  
(Saliva and Semen samples) 
 
100% humidity (37 °C) 
 
 
 
Room temperature (22 °C) 
 
Outdoor environment  
(saliva samples) 
 
 
UAE summer 
(September) 
 
 
UAE Winter 
(December/January) 
 
UK summer 
 (August) 
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Table 6.3. Indicated below are quantification results from semen and saliva samples studied 
at 100% humidity and at 37 °C. 50 µl of sample was added to a swab and the final extracted 
volume was 150 µl. Sample ‘not available’ is represented by: N/A. 
 
 
                     
Quantification values (ng/µl) 
          Saliva                                                                              Semen 
 
Days 
 
 
0 
 
3 
 
6 
 
9 
 
12 
 
15 
 
18 
 
0 
 
3 
 
6 
 
9 
 
12 
 
15 
 
18 
In
d
iv
id
u
a
l 
1
  
 
 
1.0 
 
 
 
0.22 
 
 
 
0.03 
 
 
 
0.04 
 
 
 
0.01 
 
 
 
0.01 
 
 
 
0.01 
 
 
 
4.22 
 
 
 
16.93 
 
 
 
21.42 
 
 
 
8.86 
 
 
 
22.76 
 
 
 
3.57 
 
 
 
15.49 
In
d
iv
id
u
a
l 
2
  
 
1.75 
 
 
0.04 
 
 
0.11 
 
 
0.00 
 
 
0.01 
 
 
0.01 
 
 
0.00 
 
 
5.67 
 
 
44.69 
 
 
33.32 
 
 
29.19 
 
 
NA 
 
 
21.97 
 
 
11.44 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.4. Indicated below are quantification results for DNA in saliva samples 
under natural conditions in UAE and UK environments with 50 µl samples. The 
final extracted volume was 150 µl. Sample ‘not available’ is represented by: N/A. 
 
 
Quantification values (ng/µl) 
 
 
Time intervals 
(days) 
 
 
UAE 
Dec/Jan 2008  
 
UAE 
Sept 2008 
 
UK 
Aug 2008 
 
0 
 
2.50 
 
6.01 
 
1.00 
3 3.51 1.57 3.16 
6 3.20 2.62 1.58 
9 NA NA 0.35 
12 1.59 0.31 0.20 
15 NA NA 0.09 
18 NA 0.05 0.02 
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The quantifications obtained from semen were variable in comparison with the 
reference samples for both individuals. For example in individual 1, the value for the 
sample incubated for 9 days was estimated at 9 ng/µl, compared to 22 ng/µl for the 
sample incubated for 12 days. Due to the viscosity of the semen sample a constant 
volume of pipetting could not be achieved. Also, a difference was observed between the 
amounts of DNA estimated for each individual. This could be a natural occurrence as 
different concentrations of DNA are produced by different individual. The same results 
were observed between control and degraded saliva samples, but with lesser variation 
than the semen samples. 
6.4.2. DNA Genotyping 
6.4.2.1. Performance of SNPs and STRs 
Criteria for the triplex development of 6 loci were described in Chapter 2 and Chapter 4. 
Also, as mentioned before, each sample was amplified and genotyped three times to 
ensure reproducibility, and an average of the results is presented. Based on the number 
of alleles profiled from the two triplexes (12 alleles), the genotyping results were 
calculated as a percentage (%). A partial profile was designated as (pp) and no profile as 
(np). The reference samples for each individual were genotyped as a control, producing 
12 alleles with which the subsequent profiles were compared (Figure 6.1 and Figure 
6.2). 
The results for SGM plus
®
 were also calculated as a genotype percentages with the 
amelogenin locus emitted from the analysis, therefore 100% allele profile was estimated 
as the presence of all 20 alleles in the 10 loci (Figure 6.3). The amount of sample used 
for STR genotyping was the same to that used for SNP analysis, ranged from 0.06 ng to 
0.5 ng. 
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Figure 6.1. Shown above is the electropherogram for multiples 1 for the reference sample 
that was used as standard to assess the allele profiles. 
 
[ SNP reference – triplex 1]
19-24-4
19-24-4
13-4
140 
 
 
 
Figure 6.2. Shown above is the electropherogram for multiplex 2 for the 
reference sample profiles. 
 
17-321
18-3
18-3
[SNP reference-triplex 2]
141 
 
 
 
Figure 6.3. Shown above is the electropherogram for the reference sample 
profiled with SGM plus®. 
 
 
 
 
STR reference sample 
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6.4.2.2. Degradation at 37 °C and 100% Humidity 
SNPs and STRs Typing of Saliva  
The results of the SNP and STR typing are shown in (Figure 6.4).  
In SNP typing, the signal strength obtained for each allele was dependent on the nature 
of the dyes incorporated for each ddNTP (Figure 6.5). The lowest peak heights were 
observed for ddCTP (dTAMRA
™
, yellow) and ddTTP (dROX
™
, red), which is 
consistent with previous observations (Vallone et al., 2004, Sanchez et al., 2006).  
The amount of DNA template used was 0.5 ng for the PCR reaction whenever possible. 
In some reactions, a reduced amount of DNA as low as 0.06 ng in the highly 
fragmented DNA samples was used for amplification in both SNP and STR analysis 
such as, saliva sample taken in interval 9, 12, 15 and 18. 
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Figure 6.4. Shown above is percentage of profiles obtained from artificially degraded 
DNA from saliva samples under 100% humidity at 37 °C with their corresponding DNA 
concentrations. The results are for SNaPshot™ and SGM plus® for individual 1 (A) and 
individual 2 (B). The error bars indicate the standard deviation. 
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17-321
18-3
18-3
 
 
 Figure 6.5. Shown above is an electropherogram of alleles below the RFU 
threshold (100) at C (black) and T (red) as a result of dye effect for locus 
18-3. Alleles for loci 21 and 17-3 were above the threshold. 
 
In order to evaluate the efficiency and the contribution of each locus in both triplexes, 
the percentage of each locus was calculated: for each locus, the total number of 
observed alleles in the three repeats (Appendex A2A and A2B) was divided by the total 
number of expected alleles. The average for both individuals was determined. SNP code 
21 performed the best with 100% amplification followed by 4-4 (62%), 17-3 (59.5%), 
19-2 (51.8%), 13-4 (45.2%) and 18-3 was the lowest contributor with 38.9%. Although 
both SNP code 21 and 4-4 are of a similar amplicon size, 4-4 showed a remarkably 
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lower percentage than code 21; this is because locus 4-4 for individual 1 was observed 
to be heterozygous (AG) and because of the difference in signal strength between the 
dyes (Vallone et al., 2004). Allele A was the first to dropout, giving a partial profile at 
day 12. Also, it could be that the template sequence for locus 4-4 was more affected by 
prolonged degradation (day 15 and 18) with complete allele dropout when compared to 
locus 21 (Dixon et al., 2005a). 
The percentage of each locus for SGM plus
®
 profiling (Appendex A3) was also 
calculated as for SNP profiling. 
SNPs and STRs Typing  of Semen  
The experiment performed for semen samples from both individuals showed full SNP 
and STR profiles in all incubation periods (Appendix A4A, A4B and A4C). This may 
be because the degradation period was not long enough to affect the PCR primer target 
sequence of the DNA template (Figure 6.6 A and B). However, this observation was in 
agreement with a previous degradation experiment on semen samples where full DNA 
profiles were obtained after 243 days incubation at 37 °C and after 24 days at 100% 
humidity (Cotton et al., 2000, Dixon et al., 2005b). 
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Figure 6.6. Shown above are profiles of 100% obtained from artificially degraded DNA 
from semen samples under 100% humidity and 37 °C with their corresponding DNA 
concentrations. The results are for SNaPshot™ and SGM plus® for individual 1 (A) and 
individual 2 (B). NA; represents not available sample. 
 
 
 
6.4.2.3. Degradation at Room Temperature 
SNPs and STRs Typing of Saliva and Semen  
In order to check the effect of temperature alone, or at least reducing the influence of 
other weather effects such as sun radiation and humidity, saliva and semen samples 
were kept at average room temperature, which was recorded as 22 °C. At the time, the 
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experiment was conducted, the laboratory temperature was observed to be 
approximately 4 °C higher than the average atmosphere temperature outdoors (18 °C).  
As expected from the quantification values, a full profile (100%) was obtained for saliva 
in the cases of both SNP and STR (appendex A5, A5B and A5C). This observation 
strongly indicates that an indoor temperature below 24 °C and incubation period of 18 
days did not have major effects on the DNA template (Figure 6.7 A and B).  
Since a full semen DNA profile was obtained in the previous experiment (100% 
humidity/ 37 °C temperature) at all time intervals; it was assumed that under the less 
stringent environmental factor (22 °C), the DNA template would also exhibit a 100% 
successful genotyping results. Therefore, semen DNA for this experiment was not 
genotyped.  
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Figure 6.7. Shown above are profiles obtained from artificially degraded DNA from 
saliva samples under 100% humidity and 37 °C, also shown are their corresponding 
DNA concentrations. The results are for SNaPshot™ and SGM plus® for individual 1 
(A) and individual 2 (B). The amount of DNA template used was 0.5 ng for the PCR 
reaction. 
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6.4.3. Outdoor Environment 
The reason behind this methodology was to observe the effect of different temperatures 
and other naturally occurring weather elements on biological samples. The temperature 
in this study, ranged from less than 20 °C to more than 37 °C, which was classified for 
simplicity as cold, mild and hot temperatures. In order to achieve such ranges of 
temperature naturally, the sample was exposed to three different environments; the UAE 
environment: December 2007/ January 2008 (Figure 6.8); mild temperature up to 22 °C, 
partial cloud, and average relative humidity up to 50%; September/October 2008; hot 
with average temperatures reaching 34 °C, sunny and an average relative humidity of up 
to 58% (Figure 6.9). UK weather: August 2008, cold temperature less than 20 °C, 
raining, and average relative humidity up to 92 % (Figure 6.10). An aliquot of the same 
saliva sample (female) was exposed to each of the three conditions. 
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Figure 6.8. Shown above are UAE December/ January average 
temperatures and humidity for each of the degradation period. The 
average of temperature and humidity was calculated based on the hourly 
data (24 hours) obtained for each of degradation periods.   
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Figure 6.9. Shown above are UAE September/October average 
temperatures and humidity for each of the degradation period. The 
average of temperature and humidity was calculated based on the hourly 
data (24 hours) obtained for each of degradation periods. 
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UK Weather Conditions
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Figure 6.10. Shown above are UK August average temperatures and 
humidity for each of the degradation period. The average of temperature 
and humidity was calculated based on the hourly data (24 hours) obtained 
for each of degradation periods. 
 
6.4.3.1. SNP and STR Profiles 
Based on the results obtained from quantification (above Table 6.4), 0.5 ng of DNA was 
used for amplification in most reaction unless otherwise mentioned.  
UAE- December 2007/ January 2008 
SNPs and STRs Typing 
The results are shown in (Figure 6.11). 
As mentioned above , the amplification for SNP typing of each sample was performed 
in triplicate. The duration of the experiment was for 12 days due to time constrain In 
this experiment, the sample exhibited little degradation and full SNP profiles were 
observed in all time intervals except for complete dropout at locus 13-4 in the second 
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repeat of triplex 1 and one allele dropout at locus 18-3 in the second and third repeat of 
 triplex 2 (Appendex A6).  
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Figure 6.11. Shown above is the percentage of profiles obtained from degraded DNA 
from saliva samples under natural conditions of the UAE in December/January. The 
results are for both SNaPshot™ and SGM plus®. The error bars indicate the standard 
deviation. 
 
 
The STR typing gave partial profiles with most affected alleles were those present in the 
FGA locus (Appendex A7).  
UAE- September 2008 
SNPs and STRs Typing 
The average temperature of 34 °C and average relative humidity of 58% in this period 
had a high effect on the saliva samples (Figure 6.12). An average SNP profiling 
efficiency of 48.9% (partial profile) was observed, with the most affected locus, 18-3, 
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(Appendex A8) only profiling a total of 50%. Whilst the STR typing gave an average 
profiling efficiency of 25% (Appendex A9).  
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Figure 6.12. Shown above is the percentage of profiles obtained from degraded DNA 
from saliva samples under natural conditions of the UAE in September. The results 
are for both SNaPshot™ and SGM plus®. The error bars indicate the standard 
deviation. 
 
  
UK- August 2008 
SNPs and STRs Typing 
The results are shown in (Figure 6.13). For the sample degraded for 18 days, the amount 
of DNA template used for amplification was estimated as 0.36 ng. 
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The effect of an average temperature of 16 °C and up to 92% average humidity varied 
between different time intervals (Appendex A10 and A11). The overall genotyping 
percentage was found to be 78.7% for SNPs and 40.8% for STRs.  
Saliva- UK August
0
20
40
60
80
100
120
3 6 9 12 15 18
3.16 1.58 0.35 0.2 0.09 0.02
Incubation periods and quantifications
%
 P
ro
fi
le
s
SNP
SGM plus
days
ng/µl
 
 
Figure 6.13. Shown above is the percentage of profiles obtained from degraded DNA 
from saliva samples under natural condition in the UK in August. The results are for 
both SNaPshot™ and SGM plus®. The error bars indicate the standard deviation. 
 
 
6.4.4. Comparison between SNP and STR Profiling 
In this comparison, the results obtained for degraded saliva samples incubated for 6 
days under all the conditions employed are illustrated in the following figures. 
Whenever 2 individuals were included in the degradation experiment; samples from 
individual 1 were only used for the comparison.  
Using the artificially degraded DNA samples, the comparisons between SNP and STR 
analysis showed that the amplification of severely fragmented DNA templates were 
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more successful using SNP genotyping. In many cases full allele profiling was obtained 
by using SNPs, whilst only partial profiles were sometimes recovered using STRs 
However, in severely fragmented DNA, dropout of alleles was observed for both 
systems.  
Comparing overall the percentage of genotypes obtained from all saliva samples 
degraded under 100% humidity and 37 °C temperature conditions (Figure 6.14 A and 
B), 37.7% of allele profiles were observed for SNP and 16.7% of profiles were observed 
for STR analysis.  
In the natural environment, intact DNA was exposed to more than two factors such as 
wind, sun radiation (UV), humidity, moisture and temperature. Dependent on the 
environmental conditions, the DNA samples exhibited variation in the amount of 
degradation observed. The UAE samples degraded in December/ January (Figure 6.15 
C and D) showed 95.4% SNP profiles and 48.3% of STR profiles, whilst samples 
degraded in September (Figure 6.16 E and F) gave 47.9% SNP profiles and 23.8% STR 
profiles. Alternatively, samples that were subjected to UK weather conditions (Figure 
6.17 G and H), exhibited 77.8% for SNP profiles and 42.5% for STR profiles.  
Amplification efficiency of samples that were degraded in the UAE September 
environment, showed the least efficiency, because the combination of >87% humidity, 
>37 °C and sunny conditions collectively caused the DNA to be fragmented to a greater 
extent than the other conditions (UAE, December/January and UK, August conditions). 
Also, ultraviolet radiation from the sun light could alter the primary structure of DNA 
strand leading to the formation of thymidine dimerization (Mitchell et al., 1992). This 
did not fragment the DNA, but cross-link renders the DNA inert in a PCR. Ultimately, 
dropout of larger alleles especially for STR analysis was exhibited; this system was 
approximately 19.6% less efficient than the SNP amplification. 
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However, although the temperature (cold-17 °C) for UK degradation conditions was 
much lower than the temperature observed for UAE December/January (mild-23 °C) 
conditions, the efficiency of the PCR primers for UK samples incubated longer than 6 
days gave less efficient results than were expected. A combination of 81% relative 
humidity and the damp environment resulting from continuous rain could be responsible 
of the increased degradation effects on the DNA samples.  
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[A] SNaPshot triplex1 and 2
4-4
4-4 19-2
17-3
21
 
 
[B] SGM plus
 
 
 Figure 6.14. Shown above are electropherograms showing a comparison of 
allele genotyping that was obtained from (A) SNaPshot™ triplex and (B) 
from SGM plus
®
. 0.5ng of DNA from a sample degraded under humidity 
and 37 °C for 6 days for individual 1 was used for both systems. Allele 
profiles of 58.3% were obtained for SNP and 5% (one allele is circled) for 
STR. 
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[D] SGM plus
 
 
Figure 6.15. C-T1,C-T2 and D.  Shown above are results for the samples at 6 
day intervals obtained from UAE December/January degradation. 
Electropherograms C-T1 and C-T2 represent triplex 1 and triplex 2 of 
one of the repeats obtained from SNP genotyping with 100% profiles. D 
is the result for the same sample obtained from STR genotyping with 
60% profiles. Arrows indicate alleles and circles indicate the partial and 
complete allele dropout due to degradation. 
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[F] SGM plus
 
 
Figure 6.16 E-T1, F-T2 and G. Shown above are results for the samples at 6 days 
interval obtained from UAE September degradation. Electropherograms E-
T1 and E-T2 are one of the repeats of triplex 1 and 2 of SNP genotyping 
have 100% profiles. F is the result for the same sample obtained from STR 
genotyping, which has 25% of alleles. Arrows indicate the allele peaks 
above 100 RFU and circle indicate the allele below 100 RFU. 
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[H] SGM plus
 
 
Figure 6.17 G-T1, G-T2 and H. Shown above are results for the samples at 6 day 
intervals obtained from UK August degradation. Electropherograms G-T1 
and G-T2 are one of the repeat of SNP genotyping with 100% profiles. H is 
the result for the same sample obtained from STR genotyping with 100% 
profiles. Arrows indicate the alleles.  
6.4.5. DNA Genotyping from DNase 1 Degradation 
The samples (Section 6.3) were previously identified based on the profiles obtained 
from the genotyping of STRs. The 8 pp indicated a partial profile where 8 loci including 
the ameloginin were profiled, 4 pp; when 4 loci including the ameloginin were profiled 
and no profile when none of the loci were profiled. 
The concentration of DNA in the samples (Table 6.5) were estimated using Quantifiler
®
 
Human DNA kit with the ABI 7500 real time PCR machine as described in Section 
2.2.2.1. 
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6.4.5.1. SNP Profiling 
Results are shown in (Table 6.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.5. Indicated below are quantification results for DNA in DNase І 
samples.  A partial profile is represented by pp and np represents no profile 
obtained in STRs. 
 
 
Quantification values (ng/µl) 
 
 
Samples 
 
 
8 pp 
 
 
4 pp np 
Amount 
 
0.74 0.37 0.29 
Table 6.6. Indicated below are SNP genotypes for samples treated with DNase 1 in both 
triplex. np represents no profile. 
 
Triplex 1 
 
SNP code 
 
 
AG 
4-4 
 
 
AG 
19-2 
 
CT 
13-4 
 
Samples. 
 
   
8 pp AA AG CC 
4 pp AA AG CC 
np 
 
AA AG np 
 
Triplex 2 
 
 
SNP code 
 
 
 
AG 92 
21 
 
CT 119 
18-3 
 
AC 147 
17-3 
 
Samples  
 
   
8 pp AG TT CC 
4 pp AG TT CC 
np 
 
AG AG CC 
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Samples 8pp and 4pp produced full loci with 100% allele profiles. Whilst sample np 
gave 83.3% with loss of one locus at SNP code 13-4 (Figure 6.18). 
G
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Figure 6.18. Triplex 1 and 2 electropherograms for sample NP at 100 RFU. 
83.3% allele profiles was obtained due to locus 13-4 not profiling. 
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6.4.6. Application of developed SNP  
The developed SNPs were also tested with forensic samples such as teeth extracted 
from human jaws. 
The extraction procedure for all were carried out using Qiagen DNeasy
®
 Blood and 
Tissue Kit as described in Section 2.6 (Chapter 2) and DNA was estimated using the 
Quantifiler
®
 Human DNA kit with the ABI 7500 real time PCR machine as described in 
Section 2.2.2.1 (Table 6.7). 
 
  
 
 
 
 
 
 
 
6.4.6.1. SNP and STR Profiling  
The SNP profiling results are showing in Table 6.8. Sample 13 and 14 produced 33.3% 
and 66.7% allele profiles, however, when the RFU thresholds was lowered to 50 
(Sanchez et al., 2006) with modification, the allele profiles increased to 50% and 83% 
Table 6.7. Indicated below are results for DNA extracted from teeth 
samples. The quantification was carried out in duplicate for each sample. 
ud represent undetermined sample. 
 
 
Quantification values (ng/µl) 
 
 
Samples 
 
Amount 
 
11 0.27 
11 0.28 
12 0.04 
12 0.05 
13 ud 
13 0.02 
14 0.03 
14 0.05 
15 0.01 
15 0.02 
16 0.01 
16 0.02 
17 0.58 
17 0.55 
18 0.19 
18 
 
0.14 
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respectively (Figure 6.19 to 6.20). This indicated that some of the allele profiles that 
were below the 100 RFU level were able to be pooled and identified. However, the 
lowest allele profiles were achieved for samples 15 and 16 with no profile suggesting 
that the samples were highly degraded. Maching allele profiles were observed between 
several of the samples. As an example: samples 11 and 12, 13 and 14, and 17 and 18, 
which were duplicate samples from the same individual, gave the same profiles. This 
provided additional confirmation for the genotyping results.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.8. Indicated below are SNP genotypes for teeth samples in both 
triplexes. np represents no profile. 
 
 
RFU 100 
 
 
RFU 50 
       
Triplex 1 
 
 
Triplex 1 
 
 
SNP code 
 
AG 
4-4 
 
 
AG 
19-2 
 
CT 
13-4 
 
AG 
4-4 
 
AG 
19-2 
 
CT 
13-4 
 
Samples 
  
 
    
11 AA AG CC    
12 AA AG CC    
13 G np np G G np 
14 G AG np AG AG np 
15 np np np    
16 np np np    
17 AA AG CC    
18 AA AG CC 
 
   
 
Triplex 2 
 
 
Triplex 2 
 
 
SNP code 
 
 
AG  
21 
 
 
CT  
18-3 
 
AC  
17-3 
 
AG  
21 
 
CT  
18-3 
 
AC  
17-3 
 
Samples 
 
      
11 AG TT CC    
12 AG TT CC    
13 GG np np GG np A 
14 GG np AA GG TT AC 
15 np np np    
16 np np np    
17 AG TT CC    
18 AG TT CC    
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 Figure 6.19. Shown above are Triplex 1 and 2 electropherograms for tooth 
sample 13 at 100 RFUs. Arrows represent alleles below 100 RFU. 
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Figure 6.20. Shown above are electropherograms for Triplex 1 and 2 for 
tooth sample 13 with 50 RFUs defined as the cut off point. The additional G 
and A allele detected at height 66 and 69 RFUs respectively, increased the 
total profile 50%. 
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Due to the unavailability of STR reference profiles for the teeth samples, the calculation 
of the percentage of the allele profiles was based on the observation of the peak heights 
only. From these observations (based on tooth 14) the reference profiles had the 
following genotypes: D3S1358 is heterozygote; D16S539 is homozygote; D2S1338 is 
heterozygote; D8S1179 is heterozygote; D18S51 is homozygote; D19S433 is 
homozygote and THO1 is heterozygote. 
The STR typing for sample 13 did not show any alleles, indicated a complete loss of 
loci (Figure 6.21). Twelve out of 20 alleles were partially profiled for sample 14, 
producing 60% of the total allele profile at 100 RFU threshold (Figure 6.22). Samples 
15 and 16 both gave 0% profile. STR profiles for sample 11 and 12 were not available 
for the comparison. 
 
 
 
 
 
 
 
 
 
 
 
Tooth 13
 
 
Figure 6.21. SGM plus
®
 electropherogram for tooth sample 13. 
No alleles were observed. 
 
 171 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tooth 14
 
 
Figure 6.22. SGM plus
®
 electropherogram for sample 14. There 
were 7 alleles (60%profiles).  
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6.5. Discussion 
Saliva stains can be recovered from many objects left as evidence at scenes of crime 
including: cigarette butts, chewing gums, drinking containers and on a victims body as a 
result of rape cases (Bond et al., 2008). Alternatively, semen stain can be recovered 
from sexual assault scenes found on different items such as, clothes, bed sheets, body 
swabs and car seats. The successful profiling of such samples can be dependent upon 
the time taken to recover the stain coupled with the environmental temperatures. 
Therefore in order to obtain DNA genotyping from evidence, biological samples should 
be collected for analysis as quickly as possible.  
Many factors influence the recovery of intact biological evidence from scenes of crime. 
Elements such as high temperature, humidity, and UV cause DNA degradation. Clearly, 
these elements are uncontrollable, if the evidence is found outdoors. This can lead to 
fragmentation of the DNA strands. The greater the exposure time to such insults, the 
more fragmentation is induced, and ultimately, the loss of genetic information that is 
useful for evidential purposes. However, the level of degradation also depends upon the 
type of the biological sample itself. Some samples tend to degraded faster than others. 
Saliva samples for example, because of the presence of other factors such as enzymes 
(amylase) and mouth microbial organisms, tend to enhance degradation more than 
blood and semen (Cotton et al., 2000).  
Indoor Environmental studies  
In this study, a comparison between SNP and STR genotyping was tested on artificially 
degraded semen and saliva samples. The ABI SNaPshot™ Triplex SNP set that was 
developed in this study was designed to amplify 90-147 bp of DNA template as part of 
a previous development. The STR genotyping was performed using the SGM plus
®
 
which generates amplicons ranging from approximately 100-360 bp. The performance 
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of SNP and STR analysis was greatly influenced by the degree of degradation. Semen 
samples were fully genotyped using SNPs and STRs: semen was less susceptible to 
degradation than saliva samples. Saliva DNA showed variation in degradation, 
producing both partial and a complete loss of loci.  
Highly fragmented saliva DNA gave better results using SNP amplification because the 
small length of the SNP loci amplified more efficiently than the larger loci present in 
the STR system (Gill et al., 1998). Ultimately, a higher allele profile percentage was 
recovered in degraded samples using SNaPshot™ than SGM plus®, for example the 
saliva sample collected after 6 days incubation at 37 °C and 100% humidity gave a SNP 
profile of 72.2% and a STR profile of only 5%. 
Outdoor Environmental Studies 
Altough there have been many studies on environmental degradation of DNA samples, 
the study in this chapter focused upon the comparison of different climate conditions on 
saliva samples from different geographical places; the UAE and UK. 
The DNA profiles obtained from the degradation in December/January at an average 
temperature of 22 °C (Met UAE) produced the most complete profiles in both systems 
(SNaPshot
™
 and SGM Plus
®
). The samples exposed to September with average 
temperature 34 °C (Met UAE), as expected, produced the lowest profiles in both 
systems. However, samples exposed to the UK climate of August with an average 
temperature of 16 °C resulted in fewer alleles profiling than the corresponding profiles 
obtained in December/ January (UAE). This clearly shows that lower temperature 
combined with high relative humidity such that observed in the UK in August are 
important. 
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Efficiency of obtaining DNA profiles 
This chapter demonstrated that, the efficiency of obtaining DNA profiles did not only 
depend on the amount of starting template. Sufficient amounts of sample template can 
also result in low allele profiles if the samples are in a degraded state (Dixon et al., 
2005b), such as the sample treated with DNase І for 10 minutes (8 pp). Although the 
amount of DNA was estimated to be more than 0.7 ng/ µl, only 70% of its profile was 
obtained with STRs profiling compared to 100% profile using SNP genotyping.  
For a DNA template as little as 0.02 ng/µl, (bone sample number 13) 33.3% allele 
profiles were achieved at att loci, whilst genotyping with STRs failed to produce any 
profile for the same sample. 
6.6. Conclusion 
The SNP triplex set demonistred a higher level of sensitivity in obtaining genotypes 
from heavily degraded samples than SGM Plus
®
. This result, in addition to those of  
previous studies, represents the necessity to include SNPs as a method for genotyping 
for forensic samples. Also, from the observation of the performance of triplexes in this 
study, this indicates that the 66 singleplexes that were developed in Chapter 4 could be 
combinned into large multiplexes and used for the typing of degraded samples. 
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CHAPTER 7 
GENERAL DISCUSSION 
and FUTURE WORK 
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7.1 General Discussion 
The difficulty in analysing degraded samples has been the biggest challenge for 
obtaining DNA profiles using the STR method. An alternate method is therefore 
required to overcome the problem of typing such difficult samples. SNPs have shown 
promise and may become the future marker used for forensic applications (Esther et al., 
2007). In this study, the results obtained from samples subjected to degradation and 
typed with the developed SNPs compare well to the results obtained using STRs, 
supporting the need for SNP typing of challenging samples. 
The original goals of the Human Genome Project have been the construction of 
complete genetic and physical maps of the human genome (Sachidanandam et al., 
2001). Since the completion of the human genome sequence, a comprehensive search 
for genetic influences in disease and individual genetic variation due to SNPs have been 
undertaken. According to the GenBank data base (db SNP) more than 14 million SNPs 
are submitted in the GenBank data up to date (06/10/2008).  
The SNPs were primarily discovered by two projects: The SNP Consortium (TSC) and 
the International Human Genome Sequencing Consortium (HapMap), provides a public 
resource for defining haplotype variations across the genome, and help to identify 
biomedically important genes for diagnosis and therapy (Sachidanandam et al., 2001). 
TSC contributed SNPs that were identified by shotgun sequencing of genomic 
fragments drawn from 24 ethnically diverse individuals, a representation of the human 
genome. This resulted in detecting more than one million SNPs with the sequence, 
physical and genetic maps of the human genome publicly available in GenBank 
(Sachidanandam et al., 2001). 
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HapMap project has looked at combinations of SNPs that are inherited together known 
as haplotypes to characterise linkage disequilibrium patterns across the genome to 
facilitate selection of most informative subsets of SNPs (Syvanen, 2005). These 
haplotypes enable geneticists to search for genes involved in diseases and for genome 
association studies. This required genotyping of 270 individuals from European, Sub-
Saharan, Chinese and Japanese to generate allele frequencies. More than 4 million SNPs 
are validated by HapMap and made it publicly available in the GenBank data base. 
The validated SNPs with allele frequencies and genotypic information that are presented 
in HapMap data base provide fundamental information for studying genetic variation in 
human population. However, the developed SNPs in this project were selected from 
Arab individuals rather than from HapMap data base. One important advantage of this 
selection was based on forensic application requirements to achieve high discrimination 
power and low match probability, therefore; SNPs with allele frequencies between 0.45 
and 0.55 were selected and in turn high heterozygosity of 0.47 were achieved. Also, the 
SNPs with minor allele frequency provide little information for association and linkage 
study: minor alleles frequencies that are observed in one population can disappear in 
other populations (Goddard et al., 2000).  
The recent developments in microarray technologies for SNP screening provide speed, 
efficiency and throughput. The benefit of using the Affymetrix
®
 microarray method for 
screening the SNPs from the whole genome was achieved (Chapter 2). It allowed the 
identification of SNPs from autosomal chromosomes from United Arab Emirates and 
Kuwait Arab samples. The method requires high amount of starting samples for the 
screening (Matsuzaki et al., 2004), and is therefore of little value when typing forensic 
samples. It has proven to be successful for our needs in selecting polymorphic SNPs 
from this particular population. 
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The main objective of this study was to develop SNPs that can be useful for increasing 
the allele profiles for the identification of degraded DNA in forensic samples. In this 
project 66 SNPs were developed in order to meet the requirement of forensic 
applications (Chapter 5). SNaPshot
™
 is a simple convenient method that uses an 
instrument, of which there are several possible models, and which is available in most 
forensic laboratories: the ABI Prism
®
 Genetic Analyzer (Applied Biosystems). SNP 
genotyping using this method provided valuable information that enabled samples to be 
analysed quickly.  
All the 66 SNPs conformed to Hardy-Weinberg expectation, did not show any linkage 
disequilibrium and had high heterozygosity levels when compared with the existing 52 
SNPs developed by Sanchez et al. (2006). The sensitivity study showed profiles were 
possible from as little as 100 pg DNA template with the optimum amount of 300 pg 
giving accurate results. 
The triplexes developed as representative of the 66 SNPs were shown to be useful when 
analysing degraded samples. Artificially degraded samples under different 
environmental conditions showed fuller profiles when typed with SNPs compared to 
STRs. The amplicon of the SNPs, between 90 and 147 bp, showed more resistance to 
degradation than the larger STRs length (100-360 bp). The SNP genotypes were 
reproducible among different sample types and samples degraded over different time 
periods and conditions. 
In addition to the usefulness of SNPs in typing artificially degraded samples, these 
SNPs were also tested in samples obtained from different scenarios. It was 
demonstrated in this project that these SNPs will be useful for the analysis of human 
remains such as teeth, common evidence found in mass disasters. Also, the small size of 
these SNPs gives them greater potential in producing allele profiles from enzymatically 
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degraded samples which produced partial profiles by STRs such as samples treated by 
DNase І. 
In conclusion, the 66 candidate SNPs developed in this study were shown to be a new 
tool for Arab populations, recovering useful genetic information for forensic 
identification on degraded samples. This project supports the use of SNPs as forensic 
markers for degraded samples. 
7.2 Future Work 
The developed 50 autosomal SNPs have met the expectation of the project aim which 
was to introduce new forensic markers capable of increasing the power of identification 
for degraded samples. However, the strength of genotyping degraded samples can be 
improved markedly by using larger SNP multiplexes. Profiling of the degraded samples 
by the triplex was very promising, and by increasing the combination of both PCR and 
SBE primers will increase the number of loci to be profiled which in turn will increase 
the power of identification of samples. Moreover, the amount of starting sample will be 
reduced. Rather than needing the samples for two separate triplexes, a larger multiplex 
will only require one DNA template. This is advantageous for most forensic samples. 
No doubt in the future, technology will improve allowing more SNPs to be multiplexed 
in one tube. The existing method developed by Sanchez et al. (2006) enabled a 
maximum of 29 autosomal SNPs to be multiplexed in a single tube. 
The result of genotyping SNPs using SNaPshot
™
 method showed a feature that needs to 
be considered in the future. The dyes that are used in the SBE method have 
disadvantages in some loci, especially when genotyping highly degraded samples. The 
red and yellow dyes that are incorporated to ddTTP and ddCTP respectively show very 
low signal, about 1/3 the signal obtained from ddGTP and 1/2 the signal obtained from 
ddATP (Sanchez et al., 2006). This variation in signal affected the allele calls as the first 
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loci that were below the RFUs threshold were found to be those incorporated with the 
yellow and red dye whilst the blue and green loci exhibited relatively high signals. It 
will be very helpful if the SBE method used in the SNaPshot
™
 analysis could improve 
this signal imbalance in future. This will increase the rate of allele calls better than the 
existing SBE dyes.  
To date, the SNP markers have only been tested in an Arabic population.  Further 
population studies, on diverse population groups will enable an assessment to be made 
as to how versatile the SNPs will be: many are likely to show similar allele frequencies 
in different populations; however, some may prove to be highly polymorphic only in the 
Arabic population. 
Finally, in the future it will be very useful for UAE forensic laboratories to use SNPs as 
forensic markers. The harsh weather conditions in the UAE are observed on the 
incomplete recovery of genetic information in most samples, especially when 
temperatures and humidity exceed 45 °C and 80% respectively in most summer seasons. 
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A1. Indicated below are quantification results for DNA concentration obtained from 
100 individuals from UAE. The highlighted 25 samples are selected for SNPs profiling. 
 
 
Samples 
number 
 
Concentrations 
(ng/µ) 
 
Samples 
number 
 
Concentrations 
(ng/µl) 
 
Samples 
number 
 
Concentrations 
(ng/µl) 
 
 
1 
 
1.26 
 
44 
 
0.61 
 
87 
 
7.55 
2 2.74 45 2.18 88 5.88 
3 5.58 46 1.55 89 1.23 
4 8.16 47 2.22 90 3.95 
5 0.95 48 1.10 91 0.25 
6 1.54 49 2.54 92 3.69 
7 6.41 50 2.17 93 3.69 
8 4.59 51 5.33 94 3.45 
9 4.98 52 26.76 95 3.45 
10 4.95 53 11.23 96 0.7 
11 0.86 54 0.38 97 1.72 
12 17.8 55 2.25 98 1.00 
13 3.02 56 1.64 99 3.74 
14 7.71 57 2.58 100 3.07 
15 3.02 58 1.11   
16 1.66 59 4.13   
17 5.46 60 3.64   
18 0.39 61 2.47   
19 1.22 62 8.76   
20 2.88 63 3.25   
21 4.55 64 8.57   
22 3.82 65 4.72   
23 0.54 66 1.74   
24 2.46 67 1.07   
25 3.93 68 0.92   
26 8.03 69 1.09   
27 6.86 70 1.66   
28 2.72 71 5.05   
29 1.39 72 2.69   
30 3.71 73 2.65   
31 0.67 74 5.64   
32 7.84 75 2.36   
33 26.32 76 5.23   
34 1.07 77 6.91   
35 0.95 78 2.45   
36 1.08 79 4.88   
37 14.28 80 1.31   
38 1.26 81 0.58   
39 18.46 82 0.98   
40 1.59 83 2.01   
41 1.18 84 0.36   
42 0.81 85 7.76   
43 
 
0.50 86 5.65   
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A2 A. Showing below are SNP RFUs obtained from artificially degraded DNA from saliva samples under 100% humidity and 37 °C. The results are 
for individual 1. [0A] represents the reference sample and numbers 3 to 18 are the durations of incubation. [np] indicates no profile and [pp] partial 
profile. 
  
Triplex 1 
 
 
Repeat 1 
 
  
Repeat 2 
 
  
Repeat 3 
 
SNP type amplicon 
size 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
AG/ 90 
4-4 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
In house code 
1115/2137 
 
1220/1332 
 
511 TT 
 
1217/2203 
 
1157/938 
 
464TT 
 
2957/7164 
 
1660/2708 
 
1404TT 
 
 
0A 
 
3 1985/4925 1980/1127 388 TT 2261/5099 1425/1520 489TT 2136/4613 1758/1088 374 TT 
6 310/919 205/100 np 374/485 118/pp np 302/1403 407/503 147 
9 165G/pp np np np np np 207G/pp 102A/pp np 
12 np np np np np np np np np 
15 np np np np np np np np np 
18 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
Triplex 2 
 
 
 
AG/ 92 
21 
 
 
CT/ 119 
18-3 
 
  AC/147 
    17-3 
 
    AG/ 92 
       21 
 
  CT/ 119 
     18-3 
 
AC/ 147 
   17-3 
 
   AG/ 92 
     21 
 
 CT/ 119 
    18-3 
 
 
  AC/ 147 
        21 
 
In house code 
4182 AA 
 
219/619 
 
4791AA 
 
5845 AA 
 
287/723 
 
5244A 
 
5613AA 
 
295/755 
 
5204AA 
 
 
0A 
 
3 3113AA 210/450 3039AA 3758AA 190/502 3872AA 3984AA 214/482 3476AA 
6 607AA np 810 AA 425AA np 312AA 785AA 128T/pp 718AA 
9 150AA np np 124AA np 313AA 274AA np np 
12 260 AA np np 206 np np 379AA np np 
15 189AA np np 254 np np 152 AA np np 
18 
 
134AA 
 
np 
 
np 
 
126 
 
np 
 
np 
 
145 AA 
 
np 
 
np 
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A2 B. Showing below are SNP RFUs obtained from artificially degraded DNA from saliva samples under 
100% humidity and 37 °C. The results are for individual 2. 0B represents the reference sample and numbers 
3 to 18 are the duration of incubation. [np] indicated no profile,[ pp] partial profile and [np] sample was not 
tested because the template was estimated to be 0.00 ng/ µl. 
  
Triplex 1 
 
 
Repeat 1 
 
  
Repeat 2 
 
Repeat 3 
 
 
SNP type/ 
amplicon size 
 
AG/ 90 
  4-4 
 
AG/ 110 
  19-2 
 
CT/ 142 
  13-4 
 
AG/ 90 
  4-4 
 
AG/ 110 
  19-2 
 
CT/ 142 
  13-4 
 
AG/ 90 
   4-4 
 
AG/ 110 
  19-2 
 
CT/ 142 
  13-4 
 
In house code 
6281AA 1687/2074 2166TT 6209AA 1770/3241 2244TT 5732AA 1686/2555 2242TT 
 
0B 
 
3 1112AA 354/280 150TT 899AA 266/356 153TT 1161AA 348/508 np 
6 2005 485/794 375TT 2786AA 619/845 819TT 2687 780/1207 525TT 
9 nt nt nt nt nt nt nt nt nt 
12 np np np 170AA 118 G/pp np 155AA np np 
15 np np np np np np np np np 
18 nt nt nt nt nt nt nt nt nt 
 
Triplex 2 
 
 
AG/ 92 
21 
 CT/ 119 
 18-3 
AC/ 147 
    17-3 
AG/ 92 
    21 
  CT/ 119 
    18-3 
AC/ 147 
   17-3 
AG/ 92 
   21 
CT/ 119 
   18-3 
AC/ 147 
    21 
In house code 
5747AA 244/570 2520/1298 5709AA 245/624 3050/1198 5504AA 234/607 2606/1275 
 
0B 
 
3 781AA NP 491/155 728AA 114T/pp 482/195 1464AA 188T/pp 864/358 
6 2052AA NP 551/286 2244AA 119/222 999/329 2183AA 106/208 1014/455 
9 nt nt nt nt nt nt nt nt nt 
12 176AA np 141A/pp 103AA np 119A/pp 121AA np np 
15 114AA np np 114AA np np 128AA np np 
18 nt nt nt nt nt nt nt nt nt 
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a
 number of alleles observed in each period. 
 
A3. Indicated below are SGM plus
®
 DNA RFUs obtained from artificially degraded DNA from saliva samples (humidity/temperature). The 
percentage results were based on the number of loci successfully typed (excluding amelogenin). [0A] and [0B] represent reference samples and 
numbers 3 to 18 are the durations of incubations. [np] indicates no profile, [pp] partial profile and nt; sample was not tested because the template was 
estimated to be 0.00 ng/ µl.  
 
 
 
 
 
Sample 
(days) 
SGM plus
®
 loci   
Successful
 
Results of 
SGM plus 
a 
 
  D3S1358            vWA          D16S539           D2S1338        D8S1179            D21S11        D18S51         D19S433           THO1             FGA 
Ind 1            
0A 
 
2826/2087 2273/23399 1726/1961 1595/1416 2459/1753 1804/1957 1108/1062 1530/1213 1226/1161 804/762 
 
100 
3 880/569 631/713 549/414 338/302 1068/706 419/348 135/145 447/504 388/271 122/132 100 
6 np 110/pp np np np np np np np np 5 
9 np np np np np np np np np np 0 
12 np np np np np np np np np np 0 
15 np np np np np np np np np np 0 
18 
 
np np np np np np np np np np 0 
Ind 2            
0B 2888/2747 2507/2445 1883/1498 2504 1887/1797 2142/1982 1690/1231 1793/1544 2612 1164/911 100 
 
3 
 
np 
 
181/pp 
 
np 
 
109 
 
255/186 
 
np 
 
np 
 
147/136 
 
107 
 
np 
 
55 
6 np 208/pp 121/pp 117 254/145 np np 115/pp np np 40 
9 nt nt nt nt nt nt nt nt nt nt 0 
12 np np np np np np np np np np 0 
15 np np np np np np np np np np 0 
18 
 
nt nt nt nt nt nt nt nt nt nt 0 
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A4 A. Showing below are SNP RFUs obtained from artificially degraded DNA from semen samples under 100% humidity and 37 °C for individual 1. 
[0A] represents the reference sample and 3 to 18 are the durations of incubation.  
 
 Triplex 1 
 
 
Repeat 1 
 
  
Repeat 2 
 
  
Repeat 3 
 
SNP type/ amplicon 
size 
 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
AG/ 90 
4-4 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
 
CT /142 
13-4 
 
In house code 
3189AA 
 
1165/1396 
 
702 TT 
 
4667AA 
 
1607/1636 
 
822 TT 
 
4726AA 
 
826/1305 
 
699 TT 
 
 
0A 
 
3 5583AA 1541/2439 850 TT 4496AA 1046/1536 906 TT 6216AA 2046/2596 1169 TT 
6 1481AA 1343/2449 637 TT 1559AA 1904/1659 666 TT 2270AA 2036/2886 754 TT 
9 904 AA 1029/1422 476 TT 904 AA 1149/1182 489 TT 1285AA 1487/1625 671 TT 
12 2344AA 1386/2210 758 TT 2877AA 1482/1929 932 TT 3301AA 2055/3203 1120 TT 
15 2758AA 1462/1976 919 TT 2479AA 1700/1811 755 TT 2553AA 1589/2162 791 TT 
18 
 
2099AA 
 
1573/2634 
 
821 TT 
 
2175AA 
 
1686/2539 
 
913 TT 
 
1941AA 
 
2023/1952 
 
885 TT 
 
 
Triplex 2 
 
 
 
AG/ 92  
   21     
   
CT/ 119                                              
18-3 
 
AC/ 147
17-3 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
AC /147 
17-3 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
 
AC/ 147 
17-3 
 
In house code 
3304AA 
 
157/392 
 
1405/515 
 
3603AA 
 
197/497 
 
1779/748 
 
2950AA 
 
170/489 
 
1469/671 
 
 
0A 
 
3 1592AA 137/333 982/421 3524AA 234/624 1460/662 3246AA 228/507 1579/689 
6 2445AA 134/422 1871/575 1931AA 137/324 1912/745 2376AA 109/455 2009/708 
9 2748AA 108/388 2297/935 2330AA 156/285 198/684 2079AA 136/287 1968/695 
12 3927AA 189/555 2210/884 2996AA 165/476 2131/653 1870AA 128/307 1250/606 
15 2975AA 148/343 1851/755 1792AA 122/443 1457/627 3258AA 156/424 1996/837 
18 
 
3146AA 
 
149/367 
 
2302/1133 
 
2400AA 
 
168/380 
 
2260/1075 
 
2648AA 
 
186/389 
 
2682/723 
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A4B. Showing below are SNP RFUs obtained from artificially degraded DNA from semen under 100% humidity and 37 °C for individual 2. [0B] 
represents the reference sample and 3 to 18 are the durations of incubation. na; indicates sample not available. 
 
 Triplex 1 
 
 
Repeat 1 
 
  
Repeat 2 
 
  
Repeat 3 
 
SNP type/ amplicon 
size 
 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
AG/ 90 
4-4 
 
AG/110 
19-2 
 
CT/ 142 
13-4 
 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
 
CT/142 
13-4 
 
In house code 
2208/546 2430AA 806 TT 2790/5397 2552AA 906 TT 1956/4284 2218AA 409 TT 
 
0B  
 
3 703/1843 1244AA 256 TT 908/1896 946 AA 293 TT 901/2957 1794 AA 585 TT 
6 1346/2807 1722AA 490 TT 2161/4114 2577AA 712 TT 1563/3074 2289AA 507 TT 
9 1385/2787 1698AA 663 TT 1542/3210 1858AA 534 TT 1689/2615 1737 AA 614 TT 
12 na na na na na na na na na 
15 1622/3888 2246AA 713 TT 2023/4427 2963AA 758 TT 1660/3431 2271 AA 625 TT 
18 
 
1803/2635 
 
2378AA 
 
735 TT 
 
1756/5241 
 
2831AA 
 
957 TT 
 
1648/3194 
 
2716AA 
 
775 TT 
 
Triplex 2  
       
 
 
AG/ 92 
21 
 
       
  CT/ 119 
18-3 
 
AC/ 147 
17-3 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
AC/147 
17-3 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
 
AC/ 147 
21 
 
In house code 
3727AA 250/640 2012/1107 4207AA 623/515 2345/823 3653AA 241/570 1762/1030 
 
0B 
 
3 1980AA 120/267 789/240 1853AA 121/291 1131/408 2126AA 122/190 1183/479 
6 2187AA 146/288 1268/384 2447 AA 133/358 147/509 2610 AA 205/304 1668/600 
9 2691 AA 186/428 1272/367 2154 AA 168/314 1283/553 2738 AA 176/523 1117/787 
12 na na na na na na na na na 
15 4010 AA 196/504 2140/996 3753 AA 194/396 2042/817 2906 AA 157/491 1578/711 
18 
 
3812 AA 
 
205/487 
 
2506/1049 
 
3142 AA 
 
196/425 
 
2074/837 
 
2238 AA 
 
153/357 
 
1241/770 
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a
 number of alleles observed in each period. 
A4C. Indicated below SGM plus
®
 DNA RFUs obtained from artificially degraded DNA from semen samples (humidity/temperature).  The percentage 
results were based on the number of loci successfully typed (excluding amelogenin). [0A] and [0B] represent reference samples and numbers 3 to 18 
are the durations of incubations. na; indicates sample was not available. 
 
 
 
 
Sample 
(days) 
SGM plus
®
 loci   
Successful
a 
Results of SGM 
plus
® 
 
D3S1358          vWA           D16S539       D2S1338     D8S1179       D21S11         D18S51          D19S433       THO1      FGA 
Ind 1            
0A 1216/1974 752/1092 862/832 1355 1583/1004 971/1117 842/1179 861/809 1339 956/510 100 
 
3 
 
2823/2871 
 
2727/1877 
 
1978/2059 
 
2702 
 
3468/3006 
 
2727/2249 
 
1622/1607 
 
1452/1495 
 
2101 
 
1381/1383 
 
100 
6 1187/1529 1297/834 914/894 1543 868/648 510/497 524/370 817/831 1197 289/314 100 
9 869/1273 832/689 627/613 811 600/660 149/190 305/306 341/440 770 220/151 100 
12 2072/2738 1884/1566 1727/1297 1857 1621/1421 1289/1141 1324/1176 970/1122 1836 994/783 100 
15 1209/1542 1019/531 783/592 1135 1063/693 241/604 739/561 443/420 1082 376/401 100 
18 1130/1563 1196/1006 681/763 864 701/870 387/384 405/368 652/510 1273 295/345 100 
Ind 2            
0B 1707/2426 3101 1017/1145 1077/728 2302 1588/1390 1087/930 712/774 863/564 633/744 100 
 
3 
 
419/996 
 
59 
 
277/337 
 
310/221 
 
576 
 
454/346 
 
477/343 
 
175/214 
 
484/268 
 
240/215 
 
100 
6 747/1380 1383 510/768 369/256 1289 1012/420 437/478 334/375 509/364 191/291 100 
9 684/1004 1045 610/509 321/192 988 308/344 390/352 365/356 516/381 161/236 100 
12 na na na na na na na na na na na 
15 857/1005 1334 508/604 386/324 1117 513/400 521/465 399/389 538/477 457/298 100 
18 983/1139 1958 693/600 291/312 1438 671/350 515/567 575/512 670/416 244/346 100 
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A5A. Showing below are SNP RFUs obtained from artificially degraded DNA from saliva samples under room temperature (22 °C), the results are for 
individual 1. 
 
  
Triplex 1 
 
 
Repeat 1 
 
  
Repeat 2 
 
  
Repeat 3 
 
SNP type/ amplicon size 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
C/ 142 
13-4 
 
AG/ 90 
4-4 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
 
CT/ 142 
13-4 
 
In house code 
1115/2137 1220/1332 511 TT 1217/2203 1157/938 464 TT 2957/7164 1660/2708 1404 TT 
 
0A  
 
3 1431/4091 921/1003 1026 TT 2050/3780 1172/1062 918 TT 1486/2783 702/1026 920 TT 
6 1993/2858 1069/735 959 TT 1491/2372 886/841 938 TT 2327/3097 992/888 1287 TT 
9 2538/3609 1409/1258 1182 TT 1713/3905 766/941 1266 TT 2179/4102 999/289 1442 TT 
12 2046/5609 1051/1294 1379 TT 1691/3369 791/999 1034 TT 2089/5277 1382/1461 1707 TT 
15 2002/3642 910/847 1155 TT 1239/4080 796/661 844 TT 1539/2743 642/943 816 TT 
18 
 
2047/3495 
 
685/808 
 
779 TT 
 
1554/3087 
 
622/626 
 
793 TT 
 
1404/3024 
 
678/722 
 
912 TT 
 
Triplex 2 
 
 
AG/ 92 
21 
 
 
CT/ 119 
18-3 
 
AC/ 147 
17-3 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
AC/147 
17-3 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
 
AC/ 147 
21 
 
In house code  
4182 AA 219/619 4791AA 5845 AA 287/723 5244 AA 5613 AA 295/755 5204 AA 
 
0A 
 
3 3261AA 148/352 2995AA 2721 AA 122/401 3011 AA 2792 AA 112/367 2551 AA 
6 1455AA 105/250  1741AA 2612 AA 122/340 2522 AA 2591 AA 100/252  2059 AA 
9 2865AA 139/233 2163AA 3012 AA 141/296 2555 AA 3091 AA 121/277 2697 AA 
12 3573AA 151/411 3595AA 3552 AA 191/386 3198 AA 2776 AA 139/343 2655 AA 
15 2368AA 115/276 2064AA 2634 AA 148/324 2390 AA 2447 AA 113/259 1978 AA 
18 
 
1723AA 
 
102/286 
 
2238AA 
 
2204AA 
 
105/256 
 
2593 AA 
 
2493 AA 
 
288 T/PP 
 
2221 AA 
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A5B. Showing below are SNP RFUS obtained from artificially degraded DNA from saliva samples under room temperature ( 22 °C),  the results are 
for individual 2 
 
 Triplex 1 
 
 
Repeat 1 
 
  
Repeat 2 
 
  
Repeat 3 
 
SNP type/ amplicon 
size   
 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
AG/ 90 
4-4 
 
AG/ 110 
19-2 
 
CT/ 142 
13-4 
 
 
AG/ 90 
4-4 
 
 
AG/ 110 
19-2 
 
 
CT/ 142 
13-4 
 
In house code 
6281AA 1687/2074 2166TT 6209AA 1770/3241 2244 TT 5732AA 1686/2555 2242TT 
 
0B  
 
3 2459AA 1012/1379 1189TT 3081AA 1007/1145 1146TT 3819AA 1241/1474 1325TT 
6 5878AA 2281/3987 2728TT 5874AA 2320/2795 2383TT 5896AA 2391/3153 2172TT 
9 3884AA 1190/1545 1510TT 3983AA 1346/1564 1500TT 4461AA 1354/1684 1506TT 
12 1976AA 653/648 677 TT 2147AA 732/743 832 TT 2898AA 817/705 887TT 
15 4251AA 1001/1533 1329TT 4105AA 922/1463 1316TT 2385AA 641/834 781TT 
18 
 
5941AA 
 
1403/2292 
 
1581TT 
 
5083AA 
 
1444/1777 
 
1619TT 
 
4514AA 
 
1386/1538 
 
1537TT 
 
Triplex 2 
 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
AC/ 147 
17-3 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
AC/ 147 
17-3 
 
AG/ 92 
21 
 
CT/ 119 
18-3 
 
 
AC/ 147 
21 
 
In house code 
5747AA 244/570 2520/1298 5709AA 245/624 3050/1198 5504AA 234/607 2606/1275 
 
0B 
 
3 3245AA 122/326 1455/588 3041AA 132/341 1121/694 2709AA 168/257 1639/578 
6 5663AA 226/633 2671/1188 6088AA 234/608 2760/1471 5927AA 204/602 2549/1397 
9 3134AA 137/293 1259/530 3999AA 158/402 1317/633 2533AA 125/349 1356/715 
12 2363AA 114/284 1157/530 2300AA 138/263 1070/589 2434AA 101/350 1227/455 
15 4539AA 186/428 1719/1087 5023AA 198/409 2026/753 4836AA 134/481 2241/777 
18 
 
5030AA 
 
195/533 
 
2542/101 
 
5126AA 
 
225/594 
 
2545/1196 
 
4373AA 
 
184/445 
 
1192/510 
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a
 number of alleles observed in each period 
 
A5C. Indicating below are SGM plus
®
 DNA profiles obtained from artificially degraded DNA from saliva samples (room 
temperature).  The percentage results were based on a number of loci types successfully except for amelogenin.0A and 0B 
represent reference samples and numbers 3 to 18 are the durations of incubations.  
 
 
 
 
Sample 
(days) 
SGM plus
®
 loci   
Successful
 
Results of 
SGM plus
® 
 
 D3S1358         vWA          D16S539        D2S1338       D8S1179      D21S11        D18S51         D19S433       THO1        FGA 
Ind 1            
0A 2826/2087 2273/23399 1726/1961 1595/1416 2459/1753 1804/1957 1108/1062 1530/1213 1226/1161 804/762 100 
 
3 
 
918/1207 
 
768/666 
 
730/932 
 
564/377 
 
856/862 
 
813/661 
 
506/719 
 
428/346 
 
488/535 
 
501/469 
 
100 
6 1106/632 794/833 596/741 630/521 1034/568 822/754 507/614 447/447 492/473 404/448 100 
9 1002/790 998/852 706/525 456/237 638/679 503/645 511/596 356/481 537/394 437/395 100 
12 1276/987 772/996 890/503 651/558 863/693 780/904 539/704 456/408 479/272 380/438 100 
15 947/813 530/835 655/599 545/358 917/700 745/567 402/323 512/427 141/333 354/313 100 
18 
 
794/579 494/508 536/361 565/307 849/452 690/653 314/389 290/255 316/238 295/153 100 
Ind 2            
0B 2888/2747 2507/2445 1883/1498 2504 1887/1797 2142/1982 1690/1231 1793/1544 2612 1164/911 100 
 
3 
 
1409/1365 
 
1009/992 
 
1093/836 
 
1090 
 
822/848 
 
868/1026 
 
926/761 
 
545/629 
 
1076 
 
513/295 
 
100 
6 2165/2871 2519/2201 2119/1455 2544 2090/1721 2008/1196 1517/1402 1413/1271 2507 1014/957 100 
9 1042/1181 1075/1023 930/725 909 693/670 677/876 682/622 682/449 1056 562/455 100 
12 687/606 547/426 608/414 682 376/421 427/357 452/584 387/310 662 242/247 100 
15 1593/1481 1460/1141 880/793 1365 1139/1149 1025/1137 891/945 624/754 1239 633/606 100 
18 
 
1487/1738 1800/1586 1476/1222 1564 1721/1607 1910/1272 1082/1402 1000/845 1680 819/637 100 
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a
 number of alleles observed in each period 
A6. Showing below are SNP RFUs obtained from artificially degraded DNA from saliva samples under UAE natural conditions for December 
2007/January 2008. 0A; represents reference sample and numbers 3 to 12 are the durations of incubation. [np] indicates no profile, [pp] indicates 
partial profile. 
 
Triplex 1 
 
 
Repeat 1 
 
 
Repeat 2 
 
 
Repeat 3 
 
SNP type/ 
amplicon size 
 
 
AG 90 
4-4 
 
AG 110 
19-2 
 
CT 147 
13-4 
 
AG 90 
4-4 
 
AG 110 
19-2 
 
CT 114 
13-4 
 
AG 90 
4-4 
 
AG 110 
119-2 
 
CT 147 
13-4 
 
In house code 
2638/7491 3005/4446 3007TT 2159/6762 2144/3034 2189 TT 1918/5349 2814/4043 2790 TT 
 
0A 
 
3 955/2221 794/482 311TT 656/1608 530/314 301TT 511/2122 516/301 299 TT 
6 2254/7556 3081/3194 1509 TT 298/1051 409/296 213 TT 516/1313 489/311 229 TT 
12 
 
801/1382 
 
1644/580 
 
467 TT 
 
319/868 
 
244/164 
 
Np 
 
353/573 
 
263/146 
 
131 TT 
 
  
Triplex 2 
          
 
AG 92 
21  
 
CT 119                                        
18-3 
 
AC 147 
17-3 
 
AG 92 
21 
 
CT 119 
18-3 
 
AC 147 
17-3 
 
AG 92 
21 
 
CT 119 
18-3 
 
 
AC 147 
17-3 
 
In house code 
7605 AA 498/1935 7458 AA 7287 AA 456/1781 3218 AA 2831 AA 249/377 5503 AA 
 
0A 
 
3 3173 AA 101/293 2108 AA 2580 AA 250 T/PP 1738 AA 2108 AA 104/194 1424 AA 
6 3655 AA 262/726 2473 AA 2708 AA 104/194 1424 AA 1146 AA 157T/pp 1103 AA 
12 
 
2519 AA 
 
265/403 
 
1802 AA 
 
2519 AA 
 
265/403 
 
1802 AA 
 
1425 AA 
 
151 T/pp 
 
931 AA 
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A7. Indicated below is SGM plus
®
 DNA RFUs obtained from artificially degraded DNA from saliva samples under UAE natural conditions for 
December 2007/January 2008. [0A] represents reference sample and numbers 3 to 12 are the durations of incubation. [np] indicates no profile 
observed, [pp] partial profile.    
 
 
 
 
Sample 
(days) 
SGM plus
®
 loci   
Successful
 
Results of SGM 
plus
® 
 
D3S1358 
 
vWA 
 
D16S539 
 
 
D2S1338 
 
D8S1179 
 
D21S11     D18S51 
 
D19S433 
 
THO1 
 
FGA 
 
0A 
 
 
981/1207 
 
768/668 
 
730/932 
 
564/377 
 
856/862 
 
813/661 
 
506/719 
 
428/346 
 
488/535 
 
501/549 
 
100 
3  
 
330/331 281/246 254/159 124/118 465/441 255/216 104/PP 436/387 179/142 np 85 
6  
 
355/320 243/173 139/pp np 356/247 102/119 np 231/253 137/pp np 60 
12  np np np np np np np np np np 0 
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                    a
 number of alleles observed in each period 
 
A8. Showing below are SNP RFUs obtained from artificially degraded DNA from saliva samples under UAE natural conditions for September 2008. 
[0A] represents reference sample and numbers 3 to 18 are the durations of incubation. [np] indicates no profile observed, [pp] indicates partial profile.  
 
Triplex 1 
 
Repeat 1 
 
Repeat 2 
 
Repeat 3 
 
SNP type/ amplicon 
size 
 
 
AG 90 
4-4 
 
AG 110 
19-2 
 
CT 147 
13-4 
 
AG 90 
4-4 
 
AG 110 
19-2 
 
CT 114 
13-4 
 
AG 90 
4-4 
 
AG 110 
119-2 
 
CT 147 
13-4 
 
In house code 
2010/5213 1480/893 1144 TT 2128/5274 1585/938 1422 TT 2430/6055 1845/1105 1590TT 
 
0A 
 
3 1754/3272 697/554 552 TT 1878/3257 742/557 687 TT 1524/2768 631/489 508 TT 
6 1191/2684 824/675 382 TT 1296/2795 924/717 438 TT 1044/2214 777/601 363 TT 
12 np np np np np np np np np 
18 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
 
Triplex 2 
 
          
AG 92  
21      
 
  CT 119                                  
18-3 
 
AC 147 
17-3 
 
AG 92 
21 
 
CT 119 
18-3 
 
AC 147 
17-3 
 
AG 92 
21 
 
CT 119 
18-3 
 
 
AC 147 
17-3 
 
In house code 
2673 AA 148/296 2656 AA 3159 AA 179/349 3159 AA 3424 AA 189/381 3286 AA 
 
0A 
 
3 1747 AA 238T/pp  1045 AA 1777 AA 187/106 1252 AA 2242 AA 215/102 1851 AA 
6 1997 AA 104/145 761 AA 1898 AA 170 T/pp 830 AA 1705 AA 179 T/pp 1018 AA 
12 np np np np np np np np np 
18 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
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A9. Indicated below is SGM plus
®
 DNA RFUs obtained from artificially degraded DNA from saliva samples under UAE 
natural conditions for September 2008. [A]. represents reference sample and numbers 3 to 18 are the durations of 
incubation. [np] indicates no profile observed, [ pp] indicates partial profile.    
 
 
 
 
Sample 
(days) 
SGM plus
®
 loci   
Successful
a 
Results of 
SGM plus
® 
 
D3S1358 
 
vWA 
 
D16S539 
 
D2S1338 
 
D8S1179 
 
D21S11 
 
D18S51 
 
D19S433 
 
THO1 
 
FGA 
 
0A 
 
1272/1553 
1306/1203 905/788 871/622 1270/1075 776/88 1131/647 1007/765 549/458 688/402 100 
3 618/532 318/202 221/172 NP 445/418 199/165 NP 341/236 156/128 NP 14 
6 244/PP 110/PP NP NP 190/PP NP NP 169/176 139/PP NP 6 
12 NP NP NP NP NP NP NP NP NP NP 0 
18 NP NP NP NP NP NP NP NP NP NP 0 
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A10. Showing below are SNP RFUs obtained from artificially degraded DNA from saliva samples under UK natural conditions for August 2008. 
[0A] represents reference sample and numbers 3 to 18 are the durations of incubation. [np] indicates no profile observed, [pp] indicates partial profile.    
 
 Triplex 1 
 
Repeat 1 
 
           Repeat 2 
 
                 Repeat 3 
 
 
SNP type/ 
amplicon size 
 
 
AG 90 
4-4 
 
 
AG110 
19-2 
 
CT142 
13-4 
 
AG 90 
4-4 
 
AG110 
19-2 
 
CT142 
13-4 
 
 
AG 90 
4-4 
 
 
AG110 
19-2 
 
 
CT142 
13-4 
 
In house code 
1115/2137 1220/1332 511 TT 1217/2203 1157/938 464 TT 2957/7164 1660/2708 1404TT 
 
0A 
 
3 822/1591 420/426 479 TT 902/1929 521/533 526 TT 1778/3401 957/984 801TT 
6 2333/5777 1433/1304 1588TT 1322/4087 959/942 1026 TT 700/2785 758/832 672TT 
9 2856/5590 731/686 855TT 2609/6784 718/727 1052TT 2350/6399 917/554 1055TT 
12 1730/2293 403/331 690 TT 845/2107 229/204 226 TT 1904/3748 354/405 478 TT 
15 288/901 114A/pp 111 TT 208/819 112/177 186 TT 193/780 265/108 251 TT 
18 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
 
Triplex 2 
 
 
    AG92 
      21 
 
 
CT119 
18-3 
 
AC147 
17-3 
 
AG 92 
21 
 
CT119 
18-3 
 
AC147 
17-3 
 
AG 92 
21 
 
CT119 
18-3 
 
 
AC147 
21 
 
In house code 
4182 AA 219/619 4791 5845AA 287/723 5244AA 5613AA 295/755 5204AA 
 
0A 
 
3 4169 AA 151/428 3043AA 4755AA 230/298 2840AA 4733AA 158/381 3237AA 
6 4332AA 152/331 3060AA 5658AA 157/385 3051AA 5214AA 159/466 3072AA 
9 3716AA 246T/pp 1408AA 2992AA 102/223 1058AA 2969AA 165T/pp 1429AA 
12 3111AA 138T/pp 465AA 2765AA 176T/pp 808AA 2320AA 122T/pp 648AA 
15 1209AA np 364AA 1929AA 115T/pp 431AA 1906AA 125T/pp 421AA 
18 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
 
np 
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A11. Indicated below is SGM plus
®
 DNA RFUs obtained from artificially degraded DNA from saliva samples under UK weather 
conditions UK for August 2008. [0A] represents reference sample and numbers 3 to 18 are the durations of incubation. [np] 
indicates no profile observed, [pp] indicates partial profile. 
 
 
 
 
Sample 
(days) 
SGM plus
®
 loci  
Successful
a 
Results of 
SGM plus
® 
 
D3S1358 
 
vWA 
 
D16S539 
 
D2S1338 
 
D8S1179 
 
D21S11 
 
D18S51 
 
D19S433 
 
THO1 
 
FGA 
0A 2826/2087 2273/23399 1726/1961 1595/1416 2459/1753 1804/1957 1108/1062 1530/1213 1226/1161 804/762 100 
 
3 
 
615/825 
 
802/743 
 
612/501 
 
428/202 
 
904/447 
 
491/336 
 
384/4116 
 
594/513 
 
359/275 
 
280/253 
 
100 
6 656/1052 533/401 286/433 255/214 725/683 315/358 341/225 589/404 238/155 182/140 100 
9 345/221 175/PP np np 209/pp np np 400/292 np np 35 
12 144/pp np np np 159/pp np np 120/pp np np 15 
15 np np np np 122/pp np np np np np 5 
18 np np np np np np np np np np 0 
 
        
     
a
 number of alleles observed in each period 
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APPENDIX B 
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A. Courses Attended 
 
 
1- Reference Manager Introduction 
2- Technical Writing 
3- Communication and Presentation skills workshop 
4- Microsoft Excel 
 Teambuilding, Networking and Leadership Skills 
 Research Skills Workshop 
 Word for Researchers 
 A guide to the Examination Process: Writing and Oral 
 NVivo for Research Students 
 Research Skills Conflict Management 
 Career Skills Workshop 
 Adobe Photoshop Element 
 SPSS1 and SPSS2 
 PowerPoint for Researchers 
 www. for Researchers 
 Central Postgraduate Research Student Induction Day 
 
B. Conference Proceedings 
 Annual Faculty Research Day, June 2006- Poster presentation 
 Annual Research Conference, June 2007- Poster Presentation 
 2nd National Forrest Conference 2006 – Poster Presentation 
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National Conferences 
 The Forensic Science Society and Centre for Forensic Investigative,  
 University of Teesside, September 2006 - Poster Presentation 
 Lancaster University April, 2008 
 University of Sheffield, July 2009 
International Conferences 
 ESWG 2006 Conference in Tuusula, Finland 
 ISFG Congress 2007 in Copenhagen, Denmark- Poster presentation 
 Applied Biosystems Seminar ,  May 2008 in Dubai 
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S.H. Sanqoor, S. Hadi, W. Gooodwin (2008) the study of single nucleotide 
polymorphisms (SNP) in Arab population – A tool for the analysis of degraded DNA. 
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